archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,3.9926e-07,1.6202,1.3957,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.1192e-05,1.5121,1.2888,1,1
1,GO MEMBRANE RAFT ASSEMBLY,7.0571e-06,1.4257,1.5231,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,2.5122e-07,1.3066,1.1603,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,2.8891e-07,1.2317,1.0926,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00014418,1.1881,0.98381,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.9904e-06,1.1139,0.97689,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2366e-07,1.1054,0.98596,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.3202e-07,1.0843,1.0301,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.0006154,1.0756,0.94856,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.6452e-07,1.0692,1.0508,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.5816e-05,1.0649,0.96077,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2985e-07,1.054,0.91261,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.4963e-07,1.0301,0.86747,1,1
1,GO NEUTROPHIL HOMEOSTASIS,1.104e-05,1.0288,0.9251,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.4674e-06,1.0272,0.98847,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,9.389e-05,1.0145,0.87651,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,8.628e-07,1.0115,0.97766,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.8077e-06,1.0105,1.0672,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,8.3127e-06,0.98795,0.79839,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,7.889e-07,0.9695,0.92395,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00032948,0.96203,0.73375,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.0689e-05,0.9304,0.86227,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.6452e-07,0.92007,0.89428,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00024286,0.90973,0.72951,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,6.2367e-06,0.90936,0.86293,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.0779e-06,0.892,0.7645,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,1.2454e-05,0.89181,0.75609,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,0.0001547,0.8802,0.69752,1,1
1,GO MEMBRANE RAFT ORGANIZATION,9.7801e-06,0.87229,0.93217,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.6902e-06,0.86993,0.78746,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,2.9301e-06,0.86597,0.86339,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.5813e-07,0.86061,0.75652,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.0264e-07,0.85499,0.84946,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,3.1904e-06,0.8452,0.71879,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.2862e-06,0.83091,0.78294,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.5331e-06,0.82817,0.92754,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4268e-07,0.82762,0.79249,1,1
1,GO CD40 SIGNALING PATHWAY,1.2971e-07,0.82693,0.77599,1,1
1,GO RESPONSE TO INTERFERON BETA,4.8612e-06,0.81918,0.92985,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.9301e-06,0.81777,0.75362,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,2.6307e-05,0.81615,0.76824,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.5201e-05,0.81582,0.93524,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00059588,0.81242,0.6316,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.2962e-05,0.80747,0.81432,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.0194e-07,0.80446,0.67474,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.8521e-05,0.80373,0.91387,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,8.628e-07,0.80137,0.69417,1,1
1,GO ZYMOGEN INHIBITION,1.1237e-07,0.79652,0.84926,1,1
1,GO BONE TRABECULA FORMATION,0.0019282,0.78694,0.66313,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00057693,0.78408,0.67395,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.5427e-07,0.78406,0.6651,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.8628e-07,0.78229,0.68947,1,1
1,GO PLASMINOGEN ACTIVATION,0.00019753,0.77909,0.59725,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.1663e-05,0.77097,0.63158,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.3441e-06,0.77051,0.67479,1,1
1,GO DNA DEAMINATION,8.3127e-06,0.7672,0.6408,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,4.1617e-05,0.76685,0.62662,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.7145e-05,0.76678,0.68003,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00013433,0.76551,0.6038,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.6902e-06,0.76101,0.71497,1,1
1,GO ENDODERM FORMATION,7.6603e-06,0.76072,0.73679,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,1.0184e-05,0.75393,0.60341,1,1
1,GO HIPPO SIGNALING,5.0683e-06,0.75227,0.62253,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9904e-06,0.75166,0.72184,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.1776e-06,0.74902,0.82201,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.753e-07,0.74649,0.72725,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00019753,0.74461,0.67881,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,2.6307e-05,0.74383,0.65473,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,3.3287e-06,0.73881,0.64306,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.6623e-06,0.73765,0.78822,1,1
1,GO LATERAL MESODERM DEVELOPMENT,1.4044e-06,0.73685,0.64083,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.4039e-05,0.7297,0.64031,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.0829e-07,0.72952,0.64771,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,3.5759e-05,0.72759,0.6672,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00018427,0.72155,0.5304,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,4.3763e-07,0.72044,0.71725,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,1.7118e-05,0.71488,0.59951,1,1
1,GO EPIBOLY,4.6623e-06,0.71392,0.71857,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.71003,0.6839,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,3.6228e-06,0.7086,0.59955,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00072223,0.70781,0.53161,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.0604e-05,0.70407,0.77364,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,2.3654e-06,0.70342,0.66809,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.1802e-07,0.69716,0.66467,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.6902e-06,0.69595,0.67264,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,9.7801e-06,0.6933,0.62966,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,7.5427e-07,0.69195,0.64889,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.0829e-07,0.69042,0.61433,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.00013917,0.67972,0.67995,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,7.0571e-06,0.67857,0.80367,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,3.0576e-06,0.67808,0.59429,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00074557,0.67234,0.57467,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00016595,0.67201,0.6678,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,9.7346e-05,0.66933,0.62464,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,9.4334e-07,0.66879,0.67233,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.3916e-06,0.66835,0.61904,1,1
1,GO MUCUS SECRETION,0.00084609,0.66378,0.57868,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0037331,0.66078,0.57346,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.6623e-06,0.66014,0.50538,1,1
1,GO T CELL EXTRAVASATION,0.00036427,0.65824,0.56867,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,9.389e-05,0.65756,0.56895,1,1
1,GO REGULATION OF PINOCYTOSIS,5.2837e-06,0.65699,0.6613,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.65376,0.62603,1,1
1,GO FIBRINOLYSIS,5.8301e-05,0.65363,0.73087,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,5.9841e-06,0.65247,0.67222,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,7.3528e-06,0.65032,0.67375,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.5201e-05,0.64834,0.68777,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.5122e-07,0.6482,0.73208,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,5.4121e-05,0.6478,0.55941,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00010092,0.64701,0.51738,1,1
1,GO GAP JUNCTION ASSEMBLY,1.7118e-05,0.64462,0.58393,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.00013917,0.6445,0.51222,1,1
1,GO PIGMENT GRANULE MATURATION,6.2367e-06,0.64112,0.52246,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,3.3132e-05,0.63898,0.53633,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.8084e-07,0.62907,0.60635,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,2.4692e-06,0.62853,0.60796,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,9.7801e-06,0.62743,0.50568,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.8521e-05,0.62346,0.52649,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.1702e-06,0.62295,0.58252,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.725e-07,0.62179,0.65187,1,1
1,GO ENDODERM DEVELOPMENT,6.2367e-06,0.61775,0.59546,1,1
1,GO ZYMOGEN ACTIVATION,6.7596e-05,0.6166,0.51418,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0045306,0.61651,0.66628,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001165,0.61622,0.5013,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,4.2876e-06,0.61406,0.59821,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,4.6623e-06,0.61323,0.51995,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.010245,0.61236,0.39839,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.7578e-07,0.61085,0.57039,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,2.6307e-05,0.60928,0.56943,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0026572,0.60891,0.63123,1,1
1,GO LEUKOCYTE AGGREGATION,0.00081984,0.6074,0.5151,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,5.2139e-05,0.60729,0.43299,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,1.7806e-05,0.60628,0.65626,1,1
1,GO BIOLOGICAL PHASE,0.00028792,0.60413,0.59094,1,1
1,GO VASCULOGENESIS,3.4772e-07,0.60346,0.59267,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,2.5774e-06,0.60224,0.64401,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.9418e-06,0.60153,0.55727,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.6584e-06,0.59994,0.66284,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,3.3132e-05,0.59955,0.60472,1,1
1,GO APOPTOTIC CELL CLEARANCE,3.9418e-06,0.59943,0.64989,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,4.3218e-05,0.59921,0.49325,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.1776e-06,0.59784,0.73496,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0030654,0.59725,0.39995,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.8612e-06,0.59637,0.59926,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,8.7323e-05,0.59606,0.44058,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,6.2367e-06,0.5958,0.4279,1,1
1,GO CYTOLYSIS,1.8521e-05,0.59555,0.47077,1,1
1,GO LIVER REGENERATION,3.0576e-06,0.59534,0.5415,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,1.2454e-05,0.59458,0.5184,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.5201e-05,0.58733,0.54034,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,0.00024286,0.58625,0.48282,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,4.1112e-06,0.58625,0.51379,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00063551,0.58608,0.45339,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.58529,0.6175,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.58453,0.52447,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.0784e-06,0.58278,0.55753,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.0198e-07,0.58243,0.56266,1,1
1,GO INTERLEUKIN 1 PRODUCTION,3.0689e-05,0.58224,0.46676,1,1
1,GO NOTOCHORD DEVELOPMENT,5.2837e-06,0.58159,0.63858,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6902e-06,0.5807,0.51067,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,5.8301e-05,0.57926,0.56169,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,6.8936e-07,0.57919,0.5867,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,5.9841e-06,0.57865,0.60491,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,9.7346e-05,0.57818,0.64059,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,6.7596e-05,0.57809,0.55326,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,6.0504e-05,0.57539,0.61964,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.4044e-06,0.57534,0.47189,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,0.00016023,0.57413,0.54662,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57348,0.62689,1,1
1,GO ENTRY INTO HOST,1.0311e-06,0.57198,0.56994,1,1
1,GO HEME METABOLIC PROCESS,1.4044e-06,0.57183,0.52812,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.4346e-05,0.57123,0.58818,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.00023468,0.57033,0.49294,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00081984,0.56741,0.58885,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,8.4205e-05,0.56622,0.51697,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.4421e-05,0.56455,0.57084,1,1
1,GO AMYLOID BETA CLEARANCE,3.1888e-05,0.56355,0.44185,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.0184e-05,0.5619,0.6594,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,5.2837e-06,0.5601,0.54034,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,3.9418e-06,0.55959,0.50427,1,1
1,GO TOLERANCE INDUCTION,0.00049035,0.55878,0.45802,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00026903,0.55702,0.48826,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.104e-05,0.55695,0.52321,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,0.00018427,0.55531,0.43429,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.6307e-05,0.55454,0.49991,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.5201e-05,0.55442,0.52659,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00022676,0.55338,0.52242,1,1
1,GO CELLULAR RESPONSE TO DSRNA,5.9841e-06,0.55324,0.53323,1,1
1,GO TYPE 2 IMMUNE RESPONSE,7.0571e-06,0.5506,0.556,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,7.547e-05,0.55056,0.42506,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.2786e-05,0.55054,0.45064,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00072223,0.55036,0.50734,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,7.6603e-06,0.54924,0.50633,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.4334e-07,0.54697,0.49811,1,1
1,GO RESPONSE TO X RAY,1.725e-07,0.54625,0.58124,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.2658e-06,0.54577,0.46327,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,3.1888e-05,0.54548,0.40941,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.547e-05,0.54509,0.52131,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.1831e-07,0.54479,0.63326,1,1
1,GO SALIVARY GLAND DEVELOPMENT,0.00023468,0.54391,0.50192,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00018427,0.54357,0.55042,1,1
1,GO REGULATION OF FIBRINOLYSIS,0.00038934,0.54138,0.54167,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.9841e-06,0.54087,0.50546,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00065623,0.54042,0.47741,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,2.6902e-06,0.5403,0.48195,1,1
1,GO VIRAL GENOME REPLICATION,3.9418e-06,0.53958,0.45233,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.0184e-05,0.53905,0.42778,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00014418,0.53707,0.45003,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,6.5149e-05,0.53538,0.49976,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,7.2111e-07,0.53503,0.58393,1,1
1,GO CELLULAR RESPONSE TO IRON ION,0.00012074,0.53361,0.49443,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.5813e-07,0.53268,0.52649,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.7145e-05,0.53245,0.3957,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.3418e-05,0.53243,0.5421,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.8282e-05,0.5317,0.41552,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00041602,0.53142,0.50595,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.4421e-05,0.53071,0.5597,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,7.9801e-06,0.52978,0.42911,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.9904e-06,0.52924,0.48881,1,1
1,GO RESPONSE TO TYPE I INTERFERON,9.7346e-05,0.52911,0.6007,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,5.4121e-05,0.5289,0.59621,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.0829e-07,0.52793,0.52745,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0184e-05,0.52768,0.52038,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.00034072,0.52752,0.40181,1,1
1,GO VAGINA DEVELOPMENT,2.7343e-05,0.5274,0.56462,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00063551,0.52599,0.35635,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.3287e-06,0.5233,0.5873,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.0829e-07,0.52267,0.49372,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.9301e-06,0.52137,0.47675,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,0.0049174,0.52061,0.36033,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.3287e-06,0.51992,0.44348,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.4421e-05,0.51977,0.44153,1,1
1,GO STORE OPERATED CALCIUM ENTRY,6.7596e-05,0.51969,0.38597,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.7343e-05,0.51904,0.51738,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00027832,0.51714,0.40966,1,1
1,GO RESPONSE TO ANGIOTENSIN,3.17e-07,0.51612,0.49888,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,0.00017186,0.51528,0.4657,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00010845,0.51455,0.4619,1,1
1,GO RECEPTOR CATABOLIC PROCESS,7.2111e-07,0.51135,0.46481,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.4674e-06,0.50967,0.42182,1,1
1,GO RESPONSE TO INTERFERON GAMMA,2.5308e-05,0.50958,0.48502,1,1
1,GO RESPONSE TO SALT STRESS,1.0184e-05,0.50893,0.38828,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.6729e-06,0.50763,0.468,1,1
1,GO T CELL MEDIATED IMMUNITY,8.6584e-06,0.50749,0.46159,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00074557,0.50574,0.45416,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.00023468,0.50552,0.48921,1,1
1,GO ELASTIC FIBER ASSEMBLY,0.0073363,0.50279,0.59679,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,7.547e-05,0.50077,0.49398,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010092,0.50071,0.43046,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.0221e-07,0.5007,0.62714,1,1
1,GO SKIN MORPHOGENESIS,0.00045924,0.49996,0.63011,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0021689,0.4997,0.38822,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,8.7323e-05,0.4983,0.45527,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.4692e-06,0.49818,0.42629,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.0779e-06,0.49805,0.45909,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0021062,0.49603,0.40009,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,2.3418e-05,0.49586,0.40976,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.031748,0.49399,0.30596,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.013e-05,0.49354,0.36526,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,4.4878e-05,0.49344,0.42107,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00079435,0.49327,0.42378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,4.3218e-05,0.49314,0.39942,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,7.0571e-06,0.49289,0.38754,1,1
1,GO MATURATION OF SSU RRNA,7.013e-05,0.4915,0.37101,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,2.1663e-05,0.48967,0.42667,1,1
1,GO RETINAL METABOLIC PROCESS,0.0053338,0.48923,0.35336,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.00014935,0.4887,0.42715,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,6.2985e-07,0.48604,0.54801,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00026003,0.48593,0.41418,1,1
1,GO PINOCYTOSIS,3.9926e-07,0.48579,0.61613,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00047456,0.48419,0.45417,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.0184e-05,0.48416,0.48318,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,5.0226e-05,0.48377,0.38988,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,9.389e-05,0.48321,0.66885,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.6597e-05,0.48284,0.35173,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.00059588,0.48233,0.34521,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.7118e-05,0.48168,0.55024,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,3.3132e-05,0.48084,0.42081,1,1
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.018836,0.48066,0.35725,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,1.8521e-05,0.48051,0.43902,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.007729,0.48008,0.2296,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.1802e-07,0.47881,0.41591,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0036303,0.47825,0.30549,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00081984,0.47813,0.4044,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.0018173,0.47791,0.42846,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.00027832,0.47718,0.41691,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00014935,0.47666,0.37023,1,1
1,GO NIK NF KAPPAB SIGNALING,1.6452e-07,0.47654,0.43898,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.0016129,0.47626,0.3752,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.508e-06,0.47622,0.4329,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,4.4712e-06,0.47553,0.41563,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.7323e-05,0.47511,0.43263,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.1663e-05,0.47505,0.37104,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.4712e-06,0.47487,0.47393,1,1
1,GO HAIR FOLLICLE MATURATION,0.0010206,0.4746,0.3475,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00047456,0.47433,0.39605,1,1
1,GO CYTOKINE METABOLIC PROCESS,4.1112e-06,0.47403,0.40011,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5201e-05,0.47395,0.35869,1,1
1,GO VIRAL RNA GENOME REPLICATION,7.5427e-07,0.47388,0.44772,1,1
1,GO REGULATION OF TRANSPOSITION,0.0001165,0.47325,0.47218,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.8077e-06,0.47275,0.49483,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00098941,0.4724,0.34228,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.00047456,0.4719,0.60275,1,1
1,GO BLOOD VESSEL REMODELING,0.00024286,0.47136,0.39561,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0011199,0.4707,0.44371,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.0221e-07,0.46997,0.43709,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.00032948,0.46959,0.53804,1,1
1,GO RESPONSE TO INTERLEUKIN 12,5.4977e-07,0.46955,0.43261,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00090094,0.46929,0.38858,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00030804,0.46889,0.34737,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.6307e-05,0.46886,0.42364,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00047456,0.46849,0.37585,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,3.4772e-07,0.46825,0.44514,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,7.889e-07,0.46814,0.49432,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,2.4692e-06,0.46744,0.48672,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,7.8282e-05,0.46682,0.40917,1,1
1,GO DEFENSE RESPONSE TO VIRUS,1.2962e-05,0.46678,0.42182,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,4.6597e-05,0.46674,0.42398,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.46666,0.49681,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.00035231,0.46661,0.37846,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.0689e-05,0.46654,0.40542,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.104e-05,0.4665,0.39772,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0030654,0.46592,0.36541,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,5.7413e-06,0.46552,0.49463,1,1
1,GO HYALURONAN METABOLIC PROCESS,0.00019079,0.4653,0.43524,1,1
1,GO MATURATION OF LSU RRNA,3.1888e-05,0.46526,0.44119,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0026572,0.46469,0.41319,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.8583e-05,0.46466,0.45707,1,1
1,GO RESPONSE TO HYPEROXIA,0.00044439,0.4646,0.42674,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,6.0504e-05,0.46419,0.41183,1,1
1,GO INTERLEUKIN 8 PRODUCTION,6.7728e-06,0.46405,0.40663,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0099891,0.46395,0.31686,1,1
1,GO RIG I SIGNALING PATHWAY,1.0779e-06,0.46367,0.43536,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0010528,0.46351,0.40739,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.0226e-05,0.46346,0.48464,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.0001547,0.46339,0.47152,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0018173,0.46336,0.38553,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.1112e-06,0.46315,0.3958,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.9801e-06,0.46301,0.65574,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,5.2837e-06,0.46233,0.39844,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,0.0001165,0.46159,0.64582,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,7.6603e-06,0.46056,0.42266,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026003,0.46034,0.45689,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,7.6379e-08,0.45798,0.57132,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,8.6584e-06,0.45741,0.43501,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.0017641,0.45708,0.36804,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,5.0194e-07,0.45701,0.43243,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.6174e-05,0.45558,0.4119,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00084609,0.4554,0.33115,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,2.9301e-06,0.45535,0.38867,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.00037661,0.45525,0.36044,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,4.1617e-05,0.45501,0.41578,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.1788e-07,0.45439,0.40471,1,1
1,GO PROTEASOME ASSEMBLY,6.7728e-06,0.45437,0.37866,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.0784e-06,0.45382,0.43796,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.00012074,0.45343,0.34423,1,1
1,GO LYMPHANGIOGENESIS,2.3418e-05,0.45312,0.43636,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,4.8379e-05,0.4525,0.38028,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.02268,0.45146,0.26751,1,1
1,GO INTERLEUKIN 2 PRODUCTION,4.1802e-07,0.45124,0.46555,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00014935,0.45117,0.42249,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,0.00041602,0.45081,0.40696,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,3.9418e-06,0.45052,0.38864,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.017137,0.45033,0.37198,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.2876e-06,0.45007,0.38054,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00025131,0.44966,0.35601,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.44959,0.42544,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.44945,0.41512,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00010845,0.44888,0.58664,1,1
1,GO PRIMARY MIRNA PROCESSING,2.9532e-05,0.44766,0.41171,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6455e-05,0.44759,0.41263,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,1.3441e-06,0.44643,0.44348,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00021167,0.44599,0.38546,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,5.0683e-06,0.44554,0.47882,1,1
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00065623,0.44536,0.39654,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.8521e-05,0.44479,0.57695,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.0011549,0.44472,0.43802,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,2.3654e-06,0.44463,0.498,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,2.8077e-06,0.44452,0.38166,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.2308e-06,0.44449,0.40553,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00038934,0.44432,0.54916,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0012662,0.44414,0.34153,1,1
1,GO GERMINAL CENTER FORMATION,0.00072223,0.44344,0.39309,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,6.5149e-05,0.44268,0.40266,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.8418e-05,0.44164,0.42649,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,7.0571e-06,0.44108,0.5269,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.5201e-05,0.43934,0.40627,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1237e-07,0.43909,0.41866,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00042998,0.43773,0.4073,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2139e-05,0.43747,0.45107,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0022992,0.4374,0.57632,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00032948,0.4373,0.60872,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,5.8301e-05,0.43489,0.37605,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.0604e-05,0.43431,0.34281,1,1
1,GO PROTEIN ACTIVATION CASCADE,7.013e-05,0.43358,0.33543,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.012508,0.43292,0.34523,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.7118e-05,0.43292,0.47604,1,1
1,GO MACROPHAGE PROLIFERATION,0.0057817,0.43278,0.36432,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.0057817,0.43269,0.46344,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,5.6174e-05,0.43259,0.41551,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,5.2837e-06,0.43174,0.44988,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,6.7596e-05,0.43172,0.40725,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,2.0784e-06,0.43063,0.41302,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.43051,0.47144,1,1
1,GO PLATELET AGGREGATION,1.4674e-06,0.42999,0.38679,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.030383,0.42824,0.33538,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,9.8628e-07,0.42778,0.49838,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.5816e-05,0.42744,0.35387,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.00067758,0.42727,0.58237,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,3.6228e-06,0.42704,0.51238,1,1
1,GO RIBOSOME ASSEMBLY,0.00028792,0.42689,0.34493,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00072223,0.42641,0.38834,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0057817,0.42612,0.34386,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00014418,0.42516,0.40423,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00018427,0.42445,0.37107,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00023468,0.42438,0.42738,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00069957,0.4241,0.343,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00047456,0.42338,0.38276,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,7.9801e-06,0.42291,0.39698,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,3.8583e-05,0.42226,0.31022,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0053338,0.42218,0.30648,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,3.4421e-05,0.42213,0.36917,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,5.9841e-06,0.42121,0.43398,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00040247,0.42118,0.48371,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.001228,0.42085,0.33334,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0024367,0.42075,0.34423,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.0604e-05,0.42048,0.40325,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010845,0.42,0.44515,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.3441e-06,0.41965,0.37182,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.0033e-05,0.41936,0.33316,1,1
1,GO VIRAL LIFE CYCLE,4.3763e-07,0.41928,0.42213,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,1.104e-05,0.41924,0.42554,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.906e-06,0.41872,0.40747,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,7.013e-05,0.41838,0.43811,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.1493e-05,0.41807,0.47632,1,1
1,GO ENAMEL MINERALIZATION,0.0022992,0.4175,0.39985,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,5.0683e-06,0.41743,0.36083,1,1
1,GO MULTI ORGANISM LOCALIZATION,5.986e-08,0.41721,0.42011,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00017186,0.41699,0.33483,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0504e-05,0.41699,0.35872,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,0.00016595,0.41664,0.55918,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,5.7413e-06,0.4163,0.5081,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.3916e-06,0.41589,0.3775,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0020453,0.41571,0.40457,1,1
1,GO ANIMAL ORGAN REGENERATION,1.7118e-05,0.41553,0.44192,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00069957,0.41551,0.3804,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.41549,0.35012,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,0.0014299,0.41536,0.36168,1,1
1,GO DETECTION OF BIOTIC STIMULUS,7.013e-05,0.41491,0.419,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.2524e-05,0.41479,0.39294,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,3.1888e-05,0.41397,0.44134,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,2.3654e-06,0.41376,0.36529,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,4.4878e-05,0.41374,0.34508,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0010859,0.41356,0.41647,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,4.1802e-07,0.4132,0.40584,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.1788e-07,0.41314,0.40165,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.4421e-05,0.41302,0.39102,1,1
1,GO IMMATURE T CELL PROLIFERATION,5.4121e-05,0.41288,0.4502,1,1
1,GO VIRAL TRANSLATION,5.0683e-06,0.41209,0.41362,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.7343e-05,0.41157,0.32367,1,1
1,GO INTERFERON BETA PRODUCTION,0.00012074,0.41142,0.31503,1,1
1,GO VASCULAR TRANSPORT,0.029068,0.41092,0.44521,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00017796,0.41075,0.33976,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0028141,0.41022,0.30102,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.8418e-05,0.41019,0.36723,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.4039e-05,0.40945,0.43896,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.40915,0.46253,1,1
1,GO REGULATION OF MRNA BINDING,1.5201e-05,0.40814,0.36707,1,1
1,GO ERBB2 SIGNALING PATHWAY,1.349e-05,0.40799,0.35051,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00025131,0.40715,0.41089,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00023468,0.40708,0.41105,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,5.2139e-05,0.40611,0.37476,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,3.4728e-06,0.4053,0.49367,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.02068,0.40521,0.34214,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00017796,0.40504,0.54318,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,3.0576e-06,0.40446,0.39067,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,5.508e-06,0.4044,0.48429,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,9.7346e-05,0.40435,0.3833,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0001547,0.40416,0.37624,1,1
1,GO I KAPPAB PHOSPHORYLATION,8.4205e-05,0.40407,0.29778,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,2.9532e-05,0.40402,0.44761,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.6729e-06,0.40384,0.34478,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,2.0784e-06,0.40325,0.50713,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00016595,0.40267,0.42018,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,5.2837e-06,0.40259,0.36521,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00010092,0.4013,0.3297,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0051916,0.40126,0.37925,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.9904e-06,0.40039,0.39782,1,1
1,GO FIBROBLAST MIGRATION,0.00063551,0.40016,0.3504,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,6.2985e-07,0.40003,0.35742,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.012508,0.39904,0.30553,1,1
1,GO REGULATION OF STEROL TRANSPORT,3.0689e-05,0.39811,0.3285,1,1
1,GO BONE GROWTH,0.00037661,0.39804,0.38928,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,8.4205e-05,0.39785,0.36744,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.00028792,0.39779,0.47398,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00020448,0.39778,0.38012,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0021062,0.39708,0.38766,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00012074,0.39707,0.45262,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.00036427,0.397,0.41675,1,1
1,GO EMBRYO IMPLANTATION,7.3528e-06,0.3963,0.47112,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,5.6174e-05,0.39564,0.30342,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.6729e-06,0.39555,0.42084,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.2971e-07,0.39552,0.41704,1,1
1,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0017641,0.39525,0.37051,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,8.6584e-06,0.39421,0.39242,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,7.013e-05,0.39385,0.4388,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0099891,0.39287,0.28247,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.00016023,0.39208,0.28524,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,8.7323e-05,0.39174,0.39591,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00067758,0.3914,0.32066,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00055855,0.39137,0.32459,1,1
1,GO T CELL APOPTOTIC PROCESS,2.1702e-06,0.39048,0.3671,1,1
1,GO CERAMIDE CATABOLIC PROCESS,0.00052342,0.38996,0.34096,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.1663e-05,0.38994,0.36368,1,1
1,GO INTERACTION WITH HOST,7.5427e-07,0.38851,0.43045,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.3654e-06,0.38821,0.39068,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00084609,0.38813,0.31587,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.4039e-05,0.38812,0.37197,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.00018427,0.38781,0.54037,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,1.7474e-06,0.38731,0.38453,1,1
1,GO RESPONSE TO ESTROGEN,8.628e-07,0.38605,0.38594,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.00029782,0.38585,0.3385,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.7474e-06,0.38534,0.3687,1,1
1,GO MATURATION OF 5 8S RRNA,9.7346e-05,0.38425,0.33464,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00023468,0.38396,0.31966,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.2308e-06,0.38382,0.38493,1,1
1,GO REGULATION OF GASTRULATION,5.9841e-06,0.38339,0.37265,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0031536,0.38332,0.32484,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.4039e-05,0.38263,0.34371,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.0311e-06,0.38246,0.36179,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00072223,0.38224,0.34491,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0013872,0.38206,0.35524,1,1
1,GO SPROUTING ANGIOGENESIS,1.7806e-05,0.38202,0.34709,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00055855,0.38197,0.30132,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,5.508e-06,0.38187,0.3241,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.1493e-05,0.38186,0.35393,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0011199,0.3818,0.34614,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.00011241,0.38,0.47016,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00023468,0.37959,0.31316,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,0.001191,0.37959,0.31552,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.0504e-05,0.3792,0.39861,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,1.8958e-07,0.3785,0.50019,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.6455e-05,0.37758,0.42092,1,1
1,GO MEMBRANE INVAGINATION,1.7118e-05,0.3772,0.33591,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0001547,0.37719,0.33031,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,9.7346e-05,0.37681,0.38165,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,0.0014299,0.37643,0.2966,1,1
1,GO MUSCLE FILAMENT SLIDING,4.8379e-05,0.37605,0.33182,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0026572,0.37515,0.39304,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.1964e-05,0.37484,0.31804,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.8891e-07,0.37476,0.3705,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,2.3418e-05,0.37454,0.30615,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,2.2524e-05,0.37434,0.29584,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.8418e-05,0.37424,0.32633,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.7323e-05,0.37407,0.37158,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,6.0504e-05,0.37282,0.36811,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0054795,0.37219,0.23161,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.104e-05,0.37168,0.33127,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0021062,0.3716,0.31152,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,6.4994e-06,0.3715,0.32597,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00041602,0.37108,0.31465,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0027346,0.37075,0.30499,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00016023,0.37024,0.32614,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4039e-05,0.36936,0.32904,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00074557,0.3692,0.31994,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,8.7323e-05,0.36906,0.35067,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.2658e-06,0.369,0.31609,1,1
1,GO MRNA TRANSCRIPTION,1.4039e-05,0.36896,0.36621,1,1
1,GO SNRNA PROCESSING,0.00084609,0.36826,0.5597,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.3287e-06,0.3678,0.34092,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00019079,0.36758,0.29975,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.0001165,0.36751,0.30796,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,4.1112e-06,0.36739,0.29188,1,1
1,GO INTERACTION WITH SYMBIONT,1.7806e-05,0.36728,0.31965,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.0050528,0.367,0.39712,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.00067758,0.36672,0.35964,1,1
1,GO INTERLEUKIN 17 PRODUCTION,9.7801e-06,0.36648,0.45344,1,1
1,GO GLIAL CELL ACTIVATION,0.001228,0.36566,0.31018,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.7413e-06,0.36556,0.32173,1,1
1,GO NCRNA PROCESSING,2.9532e-05,0.36512,0.28483,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,4.6597e-05,0.36482,0.33601,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00025131,0.36469,0.31166,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.36452,0.32314,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.016339,0.36373,0.27931,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.00055855,0.36366,0.3943,1,1
1,GO REGULATION OF PHAGOCYTOSIS,1.2962e-05,0.36301,0.36829,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.36298,0.3799,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.00054072,0.36294,0.28092,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,5.7413e-06,0.36285,0.37553,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0017641,0.36245,0.31144,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0018173,0.36203,0.27611,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0027346,0.36187,0.36582,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00022676,0.36154,0.51146,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.01282,0.36133,0.36756,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,0.00014935,0.3613,0.38617,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00087311,0.36122,0.45187,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0012662,0.36108,0.30771,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.0604e-05,0.36099,0.33041,1,1
1,GO NECROTIC CELL DEATH,5.0683e-06,0.36079,0.44011,1,1
1,GO REGULATION OF COAGULATION,0.00025131,0.36015,0.38288,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00016595,0.35978,0.27059,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,8.3127e-06,0.35955,0.3486,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0017123,0.35953,0.3139,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0051916,0.35916,0.34041,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.2658e-06,0.35891,0.35473,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,7.3528e-06,0.35848,0.31998,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,7.013e-05,0.35847,0.27599,1,1
1,GO TRANSLATIONAL TERMINATION,0.00024286,0.35841,0.26613,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,8.1192e-05,0.35821,0.27399,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,5.2139e-05,0.35803,0.3933,1,1
1,GO INNATE IMMUNE RESPONSE,2.5308e-05,0.35779,0.27797,1,1
1,GO RESPONSE TO VIRUS,1.0604e-05,0.35752,0.35775,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0022992,0.35747,0.30616,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5201e-05,0.35666,0.35833,1,1
1,GO RIBOSOME BIOGENESIS,0.00010462,0.35553,0.29718,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,2.6307e-05,0.35514,0.44642,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.014138,0.35505,0.37117,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,6.5149e-05,0.3549,0.26486,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00014935,0.35415,0.30298,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00018427,0.35402,0.28895,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.001872,0.35364,0.31632,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025994,0.35294,0.43775,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00017186,0.35273,0.3849,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.013465,0.35247,0.43162,1,1
1,GO CYTOKINETIC PROCESS,3.1904e-06,0.35233,0.32908,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00010845,0.35188,0.36767,1,1
1,GO FOCAL ADHESION ASSEMBLY,0.00063551,0.35161,0.35611,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.031748,0.35151,0.26121,1,1
1,GO PIGMENT ACCUMULATION,0.00013917,0.35138,0.32497,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,1.6729e-06,0.35119,0.35296,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.001872,0.35089,0.27353,1,1
1,GO HYPOTONIC RESPONSE,0.0012662,0.35069,0.29844,1,1
1,GO B CELL MEDIATED IMMUNITY,2.4346e-05,0.35039,0.3078,1,1
1,GO FOREGUT MORPHOGENESIS,0.00012512,0.35005,0.40004,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0551e-05,0.34959,0.36623,1,1
1,GO ARGININE METABOLIC PROCESS,0.0015189,0.3494,0.32554,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00019079,0.34928,0.31581,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,4.4712e-06,0.34904,0.32098,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00030804,0.34868,0.34281,1,1
1,GO ERAD PATHWAY,3.8583e-05,0.348,0.25827,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00098941,0.34775,0.33818,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8418e-05,0.34748,0.33912,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,3.5759e-05,0.34673,0.36637,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.0045306,0.34661,0.37792,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00055855,0.34661,0.29049,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00016595,0.34579,0.33916,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00032948,0.34556,0.37092,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00036427,0.34517,0.30326,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00092958,0.34513,0.34231,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.0689e-05,0.34484,0.27188,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00087311,0.34483,0.29017,1,1
1,GO FIBROBLAST PROLIFERATION,0.00025131,0.34444,0.29509,1,1
1,GO COPPER ION HOMEOSTASIS,7.9801e-06,0.34414,0.47265,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,5.4121e-05,0.34374,0.30771,1,1
1,GO NCRNA 3 END PROCESSING,0.0030654,0.34296,0.37691,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00055855,0.34235,0.41425,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.00012074,0.34182,0.30785,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0015653,0.34173,0.37575,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.349e-05,0.3417,0.36377,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0021062,0.34158,0.35089,1,1
1,GO RRNA METABOLIC PROCESS,0.00013433,0.34139,0.27879,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.02843,0.34117,0.28191,1,1
1,GO REGULATION OF PROTEIN FOLDING,2.2524e-05,0.34102,0.28965,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.00040247,0.34086,0.3235,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.9263e-05,0.34062,0.37353,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.02843,0.34037,0.238,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.016339,0.34035,0.37608,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00037661,0.34004,0.31432,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0028957,0.33988,0.31431,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00092958,0.33977,0.26611,1,1
1,GO VIRAL GENE EXPRESSION,4.3218e-05,0.33947,0.33929,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00052342,0.33911,0.3699,1,1
1,GO GASTRULATION,2.1663e-05,0.33885,0.32929,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,0.0019282,0.33884,0.44336,1,1
1,GO RESPONSE TO PROGESTERONE,0.0069616,0.33875,0.28058,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0025817,0.3385,0.32583,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.00020448,0.3383,0.35626,1,1
1,GO REGULATION OF LIPASE ACTIVITY,3.5759e-05,0.3378,0.26345,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0017123,0.33766,0.33009,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.4692e-06,0.33746,0.30383,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,2.2879e-07,0.33732,0.35442,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0022992,0.33715,0.37587,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,9.0551e-05,0.33702,0.45177,1,1
1,GO RESPONSE TO INTERLEUKIN 1,2.5774e-06,0.33695,0.35649,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,7.3528e-06,0.33693,0.32782,1,1
1,GO NATURAL KILLER CELL ACTIVATION,2.4346e-05,0.33686,0.31571,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,9.389e-05,0.33586,0.44759,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0014299,0.3356,0.31629,1,1
1,GO ALPHA BETA T CELL ACTIVATION,0.00013917,0.33552,0.25301,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.00034072,0.33543,0.32746,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.0504e-05,0.33531,0.39129,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.0576e-06,0.33525,0.32394,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,1.1964e-05,0.3351,0.30587,1,1
1,GO PLATELET DEGRANULATION,0.00034072,0.33497,0.37413,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.3916e-06,0.33454,0.3933,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00017186,0.33454,0.27578,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.9904e-06,0.3344,0.338,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.7413e-06,0.33405,0.31729,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0023671,0.33323,0.32407,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.016339,0.33282,0.34926,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.8958e-07,0.33248,0.35338,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,2.0833e-05,0.33242,0.27667,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00032948,0.33193,0.24873,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0016129,0.33184,0.22537,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,6.2786e-05,0.33159,0.35615,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00012074,0.33137,0.38916,1,1
1,GO PROTEIN OXIDATION,0.052669,0.33122,0.29643,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,6.2786e-05,0.33093,0.27386,1,1
1,GO CELL SUBSTRATE ADHESION,4.8379e-05,0.3306,0.35911,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.011612,0.33058,0.25663,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.8583e-05,0.33054,0.37677,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.017137,0.33037,0.23916,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.0015189,0.33031,0.24798,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,6.0504e-05,0.33019,0.24692,1,1
1,GO PROTEIN TARGETING TO VACUOLE,0.00021909,0.33016,0.25491,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,5.2139e-05,0.32992,0.29985,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00074557,0.32965,0.29383,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.1663e-05,0.32958,0.32372,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32926,0.28349,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00023468,0.32914,0.35243,1,1
1,GO RESPONSE TO MANGANESE ION,6.0504e-05,0.32904,0.31022,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.009256,0.32862,0.29419,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0026572,0.32858,0.33947,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.9532e-05,0.32852,0.51419,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00065623,0.32793,0.30866,1,1
1,GO IMMUNE EFFECTOR PROCESS,1.6455e-05,0.3277,0.28404,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.0014299,0.32757,0.2605,1,1
1,GO PORE COMPLEX ASSEMBLY,0.00019753,0.32744,0.26788,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.327,0.31046,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00055855,0.32695,0.33105,1,1
1,GO PLATELET MORPHOGENESIS,1.8521e-05,0.32641,0.29071,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.011047,0.32617,0.3625,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0064317,0.32597,0.39307,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00016023,0.32513,0.34986,1,1
1,GO OSTEOCLAST DEVELOPMENT,7.2754e-05,0.32501,0.37602,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00012074,0.32438,0.22687,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00092958,0.32436,0.28102,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,3.1888e-05,0.32429,0.29559,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00069957,0.32418,0.29509,1,1
1,GO SNRNA METABOLIC PROCESS,0.00031859,0.32355,0.44802,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.7145e-05,0.32349,0.27818,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,0.00016023,0.32328,0.25653,1,1
1,GO MESODERM MORPHOGENESIS,1.7118e-05,0.32325,0.3174,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00026903,0.32317,0.25587,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.00098941,0.32292,0.31671,1,1
1,GO RNA 5 END PROCESSING,0.00024286,0.3228,0.28786,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00042998,0.32241,0.28994,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,7.013e-05,0.32222,0.32272,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.2139e-05,0.32215,0.44586,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,0.0001547,0.32183,0.34225,1,1
1,GO TRANSLATIONAL INITIATION,0.00052342,0.32166,0.28664,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.4421e-05,0.32138,0.29595,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0053338,0.32102,0.27704,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0015189,0.32077,0.23886,1,1
1,GO PEPTIDE CATABOLIC PROCESS,0.00050664,0.32074,0.23697,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0030654,0.32056,0.21989,1,1
1,GO COPPER ION TRANSPORT,4.1617e-05,0.31969,0.32192,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.4421e-05,0.31946,0.26436,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,9.389e-05,0.3194,0.36691,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.00026003,0.31918,0.42276,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00026003,0.31884,0.34891,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,9.0551e-05,0.31863,0.30954,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.0030654,0.31854,0.33091,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.0226e-05,0.31847,0.29176,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.017549,0.31817,0.26501,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,3.3287e-06,0.31788,0.33556,1,1
1,GO REGULATION OF WOUND HEALING,0.00074557,0.31777,0.28617,1,1
1,GO VIRAL RELEASE FROM HOST CELL,3.8583e-05,0.31754,0.29322,1,1
1,GO REGENERATION,4.1617e-05,0.3173,0.26388,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.00025131,0.31714,0.38033,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00054072,0.3157,0.28188,1,1
1,GO HISTONE PHOSPHORYLATION,4.6597e-05,0.31565,0.27407,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00024286,0.31539,0.29945,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0029794,0.31524,0.24854,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,2.9532e-05,0.31482,0.32162,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,5.8301e-05,0.31478,0.26329,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,2.4346e-05,0.31461,0.30158,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.31443,0.30511,1,1
1,GO NCRNA METABOLIC PROCESS,5.8301e-05,0.31443,0.25174,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.0033e-05,0.31366,0.31044,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.0016129,0.31366,0.22848,1,1
1,GO VESICLE CARGO LOADING,2.1663e-05,0.31358,0.29633,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00040247,0.31352,0.33689,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0017641,0.31351,0.27097,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0025817,0.31324,0.28177,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0833e-05,0.31274,0.33104,1,1
1,GO SYMBIOTIC PROCESS,2.8891e-07,0.31248,0.28731,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00047456,0.31232,0.2932,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0012662,0.31214,0.27169,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0075304,0.31205,0.27038,1,1
1,GO SYNCYTIUM FORMATION,9.389e-05,0.31191,0.31342,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,2.9532e-05,0.31153,0.38896,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.001228,0.31114,0.25697,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,1.7118e-05,0.31034,0.29134,1,1
1,GO PROTEIN DEGLYCOSYLATION,0.00081984,0.31014,0.28114,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0019282,0.30999,0.26357,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.2524e-05,0.30991,0.34417,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.015574,0.30976,0.30155,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.024846,0.30968,0.29175,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00059588,0.30968,0.27896,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.0025817,0.30964,0.24008,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.7728e-06,0.30961,0.34701,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.019739,0.30939,0.25599,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.027188,0.30919,0.17863,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,2.7343e-05,0.30811,0.33454,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.00353,0.30801,0.28563,1,1
1,GO CHONDROCYTE DIFFERENTIATION,0.00034072,0.30746,0.27932,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.6729e-06,0.30727,0.28153,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017641,0.30708,0.29187,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0028957,0.30683,0.30134,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.0027346,0.30655,0.35307,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00067758,0.30639,0.28696,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.4039e-05,0.30576,0.27989,1,1
1,GO TISSUE REGENERATION,0.00037661,0.30523,0.27292,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.5308e-05,0.30478,0.38181,1,1
1,GO ASTROCYTE ACTIVATION,0.0066042,0.30474,0.2739,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,6.2985e-07,0.3045,0.27665,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.015203,0.30418,0.39584,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00098941,0.304,0.20245,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00035231,0.30395,0.25098,1,1
1,GO ACTIN FILAMENT SEVERING,0.0022332,0.30394,0.34924,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.0073e-05,0.30377,0.30623,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00011241,0.30376,0.33347,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.009256,0.30363,0.27188,1,1
1,GO VASCULATURE DEVELOPMENT,3.8583e-05,0.30356,0.28461,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00019753,0.3035,0.33214,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.9904e-06,0.30344,0.23357,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00069957,0.30326,0.34594,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,2.4346e-05,0.30325,0.28835,1,1
1,GO CYTOKINE PRODUCTION,4.6597e-05,0.30307,0.25563,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0026572,0.30294,0.35738,1,1
1,GO REPLICATIVE SENESCENCE,0.0073363,0.30279,0.36457,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.7791e-06,0.30251,0.43386,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,3.4421e-05,0.30227,0.25794,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,1.0311e-06,0.30217,0.31619,1,1
1,GO PIGMENT METABOLIC PROCESS,2.8418e-05,0.30198,0.25685,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00069957,0.30179,0.2162,1,1
1,GO CARNITINE METABOLIC PROCESS,0.013465,0.30166,0.2488,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.0053338,0.3013,0.22965,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00030804,0.30113,0.25674,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00035231,0.30084,0.24939,1,1
1,GO MACROPHAGE MIGRATION,4.8612e-06,0.30081,0.35775,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0040578,0.30076,0.26845,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.004408,0.30062,0.23728,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00024286,0.30006,0.20834,1,1
1,GO T CELL CYTOKINE PRODUCTION,2.9532e-05,0.29996,0.39267,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2962e-05,0.29994,0.29921,1,1
1,GO URETER DEVELOPMENT,0.0036303,0.29983,0.29817,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00018427,0.29968,0.25199,1,1
1,GO RESPONSE TO CYTOKINE,1.9263e-05,0.29966,0.29208,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00065623,0.29954,0.24342,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,0.00019079,0.29938,0.23359,1,1
1,GO RRNA MODIFICATION,0.0020453,0.2993,0.21211,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00098941,0.29927,0.23932,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00012512,0.29918,0.29352,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.0029794,0.2991,0.3586,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0010528,0.29907,0.33454,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.00095906,0.29838,0.25679,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0027346,0.29833,0.26917,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,3.8583e-05,0.29831,0.30479,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.29831,0.30926,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00065623,0.29829,0.25478,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00024286,0.29828,0.22959,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0099891,0.29824,0.4015,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,0.00012074,0.29815,0.28293,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.0604e-05,0.29803,0.30704,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00042998,0.29797,0.2276,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.29781,0.23693,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,7.013e-05,0.29777,0.28742,1,1
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0026572,0.29765,0.33247,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.0011549,0.29696,0.32403,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.00079435,0.2969,0.23221,1,1
1,GO PODOSOME ASSEMBLY,7.013e-05,0.2969,0.38997,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.1617e-05,0.29644,0.34107,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00026903,0.29619,0.37838,1,1
1,GO ENDOTHELIAL CELL MIGRATION,7.2754e-05,0.29597,0.30658,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.02843,0.29537,0.3781,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00052342,0.2953,0.27673,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.7596e-05,0.29489,0.23356,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0047853,0.29484,0.27576,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.5774e-06,0.2948,0.28352,1,1
1,GO SELECTIVE AUTOPHAGY,1.1776e-06,0.29472,0.29955,1,1
1,GO CELLULAR RESPONSE TO VIRUS,8.6584e-06,0.29412,0.31565,1,1
1,GO REGULATION OF CELL AGING,2.4692e-06,0.29407,0.30357,1,1
1,GO SPERM EGG RECOGNITION,6.7596e-05,0.29394,0.24076,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.0016129,0.29345,0.31072,1,1
1,GO GLAND MORPHOGENESIS,0.00036427,0.29338,0.3438,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0059384,0.29308,0.1831,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,3.5759e-05,0.29304,0.2898,1,1
1,GO T CELL CHEMOTAXIS,5.4121e-05,0.29304,0.26329,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.8583e-05,0.29279,0.31531,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.0073363,0.29263,0.21017,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00030804,0.29181,0.31435,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.00055855,0.29178,0.30459,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.0001165,0.29172,0.24372,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00074557,0.29105,0.29146,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00095906,0.29091,0.22177,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00012512,0.29066,0.25398,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.037747,0.29056,0.22054,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.0018173,0.29048,0.3143,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00049035,0.29039,0.29211,1,1
1,GO MYOBLAST DIFFERENTIATION,7.6603e-06,0.29037,0.32118,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.2962e-05,0.29034,0.31038,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00026003,0.28993,0.28218,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.6307e-05,0.28976,0.3087,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.00030804,0.28953,0.32322,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00052342,0.2893,0.21285,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5201e-05,0.28929,0.30646,1,1
1,GO MYOBLAST MIGRATION,0.0022992,0.28919,0.44014,1,1
1,GO TRACHEA MORPHOGENESIS,0.0010528,0.28909,0.27126,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,0.00038934,0.28899,0.38686,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013433,0.28896,0.22138,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00045924,0.28892,0.23298,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0012662,0.28884,0.21559,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,6.2786e-05,0.28882,0.26314,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,8.628e-07,0.28881,0.28488,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0017641,0.28853,0.25921,1,1
1,GO RESPONSE TO DSRNA,6.5149e-05,0.28845,0.3282,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.8282e-05,0.28802,0.35232,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.0030654,0.28785,0.28414,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00028792,0.28779,0.29925,1,1
1,GO MYOBLAST FUSION,0.00017186,0.28771,0.33429,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.0028957,0.28759,0.25987,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0015653,0.28755,0.20048,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.001662,0.28736,0.26418,1,1
1,GO REGULATION OF RNA BINDING,9.7801e-06,0.28722,0.28969,1,1
1,GO WOUND HEALING,8.7323e-05,0.28717,0.30468,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.28707,0.27274,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,0.00013433,0.28691,0.29564,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.1802e-07,0.28667,0.30169,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00029782,0.28584,0.42322,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.8521e-05,0.28568,0.2464,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.00042998,0.28566,0.28653,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00054072,0.28523,0.29039,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.28517,0.24482,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00014935,0.28445,0.41232,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00030804,0.28441,0.29813,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00013917,0.28439,0.30166,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,2.9532e-05,0.28434,0.22491,1,1
1,GO RESPONSE TO PROTOZOAN,0.00042998,0.28426,0.29939,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,3.4728e-06,0.28424,0.3367,1,1
1,GO RNA CATABOLIC PROCESS,7.2111e-07,0.28421,0.26553,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0026572,0.2842,0.2881,1,1
1,GO CELL CELL RECOGNITION,3.9418e-06,0.28408,0.27963,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.016339,0.28406,0.20261,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0032441,0.28369,0.23735,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.027803,0.28362,0.25541,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0013054,0.28302,0.2956,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00069957,0.28287,0.35184,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00012964,0.28275,0.32583,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00019753,0.28262,0.25386,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00032948,0.28245,0.32339,1,1
1,GO MACROPHAGE DIFFERENTIATION,2.0033e-05,0.2823,0.35983,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0014299,0.28217,0.26883,1,1
1,GO DECIDUALIZATION,0.017549,0.28206,0.27599,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,1.9263e-05,0.28176,0.34596,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0017641,0.2817,0.24119,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.8583e-05,0.28105,0.24942,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00049035,0.28092,0.28541,1,1
1,GO SEQUESTERING OF METAL ION,0.00026903,0.28084,0.2613,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0079323,0.28079,0.21595,1,1
1,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.014841,0.28058,0.23468,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.033166,0.28057,0.18419,1,1
1,GO PHAGOCYTOSIS,5.508e-06,0.2804,0.32036,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0060989,0.2804,0.33175,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,0.00020448,0.27967,0.23936,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,4.3218e-05,0.27951,0.21718,1,1
1,GO TRABECULA FORMATION,0.0057817,0.27947,0.35518,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.001228,0.27944,0.25624,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.6307e-05,0.27927,0.377,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,0.00036427,0.27906,0.30669,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0064317,0.27899,0.31833,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00063551,0.27887,0.31931,1,1
1,GO NUCLEOSIDE SALVAGE,0.00081984,0.27852,0.42899,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,9.0551e-05,0.27809,0.26738,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,8.4205e-05,0.27782,0.26966,1,1
1,GO CHEMOKINE PRODUCTION,0.0020453,0.27751,0.24934,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.5816e-05,0.27713,0.27484,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00059588,0.27711,0.27779,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.013139,0.27702,0.22178,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,7.6603e-06,0.27674,0.26988,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00069957,0.27652,0.26404,1,1
1,GO ASYMMETRIC CELL DIVISION,0.0017641,0.27633,0.24158,1,1
1,GO T CELL ACTIVATION,0.0001547,0.27628,0.21391,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,3.8583e-05,0.27595,0.23898,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.27563,0.21094,1,1
1,GO CARTILAGE DEVELOPMENT,0.0017123,0.27548,0.225,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,2.9532e-05,0.27544,0.3342,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0067808,0.27542,0.17791,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00052342,0.27517,0.24391,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00024286,0.27467,0.24683,1,1
1,GO CELL REDOX HOMEOSTASIS,3.1888e-05,0.27441,0.27871,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00042998,0.27406,0.29919,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,4.8379e-05,0.27378,0.21661,1,1
1,GO ACUTE PHASE RESPONSE,0.0060989,0.27373,0.25734,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,8.7323e-05,0.2735,0.23198,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.3287e-06,0.2735,0.27005,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00016595,0.273,0.26527,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0010528,0.27299,0.23474,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0025817,0.27293,0.2131,1,1
1,GO RESPONSE TO THYROID HORMONE,0.0015653,0.27259,0.27612,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0034322,0.27223,0.17982,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,0.0030654,0.27181,0.28109,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,0.0010859,0.2718,0.23741,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00072223,0.27165,0.24099,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.0011199,0.27164,0.34143,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,0.00090094,0.27146,0.32009,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.00052342,0.27134,0.26153,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,3.5759e-05,0.2712,0.2397,1,1
1,GO T CELL MIGRATION,0.00072223,0.27115,0.25813,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,1.2862e-06,0.27113,0.27174,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.016734,0.27104,0.22227,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,3.1888e-05,0.27086,0.28127,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00072223,0.2708,0.31769,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0013054,0.27078,0.30401,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00069957,0.27069,0.36586,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.4421e-05,0.27044,0.21743,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001986,0.2703,0.3197,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0049174,0.27001,0.2902,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00024286,0.26994,0.27278,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0083534,0.26958,0.20729,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.00032948,0.26924,0.20175,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,0.0007696,0.26924,0.21979,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.0053338,0.26889,0.21193,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,5.0226e-05,0.26849,0.28137,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0013872,0.2681,0.20463,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0019282,0.268,0.22054,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0018173,0.26754,0.21411,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.00098941,0.26751,0.25773,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00011241,0.2674,0.39395,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,9.7346e-05,0.26735,0.28143,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0050528,0.2673,0.20584,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0042883,0.26706,0.29047,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,1.1493e-05,0.26688,0.35378,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0038387,0.26675,0.20169,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,0.0013457,0.26654,0.26252,1,1
1,GO MEMBRANE DISASSEMBLY,0.0050528,0.26613,0.24921,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.011326,0.26555,0.29292,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00079435,0.26552,0.20392,1,1
1,GO KERATINOCYTE MIGRATION,0.001872,0.26548,0.25797,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.033166,0.26543,0.20304,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00014935,0.26537,0.24704,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0057817,0.26522,0.30449,1,1
1,GO HISTONE H4 DEACETYLATION,0.0049174,0.26479,0.23153,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00038934,0.26476,0.25895,1,1
1,GO TRANSLATIONAL ELONGATION,0.00092958,0.2646,0.21184,1,1
1,GO IRON ION HOMEOSTASIS,1.1493e-05,0.26454,0.26054,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00014418,0.26446,0.29141,1,1
1,GO VIRION ASSEMBLY,1.1964e-05,0.26433,0.22917,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0045306,0.26425,0.2403,1,1
1,GO TRANSPOSITION,0.025994,0.26409,0.2092,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00084609,0.26387,0.23958,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0038387,0.26372,0.29784,1,1
1,GO DETECTION OF OTHER ORGANISM,0.011904,0.2637,0.26818,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0013457,0.26363,0.42808,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,1.7806e-05,0.26346,0.39003,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.2524e-05,0.26333,0.24661,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00025131,0.2633,0.29067,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.5201e-05,0.26314,0.32581,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.024846,0.26298,0.16793,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.1888e-05,0.26294,0.2682,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.0073e-05,0.26289,0.19758,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.0016129,0.26284,0.25948,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26264,0.20873,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00052342,0.26233,0.25426,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.6307e-05,0.26219,0.24067,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.00034072,0.26192,0.20871,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0012662,0.26154,0.21115,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0010859,0.26151,0.22382,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.0041716,0.26132,0.24233,1,1
1,GO NADP METABOLIC PROCESS,0.0099891,0.26127,0.20782,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0015653,0.2612,0.20556,1,1
1,GO OSTEOBLAST DIFFERENTIATION,0.00059588,0.26112,0.24001,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0031536,0.26106,0.20988,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00072223,0.26101,0.22551,1,1
1,GO AUTOPHAGOSOME MATURATION,6.5149e-05,0.26096,0.26182,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0015189,0.26095,0.27211,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,4.8379e-05,0.2609,0.2612,1,1
1,GO STEROL TRANSPORT,0.0011549,0.26086,0.19787,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.3418e-05,0.26079,0.26977,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.1904e-06,0.26056,0.33024,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,6.0504e-05,0.26053,0.29347,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.025994,0.2605,0.14916,1,1
1,GO RESPONSE TO WOUNDING,0.00010845,0.26042,0.25377,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0010528,0.25988,0.22792,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00037661,0.25986,0.23348,1,1
1,GO BILE ACID AND BILE SALT TRANSPORT,0.049546,0.25951,0.11902,1,1
1,GO REGULATION OF GENE SILENCING,2.0784e-06,0.25947,0.25481,1,1
1,GO DNA DEALKYLATION,0.00092958,0.25913,0.24444,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.0784e-06,0.25877,0.25293,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00074557,0.25865,0.21432,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0069616,0.25832,0.23541,1,1
1,GO RNA DESTABILIZATION,2.5308e-05,0.25812,0.25818,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00092958,0.2581,0.16276,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.7323e-05,0.25801,0.24964,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.4692e-06,0.25786,0.23826,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00044439,0.25753,0.29185,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.026586,0.25752,0.24451,1,1
1,GO GRANULOCYTE MIGRATION,0.00047456,0.2574,0.26925,1,1
1,GO CELL ACTIVATION,6.0504e-05,0.25723,0.22754,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.0551e-05,0.25674,0.33477,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0031536,0.25649,0.20109,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0010528,0.25644,0.26581,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0010206,0.25642,0.22591,1,1
1,GO TRNA 5 END PROCESSING,0.00028792,0.25637,0.28881,1,1
1,GO CRISTAE FORMATION,0.015203,0.25634,0.20168,1,1
1,GO CHOLESTEROL EFFLUX,0.00030804,0.25607,0.24302,1,1
1,GO PROTEIN FOLDING,0.00036427,0.25591,0.2084,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,7.2754e-05,0.25568,0.24326,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00019753,0.25564,0.23393,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,0.0017123,0.25553,0.24099,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0011549,0.25552,0.26642,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.011047,0.25536,0.28861,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.044685,0.25513,0.24301,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.00037661,0.2551,0.27881,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00016595,0.25502,0.25054,1,1
1,GO CELL MATRIX ADHESION,0.00032948,0.25483,0.30045,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.023205,0.25482,0.32281,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0013872,0.2546,0.20229,1,1
1,GO RRNA TRANSCRIPTION,0.0010859,0.25457,0.23091,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.00087311,0.25454,0.33258,1,1
1,GO REGULATION OF CELL KILLING,0.0094949,0.25435,0.18829,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,4.6597e-05,0.25431,0.22745,1,1
1,GO REGULATION OF IMMUNE RESPONSE,4.8379e-05,0.25381,0.21346,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001872,0.25378,0.31171,1,1
1,GO COAGULATION,7.8282e-05,0.25352,0.27348,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.2786e-05,0.25346,0.25657,1,1
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.02843,0.25341,0.19188,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.0571e-06,0.25329,0.27148,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0027346,0.25316,0.237,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.2876e-06,0.253,0.24813,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00041602,0.25296,0.26689,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00012074,0.25286,0.20969,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.6015e-06,0.25279,0.22905,1,1
1,GO POSITIVE REGULATION OF CELL SIZE,0.041967,0.25229,0.22199,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00047456,0.25186,0.21525,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.9532e-05,0.25167,0.24354,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00072223,0.2516,0.24453,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.03939,0.25147,0.40019,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0012662,0.25097,0.2745,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00030804,0.25092,0.28924,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.046579,0.25089,0.15925,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.0017123,0.25079,0.24592,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0020453,0.25077,0.20496,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.001986,0.2507,0.24499,1,1
1,GO REGULATION OF HEART GROWTH,0.00052342,0.25055,0.21439,1,1
1,GO ERK1 AND ERK2 CASCADE,4.0073e-05,0.25018,0.23143,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00025131,0.25003,0.19607,1,1
1,GO PLATELET ACTIVATION,0.00028792,0.24983,0.23061,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,2.0833e-05,0.24972,0.2529,1,1
1,GO LYMPHOCYTE MIGRATION,0.00098941,0.24937,0.20427,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.020205,0.24926,0.23606,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,1.349e-05,0.24925,0.24856,1,1
1,GO TRNA METHYLATION,0.00021909,0.24895,0.23175,1,1
1,GO REGULATION OF ORGAN GROWTH,5.9841e-06,0.24884,0.28224,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0037331,0.24872,0.23319,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.014138,0.2485,0.25172,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00044439,0.24842,0.21623,1,1
1,GO FATTY ACID BETA OXIDATION,0.0016129,0.24817,0.22211,1,1
1,GO TOXIN TRANSPORT,0.0094949,0.2481,0.15797,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,5.6174e-05,0.24788,0.20396,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.3287e-06,0.24788,0.30815,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,3.5759e-05,0.24783,0.28613,1,1
1,GO LIPID OXIDATION,0.0083534,0.24758,0.16615,1,1
1,GO MITOPHAGY,0.00035231,0.24745,0.2355,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00014935,0.24725,0.20774,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.8418e-05,0.24713,0.23511,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00055855,0.24698,0.21654,1,1
1,GO TRNA PROCESSING,0.00042998,0.2469,0.18179,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0013457,0.2468,0.25112,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0097392,0.24667,0.24378,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.24665,0.34812,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0060989,0.24659,0.33057,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,7.547e-05,0.24627,0.20785,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0001547,0.24621,0.44,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00021167,0.24615,0.22616,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,0.00021909,0.24613,0.24992,1,1
1,GO MIDBODY ABSCISSION,0.00095906,0.24608,0.26348,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.027188,0.24603,0.35099,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00069957,0.24586,0.26087,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.4121e-05,0.24585,0.22762,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0011549,0.24579,0.17667,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00047456,0.24559,0.17801,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.7118e-05,0.24559,0.21741,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0099891,0.24555,0.21671,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0071468,0.24553,0.21313,1,1
1,GO RESPONSE TO BACTERIUM,0.00010845,0.24518,0.24381,1,1
1,GO REGULATION OF HEMOPOIESIS,1.5201e-05,0.24503,0.21268,1,1
1,GO LIPID IMPORT INTO CELL,0.036164,0.24502,0.19441,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,3.8583e-05,0.24501,0.19682,1,1
1,GO METANEPHROS DEVELOPMENT,9.7346e-05,0.245,0.24616,1,1
1,GO REGULATION OF DEFENSE RESPONSE,0.00017186,0.24491,0.19959,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00021909,0.24468,0.19316,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00025131,0.24459,0.25013,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00014418,0.24458,0.19315,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.011047,0.24439,0.20184,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.010506,0.24435,0.24159,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.8282e-05,0.24394,0.20963,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,0.0001165,0.24384,0.24281,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00353,0.24367,0.18904,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.00022676,0.24332,0.24714,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0019282,0.24281,0.24966,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0066042,0.24271,0.25654,1,1
1,GO TISSUE REMODELING,0.0022992,0.24263,0.22996,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0011199,0.2426,0.25509,1,1
1,GO RESPONSE TO GAMMA RADIATION,3.7145e-05,0.24248,0.24556,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.018836,0.24242,0.1651,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.010245,0.24214,0.18581,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00052342,0.24174,0.19997,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,0.00038934,0.2417,0.27589,1,1
1,GO RESPONSE TO TESTOSTERONE,8.4205e-05,0.24163,0.26615,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00012512,0.24162,0.23695,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.015953,0.24161,0.15445,1,1
1,GO L GLUTAMATE IMPORT,0.037747,0.24156,0.17912,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00044439,0.24124,0.23592,1,1
1,GO TONGUE MORPHOGENESIS,0.029068,0.24098,0.27712,1,1
1,GO CELL KILLING,0.010773,0.24092,0.14573,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0013457,0.2409,0.18284,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0097392,0.24068,0.17891,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.053746,0.24064,0.17354,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00020448,0.24023,0.20478,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010206,0.24011,0.3314,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.001872,0.23979,0.25432,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,1.7806e-05,0.23978,0.22171,1,1
1,GO RESPONSE TO CORTICOSTEROID,0.0010528,0.23978,0.21771,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00019079,0.23965,0.22347,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0057817,0.23955,0.20924,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0039469,0.23946,0.22762,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.7343e-05,0.23942,0.20357,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.8379e-05,0.2394,0.37154,1,1
1,GO HISTONE H2B UBIQUITINATION,0.00063551,0.23918,0.21001,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.047551,0.23888,0.28063,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.00027832,0.23884,0.22603,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0057817,0.23862,0.20385,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,0.001986,0.23846,0.17115,1,1
1,GO POSITIVE REGULATION OF COAGULATION,0.007729,0.23845,0.25508,1,1
1,GO NEPHRON TUBULE FORMATION,0.026586,0.23827,0.24413,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.104e-05,0.2382,0.23967,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0025083,0.23797,0.20677,1,1
1,GO COMPLEMENT ACTIVATION,0.00092958,0.23792,0.2281,1,1
1,GO RNA 3 END PROCESSING,3.3132e-05,0.23766,0.2125,1,1
1,GO NUCLEAR EXPORT,4.4712e-06,0.23723,0.21894,1,1
1,GO NEURAL TUBE PATTERNING,0.010773,0.23708,0.19163,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00074557,0.23676,0.18703,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0007696,0.23619,0.32206,1,1
1,GO PROTEIN PROCESSING,0.0010206,0.23607,0.19102,1,1
1,GO TISSUE MIGRATION,9.0551e-05,0.23604,0.28409,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0057817,0.23515,0.2074,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0016129,0.23508,0.31439,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,5.8301e-05,0.23496,0.22249,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.0083534,0.23477,0.15871,1,1
1,GO DEFENSE RESPONSE,0.00019079,0.23443,0.21186,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0020453,0.23433,0.21793,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0060989,0.23395,0.28223,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0045306,0.23387,0.23548,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.012203,0.23377,0.32412,1,1
1,GO MESODERM DEVELOPMENT,6.0504e-05,0.23369,0.20219,1,1
1,GO LIPID STORAGE,0.00036427,0.23358,0.24103,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.0019282,0.23332,0.22847,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0006154,0.23332,0.24446,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031059,0.23255,0.18275,1,1
1,GO T CELL PROLIFERATION,0.0015189,0.23232,0.20009,1,1
1,GO RRNA METHYLATION,0.009256,0.23227,0.15734,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0013872,0.23208,0.25568,1,1
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.0041716,0.23201,0.25414,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,2.6902e-06,0.232,0.20803,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00057693,0.23168,0.29585,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.00012964,0.23146,0.34363,1,1
1,GO AXIS ELONGATION,0.009256,0.23132,0.25337,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,5.0226e-05,0.2312,0.23804,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.23097,0.20017,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.8418e-05,0.23091,0.23452,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.010245,0.23087,0.25878,1,1
1,GO RNA MODIFICATION,8.4205e-05,0.23061,0.19649,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.013798,0.23029,0.19251,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.0010528,0.23028,0.36092,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00021909,0.23025,0.22024,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0050528,0.23023,0.15979,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,1.4039e-05,0.23022,0.23193,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.046579,0.23012,0.2835,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0019282,0.22996,0.27294,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,6.7596e-05,0.2298,0.28467,1,1
1,GO HYPEROSMOTIC RESPONSE,0.004408,0.22955,0.23424,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.029068,0.22915,0.1394,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0039469,0.22912,0.17492,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,2.4346e-05,0.22888,0.21948,1,1
1,GO BODY FLUID SECRETION,0.00022676,0.22887,0.21845,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.00031859,0.22824,0.25793,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.0226e-05,0.22821,0.20483,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.1964e-05,0.22814,0.2121,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.023741,0.22813,0.16212,1,1
1,GO OSTEOCLAST DIFFERENTIATION,7.013e-05,0.2281,0.20187,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.22807,0.19955,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00044439,0.22799,0.27463,1,1
1,GO PEPTIDE METABOLIC PROCESS,1.2454e-05,0.22794,0.19902,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,1.1493e-05,0.22789,0.23691,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0050528,0.22766,0.23052,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0075304,0.22756,0.23025,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0020453,0.22748,0.21291,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0040578,0.22743,0.19344,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,7.2754e-05,0.22728,0.26424,1,1
1,GO REGULATION OF PROTEOLYSIS,0.00018427,0.22716,0.18204,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.0604e-05,0.227,0.24473,1,1
1,GO RNA POLYADENYLATION,0.00022676,0.22693,0.18156,1,1
1,GO FOAM CELL DIFFERENTIATION,0.0028957,0.22665,0.23289,1,1
1,GO TRNA MODIFICATION,0.00072223,0.22664,0.1792,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.00019079,0.22657,0.21338,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.013465,0.22654,0.1852,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.041093,0.22626,0.20424,1,1
1,GO RUFFLE ORGANIZATION,0.00028792,0.22615,0.18025,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.0015653,0.22612,0.24416,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00021167,0.22599,0.2365,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00065623,0.22575,0.20545,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,2.9532e-05,0.2257,0.27981,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0021689,0.22541,0.20526,1,1
1,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.036948,0.2252,0.18425,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00044439,0.22509,0.18472,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.00019753,0.22464,0.27276,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00072223,0.22453,0.30708,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.014841,0.22432,0.23505,1,1
1,GO CERAMIDE TRANSPORT,0.038561,0.2242,0.21445,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.0046564,0.22419,0.16833,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.00067758,0.22413,0.1829,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.001986,0.22398,0.21376,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00010462,0.22367,0.24166,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,0.0079323,0.22328,0.19698,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0032441,0.22312,0.169,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00022676,0.22286,0.23472,1,1
1,GO REGULATION OF VASCULOGENESIS,0.017137,0.22229,0.28856,1,1
1,GO BONE MORPHOGENESIS,0.0036303,0.22204,0.21887,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0073363,0.22201,0.20547,1,1
1,GO PROTEIN KINASE B SIGNALING,0.00050664,0.22199,0.18497,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0066042,0.2217,0.18764,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0025083,0.22159,0.16038,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0057817,0.22126,0.16742,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.010245,0.22105,0.26983,1,1
1,GO MACROPHAGE CHEMOTAXIS,6.2786e-05,0.22063,0.33288,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.00013917,0.22058,0.22416,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.4121e-05,0.22051,0.20809,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00042998,0.21998,0.18048,1,1
1,GO OVULATION,0.036164,0.21987,0.22594,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0013457,0.21975,0.24573,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0099891,0.21963,0.19169,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.015203,0.21936,0.16967,1,1
1,GO PLACENTA DEVELOPMENT,0.0013457,0.21915,0.19367,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0050528,0.21909,0.19526,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.0031536,0.21901,0.22766,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,5.4121e-05,0.21894,0.21876,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.0013872,0.21889,0.16791,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00036427,0.2188,0.23295,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0097392,0.21856,0.21621,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,1.3441e-06,0.21853,0.20715,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00049035,0.21841,0.21952,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,7.013e-05,0.21821,0.21463,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00017796,0.21813,0.18378,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025414,0.2176,0.16326,1,1
1,GO TRNA METABOLIC PROCESS,0.00074557,0.21758,0.17607,1,1
1,GO ERBB SIGNALING PATHWAY,0.00026003,0.21744,0.23781,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.015574,0.21699,0.24982,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00087311,0.21687,0.35208,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0094949,0.2168,0.19654,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00019753,0.21654,0.24949,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00044439,0.21649,0.17027,1,1
1,GO REGULATION OF URINE VOLUME,0.00098941,0.21647,0.22207,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001662,0.2164,0.19404,1,1
1,GO PLASMA MEMBRANE FUSION,0.036164,0.21637,0.18681,1,1
1,GO RESPONSE TO RETINOIC ACID,0.0007696,0.21608,0.21074,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0011199,0.21592,0.21247,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,9.7346e-05,0.2159,0.26585,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0018173,0.21588,0.2003,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0029794,0.21587,0.17787,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00057693,0.21583,0.19268,1,1
1,GO LEUKOCYTE MIGRATION,0.0075304,0.21566,0.17549,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.0069616,0.21544,0.17107,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00050664,0.21527,0.20883,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,4.0073e-05,0.21526,0.17854,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.015574,0.21516,0.15113,1,1
1,GO VESICLE TARGETING,7.2754e-05,0.21491,0.22302,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0006154,0.21472,0.20847,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00030804,0.21456,0.19004,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0033369,0.21425,0.24762,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00032948,0.21412,0.1947,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,1.7118e-05,0.21408,0.19582,1,1
1,GO RNA PROCESSING,8.7323e-05,0.21369,0.16966,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.001228,0.21359,0.1608,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.050569,0.21355,0.23998,1,1
1,GO MRNA TRANSPORT,7.8282e-05,0.21354,0.1901,1,1
1,GO ORGANELLE INHERITANCE,0.00084609,0.21327,0.18272,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0022332,0.21308,0.17067,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00026003,0.21296,0.22886,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00020448,0.21268,0.16655,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00353,0.21267,0.22414,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0042883,0.21238,0.17149,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.011904,0.21229,0.21386,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.024846,0.2118,0.17286,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.042857,0.2118,0.11976,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0026572,0.21173,0.29046,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.0062634,0.21153,0.27922,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0022992,0.2115,0.21223,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,5.508e-06,0.21117,0.19448,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0011199,0.21109,0.16033,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0013457,0.21098,0.14793,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0013457,0.21078,0.20982,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0032441,0.21033,0.20221,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,2.9301e-06,0.2098,0.22786,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00020448,0.20918,0.22549,1,1
1,GO RNA METHYLATION,0.00027832,0.20916,0.19183,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0030654,0.2091,0.17716,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0017641,0.20902,0.20132,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.052669,0.20883,0.19179,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0020453,0.20854,0.176,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.013465,0.20852,0.16174,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00081984,0.20827,0.19659,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.030383,0.20823,0.24294,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,5.508e-06,0.20805,0.2105,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0022332,0.20801,0.19775,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00054072,0.20748,0.18107,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.013139,0.20736,0.14167,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00012074,0.20696,0.19564,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.00029782,0.20683,0.1866,1,1
1,GO ENDOSOME ORGANIZATION,0.00038934,0.20655,0.17273,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00044439,0.20654,0.17895,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0025083,0.20639,0.20065,1,1
1,GO MYELOID CELL DIFFERENTIATION,4.3218e-05,0.20609,0.17783,1,1
1,GO TOOTH MINERALIZATION,0.03245,0.2058,0.21843,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0036303,0.2057,0.18639,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0019282,0.20557,0.21352,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.047551,0.20552,0.17715,1,1
1,GO GRANULOCYTE CHEMOTAXIS,0.0081404,0.2054,0.23856,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.012203,0.20495,0.22614,1,1
1,GO RNA LOCALIZATION,8.4205e-05,0.20488,0.20366,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00021909,0.2047,0.18128,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00034072,0.20427,0.17861,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0010206,0.20418,0.21379,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,3.5759e-05,0.20392,0.19086,1,1
1,GO NEGATIVE T CELL SELECTION,0.054842,0.20383,0.16179,1,1
1,GO TRNA TRANSPORT,0.0041716,0.20381,0.18781,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.0001165,0.20346,0.22031,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0007696,0.20337,0.18647,1,1
1,GO PROTEIN MATURATION,0.00054072,0.20272,0.14604,1,1
1,GO STRESS FIBER ASSEMBLY,0.0019282,0.20259,0.2182,1,1
1,GO CELLULAR RESPONSE TO ATP,0.0010859,0.20257,0.19442,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0094949,0.20255,0.14998,1,1
1,GO REGULATION OF CELL CELL ADHESION,0.0031536,0.20235,0.15379,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,6.0504e-05,0.20228,0.20034,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00090094,0.20208,0.19098,1,1
1,GO PROTEIN AUTOPROCESSING,0.027803,0.20206,0.13198,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0037331,0.20191,0.21281,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0025083,0.20189,0.15971,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.0016129,0.20144,0.22573,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00032948,0.20137,0.28109,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0014738,0.20136,0.17577,1,1
1,GO REGULATION OF LIPID STORAGE,0.00098941,0.20122,0.23762,1,1
1,GO MITOTIC RECOMBINATION,0.0029794,0.20102,0.20263,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.001986,0.2006,0.21529,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00010462,0.2004,0.17371,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00025131,0.20037,0.22038,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.013139,0.20023,0.1707,1,1
1,GO TONGUE DEVELOPMENT,0.009256,0.2,0.24937,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0010206,0.19982,0.14742,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.00079435,0.19955,0.18518,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,3.3132e-05,0.19935,0.22181,1,1
1,GO MITOTIC CYTOKINESIS,0.0011549,0.19935,0.20166,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.0060989,0.19932,0.17847,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0007696,0.19931,0.23034,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0011199,0.19888,0.14247,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.0311e-06,0.19884,0.16361,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.00032948,0.19807,0.16933,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0011549,0.19791,0.17478,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.054842,0.19781,0.1425,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0099891,0.19748,0.16287,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00353,0.19721,0.15238,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0071468,0.19713,0.26421,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.8379e-05,0.19683,0.19881,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1.8251e-06,0.19672,0.19143,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0010206,0.19671,0.17792,1,1
1,GO LACTATION,0.0037331,0.1965,0.18953,1,1
1,GO REGULATION OF CELL ADHESION,0.0047853,0.19633,0.17584,1,1
1,GO CELL AGING,5.9841e-06,0.19624,0.21193,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0023671,0.19603,0.17005,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.0042883,0.19596,0.14517,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.0066042,0.19587,0.17961,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0017641,0.19564,0.192,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.031748,0.19555,0.15768,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00054072,0.1955,0.19151,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00025131,0.19549,0.19861,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,9.389e-05,0.19521,0.16845,1,1
1,GO TUBE MORPHOGENESIS,0.00044439,0.19429,0.20007,1,1
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.018398,0.19429,0.14614,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.018398,0.19402,0.1216,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.02268,0.19387,0.14544,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,1.9263e-05,0.19381,0.17199,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.0010859,0.19356,0.17729,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.017969,0.1933,0.12135,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0060989,0.19309,0.21152,1,1
1,GO RNA INTERFERENCE,0.034637,0.19302,0.15537,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.04854,0.19202,0.27113,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0060989,0.19191,0.16988,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.1888e-05,0.19162,0.19082,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00011241,0.19137,0.15548,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,6.0504e-05,0.19026,0.18671,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.18348,1,1
1,GO PROTEIN DENEDDYLATION,0.015203,0.18983,0.15017,1,1
1,GO NUCLEAR TRANSPORT,2.2524e-05,0.18981,0.162,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00028792,0.18977,0.19585,1,1
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.027188,0.18975,0.18581,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0062634,0.18975,0.33395,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0099891,0.18956,0.14537,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,0.00030804,0.18952,0.16505,1,1
1,GO B CELL ACTIVATION,0.0011549,0.1892,0.14484,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00041602,0.1892,0.24035,1,1
1,GO VACUOLAR ACIDIFICATION,0.0050528,0.18904,0.16947,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.03245,0.18866,0.18126,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011326,0.18863,0.17496,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,6.7596e-05,0.1883,0.20653,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0038387,0.18797,0.1835,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.004408,0.18779,0.16621,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.03245,0.18774,0.24951,1,1
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.029719,0.18741,0.17628,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00019753,0.1872,0.19555,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,1.1776e-06,0.18718,0.17151,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00027832,0.18711,0.19847,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.0083534,0.18702,0.15516,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00025131,0.18699,0.19125,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0090226,0.18693,0.20305,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.0087944,0.18691,0.12974,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,0.0036303,0.18681,0.16308,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.00079435,0.18661,0.17683,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.025414,0.18653,0.13034,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.011326,0.1863,0.15933,1,1
1,GO INFLAMMATORY RESPONSE,0.00057693,0.18622,0.22072,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,6.7728e-06,0.18588,0.22228,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.03939,0.18583,0.15983,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.012203,0.18558,0.19428,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00021167,0.18551,0.1963,1,1
1,GO CENTRIOLE ASSEMBLY,0.0031536,0.1853,0.13807,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00353,0.18519,0.2361,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.5201e-05,0.18498,0.14743,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,0.00027832,0.18497,0.16631,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,5.0226e-05,0.18486,0.16166,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00063551,0.18428,0.17359,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0010206,0.18421,0.19971,1,1
1,GO ESCRT COMPLEX DISASSEMBLY,0.044685,0.18403,0.15263,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0046564,0.18378,0.14717,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00059588,0.18356,0.33932,1,1
1,GO CELL CHEMOTAXIS,0.0064317,0.18333,0.18454,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00065623,0.18319,0.15843,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022332,0.183,0.18645,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.3528e-06,0.18256,0.169,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.025414,0.1824,0.21707,1,1
1,GO PROTEIN NEDDYLATION,0.0013457,0.18232,0.18801,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.012508,0.18231,0.24807,1,1
1,GO GOLGI VESICLE BUDDING,0.00049035,0.18208,0.18191,1,1
1,GO LEUKOCYTE DIFFERENTIATION,0.00040247,0.18194,0.16505,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00098941,0.18194,0.16927,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.4609e-05,0.18187,0.22785,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0038387,0.18145,0.17872,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.0017123,0.18141,0.14984,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00044439,0.18081,0.14485,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0057817,0.18074,0.21567,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,0.00010845,0.18067,0.15969,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.013465,0.18052,0.17049,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.0016129,0.18031,0.15188,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.02843,0.18029,0.18242,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0069616,0.18028,0.1636,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0026572,0.18006,0.16975,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,3.7145e-05,0.18001,0.20687,1,1
1,GO RNA CAPPING,4.0073e-05,0.17984,0.17955,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0030654,0.17981,0.15006,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00024286,0.17966,0.15591,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,8.7323e-05,0.1795,0.21587,1,1
1,GO AGING,0.00036427,0.1789,0.16438,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.025994,0.17885,0.14248,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0014738,0.17879,0.1828,1,1
1,GO LEUKOCYTE HOMEOSTASIS,0.00047456,0.1785,0.18476,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0013457,0.17841,0.15427,1,1
1,GO FACE DEVELOPMENT,0.0013054,0.17832,0.23535,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00069957,0.17739,0.17653,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.547e-05,0.17718,0.24985,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.17688,0.13697,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.022165,0.17619,0.14915,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,0.00029782,0.17532,0.19285,1,1
1,GO VACUOLAR TRANSPORT,0.0010528,0.17499,0.14663,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00018427,0.17497,0.14421,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.013798,0.17465,0.12585,1,1
1,GO HISTONE DEACETYLATION,0.00084609,0.17461,0.12594,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,2.9532e-05,0.17459,0.21057,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.00042998,0.17438,0.1474,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0010206,0.17413,0.16944,1,1
1,GO GOLGI VESICLE TRANSPORT,6.0504e-05,0.17379,0.15938,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,0.00010092,0.17348,0.18511,1,1
1,GO PROTEIN TARGETING,0.00072223,0.17315,0.15369,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00035231,0.17309,0.17913,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.012203,0.17266,0.17367,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.0012662,0.17242,0.17485,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.050569,0.17239,0.12843,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,6.2786e-05,0.17205,0.16352,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00020448,0.17203,0.17085,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0013457,0.172,0.1457,1,1
1,GO PROTEIN IMPORT,4.6597e-05,0.1717,0.1673,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0050528,0.17154,0.13589,1,1
1,GO STEROL IMPORT,0.0017123,0.17151,0.39713,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.013139,0.17146,0.16419,1,1
1,GO LYSOSOMAL TRANSPORT,0.0013457,0.17139,0.16093,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0010528,0.1712,0.14963,1,1
1,GO LEFT RIGHT PATTERN FORMATION,0.021165,0.17109,0.2111,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001662,0.17106,0.20749,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.6307e-05,0.17089,0.14946,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.0083534,0.17045,0.15005,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0056288,0.16934,0.1658,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0031536,0.16916,0.14135,1,1
1,GO RRNA 3 END PROCESSING,0.0025817,0.16903,0.17091,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0011549,0.16866,0.23149,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.050569,0.16865,0.18787,1,1
1,GO MRNA METABOLIC PROCESS,3.0689e-05,0.16862,0.16171,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.029068,0.16826,0.2146,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.001872,0.16809,0.11888,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.052669,0.16805,0.13802,1,1
1,GO IMPORT INTO NUCLEUS,0.00021909,0.16798,0.14618,1,1
1,GO DRUG METABOLIC PROCESS,0.045624,0.16779,0.091395,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00025131,0.1677,0.22018,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.036948,0.16759,0.14268,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00025131,0.16742,0.17059,1,1
1,GO SPINDLE LOCALIZATION,0.00057693,0.16731,0.15215,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0046564,0.16718,0.15797,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.021165,0.16695,0.1581,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00029782,0.16683,0.19198,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0051916,0.16668,0.17152,1,1
1,GO NEUTROPHIL MIGRATION,0.019739,0.16634,0.20815,1,1
1,GO REGULATION OF RESPONSE TO STRESS,0.00021167,0.16626,0.15059,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0034322,0.1658,0.13977,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.004408,0.1658,0.13995,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0051916,0.16574,0.13916,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021062,0.16567,0.18735,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.017969,0.16565,0.16147,1,1
1,GO COPII COATED VESICLE BUDDING,0.0011199,0.16531,0.18042,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00047456,0.16525,0.19027,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.012508,0.16523,0.14233,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00098941,0.16514,0.18856,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,3.5759e-05,0.16465,0.16368,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0029794,0.16464,0.13611,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0045306,0.16417,0.15017,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,1.6455e-05,0.16397,0.14746,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0034322,0.16395,0.15024,1,1
1,GO GLOMERULUS DEVELOPMENT,0.00041602,0.16344,0.34836,1,1
1,GO TRANSLESION SYNTHESIS,0.0007696,0.16296,0.16062,1,1
1,GO OSSIFICATION,0.010245,0.16293,0.15834,1,1
1,GO RESPONSE TO HEAT,0.00020448,0.1628,0.18267,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.030383,0.16267,0.11329,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0012662,0.16234,0.14102,1,1
1,GO TELOMERE ORGANIZATION,0.00047456,0.16219,0.14022,1,1
1,GO VACUOLE ORGANIZATION,0.0011199,0.16206,0.12945,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.1617e-05,0.16175,0.17398,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,0.02843,0.16166,0.1762,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00029782,0.16123,0.16036,1,1
1,GO RECEPTOR RECYCLING,0.020205,0.16122,0.12322,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0038387,0.16114,0.13758,1,1
1,GO PROTEIN POLYUBIQUITINATION,1.0184e-05,0.161,0.16219,1,1
1,GO SULFUR COMPOUND TRANSPORT,0.0022992,0.16089,0.13313,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00079435,0.1608,0.14446,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.017137,0.16069,0.14923,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.018398,0.16049,0.12005,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00081984,0.16045,0.16534,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0050528,0.16028,0.24521,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.02268,0.15957,0.11033,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.018836,0.15931,0.15302,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,4.8379e-05,0.15897,0.15164,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.0013872,0.15896,0.15697,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0029794,0.15896,0.1415,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00042998,0.15834,0.17673,1,1
1,GO RNA STABILIZATION,0.015203,0.15833,0.13609,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.05161,0.15801,0.23768,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,4.6623e-06,0.15801,0.16315,1,1
1,GO REGULATION OF MITOPHAGY,0.024288,0.15751,0.17925,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.037747,0.15746,0.18903,1,1
1,GO REGULATION OF LIPID TRANSPORT,0.0019282,0.15735,0.1424,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0045306,0.15703,0.11476,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,7.013e-05,0.15693,0.21631,1,1
1,GO PROTEOLYSIS,0.00017186,0.15686,0.13027,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE,0.0075304,0.1565,0.11965,1,1
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.024846,0.1565,0.1148,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.012203,0.15616,0.1432,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,2.8418e-05,0.15603,0.13904,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0046564,0.15523,0.17671,1,1
1,GO REGULATION OF VASOCONSTRICTION,0.0028957,0.15513,0.20814,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00019079,0.15488,0.1393,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.011612,0.15445,0.15974,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,4.0073e-05,0.154,0.14843,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00012512,0.15364,0.1497,1,1
1,GO MAINTENANCE OF LOCATION,9.0551e-05,0.1534,0.16322,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,5.0226e-05,0.15305,0.17078,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00017796,0.15291,0.17667,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00087311,0.15278,0.17229,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.013139,0.15267,0.12754,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0039469,0.15242,0.13091,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,0.00059588,0.15239,0.15364,1,1
1,GO BONE DEVELOPMENT,0.0029794,0.15235,0.17777,1,1
1,GO PROTEIN CATABOLIC PROCESS,4.3218e-05,0.15231,0.13385,1,1
1,GO REPLACEMENT OSSIFICATION,0.025994,0.15222,0.21449,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,1.5816e-05,0.15213,0.15624,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0085714,0.15194,0.20737,1,1
1,GO ANIMAL ORGAN FORMATION,0.053746,0.15173,0.14129,1,1
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0073363,0.15168,0.11887,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.023205,0.15153,0.29717,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.0010206,0.15136,0.1577,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00098941,0.15101,0.13665,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.0017123,0.15088,0.11461,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.02068,0.15085,0.17911,1,1
1,GO DNA BIOSYNTHETIC PROCESS,2.0784e-06,0.15081,0.16466,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0051916,0.15039,0.16887,1,1
1,GO TUBE DEVELOPMENT,0.0038387,0.15007,0.15137,1,1
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0064317,0.14993,0.15936,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.017549,0.1498,0.17049,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.027188,0.14962,0.15942,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.001662,0.14949,0.274,1,1
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.023741,0.14916,0.13149,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0040578,0.14901,0.13855,1,1
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.030383,0.14878,0.1342,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.0051916,0.14871,0.13627,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0025083,0.14833,0.15994,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.043763,0.14784,0.10534,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.00021167,0.14777,0.15679,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.049546,0.14774,0.16738,1,1
1,GO REGULATION OF BINDING,0.0050528,0.14765,0.11736,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00034072,0.14734,0.13433,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00042998,0.14727,0.15282,1,1
1,GO PIGMENT GRANULE ORGANIZATION,0.026586,0.14705,0.19356,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.011612,0.14682,0.15816,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00012074,0.14654,0.14448,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00065623,0.14653,0.13666,1,1
1,GO REGULATION OF PROTEIN BINDING,0.0014299,0.14649,0.14025,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0085714,0.14636,0.12619,1,1
1,GO REGULATION OF CATABOLIC PROCESS,8.3127e-06,0.14626,0.14718,1,1
1,GO REGULATION OF CELL DEATH,0.0007696,0.14611,0.12253,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001228,0.14597,0.12798,1,1
1,GO CHROMOSOME LOCALIZATION,0.027803,0.14565,0.11549,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0069616,0.14544,0.11061,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.01282,0.1452,0.12295,1,1
1,GO NEURAL TUBE FORMATION,0.013798,0.14497,0.16372,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00079435,0.14495,0.13429,1,1
1,GO NCRNA CATABOLIC PROCESS,0.044685,0.14454,0.1379,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00087311,0.14452,0.12345,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00025131,0.1445,0.17725,1,1
1,GO TRANSCYTOSIS,0.033894,0.14396,0.14216,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,0.0047853,0.14396,0.19645,1,1
1,GO BLASTOCYST GROWTH,0.0083534,0.14348,0.22245,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.024288,0.14317,0.15704,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00057693,0.14298,0.11548,1,1
1,GO RESPONSE TO UV,0.0017641,0.14281,0.13692,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00021909,0.14279,0.13806,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.00044439,0.14278,0.17324,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0075304,0.14268,0.14133,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.024288,0.14254,0.13236,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.0023671,0.14251,0.10571,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.052669,0.14225,0.097928,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00042998,0.1422,0.18317,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0012662,0.14083,0.17403,1,1
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.054842,0.1408,0.083507,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.010773,0.14075,0.13709,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.0022332,0.14047,0.11008,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.014138,0.14036,0.13203,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,5.2139e-05,0.14031,0.13611,1,1
1,GO GENE SILENCING,6.5149e-05,0.14012,0.13875,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0045306,0.13997,0.15474,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.0025817,0.13995,0.12351,1,1
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.05161,0.13963,0.12189,1,1
1,GO POSTREPLICATION REPAIR,0.00063551,0.13961,0.14206,1,1
1,GO CELLULAR RESPONSE TO UV,0.0067808,0.13961,0.12866,1,1
1,GO TRABECULA MORPHOGENESIS,0.02843,0.13919,0.18404,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,4.0073e-05,0.13859,0.17591,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,0.00074557,0.13806,0.17902,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.035393,0.13771,0.095157,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.0016129,0.13765,0.12558,1,1
1,GO RESPONSE TO CHEMOKINE,0.023205,0.13739,0.17569,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.013139,0.13709,0.10573,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0016129,0.13689,0.13978,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.010245,0.13688,0.19336,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.034637,0.13605,0.069149,1,1
1,GO RESPONSE TO LIPID,0.0041716,0.13589,0.14131,1,1
1,GO NUCLEUS ORGANIZATION,0.019739,0.13547,0.10785,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.007729,0.13541,0.19393,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.017137,0.13522,0.10809,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0053338,0.13485,0.089591,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0020453,0.1348,0.18059,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.040234,0.13471,0.17964,1,1
1,GO BODY MORPHOGENESIS,0.038561,0.13442,0.13415,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.0045306,0.13415,0.20023,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,3.7145e-05,0.13404,0.14585,1,1
1,GO REGULATION OF MAPK CASCADE,0.0030654,0.13398,0.1297,1,1
1,GO EXOCYTOSIS,0.0057817,0.13386,0.11791,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.0087944,0.13381,0.10975,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.0047853,0.13368,0.1155,1,1
1,GO STEM CELL DIFFERENTIATION,0.00014418,0.13358,0.16694,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0090226,0.13328,0.16162,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,0.021165,0.13301,0.15418,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00052342,0.13283,0.13973,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.0013872,0.13276,0.091691,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.0023671,0.13261,0.14533,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.001228,0.13258,0.14901,1,1
1,GO VIRAL BUDDING,0.0013872,0.13218,0.16172,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015953,0.13196,0.097798,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.00026003,0.13195,0.13512,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.01282,0.13191,0.12295,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0011199,0.13146,0.14455,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0025083,0.13123,0.098971,1,1
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.055956,0.13099,0.13986,1,1
1,GO REGULATION OF CHEMOTAXIS,0.017969,0.13062,0.11933,1,1
1,GO GENITALIA DEVELOPMENT,0.025414,0.13028,0.098901,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0037331,0.13023,0.14715,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00074557,0.13002,0.1283,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0036303,0.12977,0.10798,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.013798,0.1297,0.092286,1,1
1,GO MRNA 3 END PROCESSING,0.0030654,0.12957,0.13614,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.00087311,0.12952,0.1097,1,1
1,GO RESPONSE TO LEPTIN,0.05161,0.12928,0.15102,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,0.00031859,0.12923,0.15068,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.00087311,0.12876,0.12337,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.025994,0.12869,0.12267,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0046564,0.12865,0.13428,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.041093,0.12846,0.11738,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.012203,0.12816,0.097961,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0062634,0.12811,0.16599,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.0038387,0.12743,0.12521,1,1
1,GO METAPHASE PLATE CONGRESSION,0.015203,0.1273,0.11905,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013798,0.12646,0.11062,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036303,0.12635,0.12276,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00353,0.12631,0.13138,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.029719,0.1261,0.18239,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.011612,0.12584,0.11961,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02068,0.12549,0.11746,1,1
1,GO ORGAN GROWTH,0.0031536,0.12521,0.16762,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.019739,0.12488,0.12086,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.0045306,0.12407,0.091485,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00052342,0.124,0.21988,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.001228,0.12391,0.11067,1,1
1,GO CYTOKINESIS,0.0090226,0.12373,0.10505,1,1
1,GO APOPTOTIC PROCESS,0.00079435,0.1235,0.11336,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0060989,0.12251,0.11351,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0030654,0.12241,0.13441,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00025131,0.12222,0.11303,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0083534,0.12215,0.1213,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.018836,0.1221,0.13221,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00022676,0.12208,0.11276,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0019282,0.12207,0.16077,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.016339,0.12191,0.12156,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.041093,0.12171,0.096139,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.029719,0.12141,0.12932,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0049174,0.12098,0.11163,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0041716,0.12088,0.094183,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0025817,0.12022,0.12142,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0027346,0.11978,0.10976,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.013465,0.11876,0.1654,1,1
1,GO REGULATION OF HISTONE UBIQUITINATION,0.0081404,0.11871,0.14013,1,1
1,GO CELL DIVISION,0.012508,0.11853,0.091467,1,1
1,GO REGULATION OF OSSIFICATION,0.022165,0.11837,0.15118,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.015574,0.11826,0.089286,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.042857,0.11822,0.12083,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.046579,0.11822,0.14724,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00030804,0.11775,0.12763,1,1
1,GO GOLGI ORGANIZATION,0.0051916,0.11731,0.11124,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.04854,0.11726,0.091386,1,1
1,GO CELLULAR SENESCENCE,0.0029794,0.11703,0.12509,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0073363,0.11682,0.11664,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0014299,0.11625,0.12088,1,1
1,GO TISSUE MORPHOGENESIS,0.001662,0.11597,0.15024,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0071468,0.11568,0.12432,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.0049174,0.11547,0.16403,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00084609,0.11502,0.1375,1,1
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0087944,0.1146,0.10431,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0036303,0.11335,0.11658,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0047853,0.11332,0.10566,1,1
1,GO REGULATION OF DNA REPLICATION,0.012508,0.11296,0.094317,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0001165,0.11294,0.12809,1,1
1,GO REGULATION OF AUTOPHAGY,0.0010528,0.11277,0.11173,1,1
1,GO MEMBRANE ORGANIZATION,0.013139,0.11274,0.082158,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.017137,0.11223,0.097598,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.041093,0.11204,0.11507,1,1
1,GO ORGANELLE FISSION,0.02843,0.11178,0.076591,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00054072,0.11155,0.103,1,1
1,GO FEMALE GAMETE GENERATION,0.01282,0.11153,0.081845,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0064317,0.11115,0.094958,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.00055855,0.1109,0.15421,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.043763,0.11009,0.13576,1,1
1,GO HEART GROWTH,0.043763,0.10984,0.1187,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0020453,0.10974,0.10906,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.00011241,0.10894,0.118,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.010506,0.10883,0.12597,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0019282,0.10861,0.11321,1,1
1,GO MRNA EXPORT FROM NUCLEUS,0.010506,0.10851,0.11208,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00353,0.10794,0.091252,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00063551,0.1076,0.12054,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00012074,0.10751,0.10516,1,1
1,GO MACROAUTOPHAGY,7.547e-05,0.10746,0.13176,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.0018173,0.10742,0.096355,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.013e-05,0.10712,0.10474,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.013465,0.10624,0.14125,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.0011199,0.10561,0.10639,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001228,0.10557,0.18316,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.0021689,0.10542,0.11328,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.017549,0.1053,0.083644,1,1
1,GO B CELL DIFFERENTIATION,0.027188,0.10446,0.10894,1,1
1,GO SPINDLE ORGANIZATION,0.046579,0.10392,0.088331,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.016734,0.10354,0.13362,1,1
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.036948,0.10305,0.10625,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0023671,0.10292,0.1301,1,1
1,GO REGULATION OF DNA REPAIR,0.011612,0.10232,0.091418,1,1
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.038561,0.10224,0.06092,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.038561,0.10135,0.078448,1,1
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.014486,0.10134,0.12466,1,1
1,GO RNA SURVEILLANCE,0.00353,0.10112,0.16302,1,1
1,GO MITOTIC CELL CYCLE,0.00353,0.10003,0.098733,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0018173,0.099729,0.072648,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.027803,0.09936,0.087252,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.034637,0.098714,0.094361,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.035393,0.098571,0.090304,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.035393,0.098241,0.086669,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00045924,0.098195,0.091999,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.035393,0.09817,0.082267,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00026903,0.098126,0.094432,1,1
1,GO RUFFLE ASSEMBLY,0.015203,0.096832,0.11848,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.0062634,0.096651,0.096257,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0029794,0.096475,0.099852,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0073363,0.096333,0.094354,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013798,0.096307,0.08611,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0034322,0.096167,0.10662,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.029068,0.095725,0.084299,1,1
1,GO CHROMOSOME SEPARATION,0.017137,0.095352,0.12818,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.00353,0.094944,0.089031,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.0053338,0.093448,0.089749,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.093265,0.10591,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.009256,0.093032,0.07966,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.092091,0.13185,1,1
1,GO CELL CYCLE PROCESS,0.011612,0.092088,0.07622,1,1
1,GO ORGANELLE DISASSEMBLY,0.0014738,0.091245,0.11025,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.031059,0.0906,0.085434,1,1
1,GO DNA METABOLIC PROCESS,0.00063551,0.090204,0.095756,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.007729,0.089732,0.087781,1,1
1,GO IRON ION TRANSPORT,0.017137,0.08938,0.085667,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.042857,0.088474,0.11477,1,1
1,GO TUBE FORMATION,0.029719,0.08837,0.11836,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0046564,0.088307,0.11812,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0064317,0.08754,0.071453,1,1
1,GO RESPONSE TO PEPTIDE,0.026586,0.087436,0.072104,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.009256,0.086876,0.082554,1,1
1,GO REGULATION OF CELL CYCLE,0.015574,0.086329,0.066633,1,1
1,GO ENDOCYTOSIS,0.009256,0.086194,0.10299,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00047456,0.085755,0.085941,1,1
1,GO SNRNA TRANSCRIPTION,0.0042883,0.085252,0.099109,1,1
1,GO DNA INTEGRITY CHECKPOINT,0.050569,0.084952,0.079297,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.015574,0.084843,0.10019,1,1
1,GO CELL CELL SIGNALING BY WNT,0.047551,0.084622,0.094761,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.014486,0.083716,0.077738,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017549,0.083705,0.053928,1,1
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.015953,0.083256,0.067405,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00035231,0.082616,0.10252,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.025994,0.082129,0.090953,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011904,0.081474,0.12437,1,1
1,GO HEART DEVELOPMENT,0.021165,0.080762,0.11303,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.034637,0.080452,0.059552,1,1
1,GO RESPONSE TO HORMONE,0.019283,0.080122,0.084885,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.010245,0.078081,0.096371,1,1
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.050569,0.077702,0.080763,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.035393,0.077628,0.081701,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.031748,0.077543,0.066286,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.011047,0.077444,0.091997,1,1
1,GO SULFATE TRANSPORT,0.03939,0.077033,0.082838,1,1
1,GO CELL CYCLE,0.018398,0.077,0.063208,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.031748,0.076283,0.066856,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.018836,0.075809,0.094948,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.025994,0.075168,0.11064,1,1
1,GO CELL CYCLE CHECKPOINT,0.016339,0.075122,0.079891,1,1
1,GO CHROMOSOME SEGREGATION,0.038561,0.074881,0.082981,1,1
1,GO DOUBLE STRAND BREAK REPAIR,0.0069616,0.074853,0.10312,1,1
1,GO DNA MODIFICATION,0.017549,0.074223,0.088602,1,1
1,GO CHROMOSOME CONDENSATION,0.009256,0.074131,0.12035,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.046579,0.073238,0.061459,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.031059,0.072369,0.064581,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.02843,0.070309,0.083239,1,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.016734,0.070249,0.083786,1,1
1,GO INTRACELLULAR TRANSPORT,0.0054795,0.069634,0.064029,1,1
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.047551,0.067762,0.074774,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.013798,0.066613,0.075086,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.03939,0.064966,0.089485,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.036948,0.063781,0.065656,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.054842,0.062556,0.11441,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.021165,0.061405,0.11174,1,1
1,GO DNA CATABOLIC PROCESS,0.052669,0.060456,0.054951,1,1
1,GO DNA RECOMBINATION,0.02268,0.059759,0.095868,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.027803,0.059605,0.059179,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.033894,0.059151,0.076623,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.036164,0.058854,0.098284,1,1
1,GO DNA REPAIR,0.0060989,0.058216,0.084605,1,1
1,GO ENDOSOMAL TRANSPORT,0.023205,0.055684,0.077908,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.03939,0.039935,0.087105,1,1
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
2,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
2,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
2,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
2,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
2,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
2,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
2,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
2,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
2,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
2,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
2,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
2,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
2,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
2,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
2,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
2,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
2,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
2,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
2,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
2,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
2,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
2,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
2,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
2,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
2,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
2,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
2,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
2,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
2,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
2,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
2,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
2,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
2,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
2,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
2,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
2,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
2,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,1
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
2,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
2,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
2,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
2,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
2,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
2,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
2,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
2,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
2,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
2,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
2,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
2,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
2,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
2,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
2,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
2,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
2,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
2,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
2,GO GLYCINE METABOLIC PROCESS,0.054842,0.29931,0.20115,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
2,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
2,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
2,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
2,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
2,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.054842,0.29297,0.1712,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
2,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
2,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
2,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
2,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
2,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
2,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
2,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
2,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
2,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
2,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
2,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,1
2,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
2,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
2,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
2,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
2,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
2,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
2,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
2,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
2,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
2,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
2,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,1,1
2,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
2,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.054842,0.24402,0.13174,1,1
2,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
2,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
2,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
2,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
2,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
2,GO POLYOL TRANSPORT,0.0079323,0.23114,0.18719,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
2,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
2,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
2,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
2,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
2,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
2,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
2,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
2,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
2,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
2,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
2,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
2,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
2,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
2,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
2,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
2,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
2,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
2,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
2,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
2,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
2,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
2,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
2,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
2,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
2,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
2,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
2,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
2,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
2,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
2,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.013798,0.18278,0.18877,1,1
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
2,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
2,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
2,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
2,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
2,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
2,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
2,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
2,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
2,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
2,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
2,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
2,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
2,GO REGULATION OF CARDIAC CONDUCTION,0.024846,0.15042,0.12439,1,1
2,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
2,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,1,1
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,1
2,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
2,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
2,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
2,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
2,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
2,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
2,GO LIMBIC SYSTEM DEVELOPMENT,0.04854,0.13163,0.11612,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
2,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
2,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
2,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
2,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
2,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
2,GO MATING,0.033166,0.12237,0.091484,1,1
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
2,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
2,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,1
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
2,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,1
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
2,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
2,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
2,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
2,GO MITOTIC RECOMBINATION,0.03939,0.10239,0.12336,1,1
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
2,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
2,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
2,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
2,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,1
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
2,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
2,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.011326,0.094873,0.17996,1,1
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.041967,0.09449,0.13653,1,1
2,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
2,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,1,1
2,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
2,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.029068,0.08883,0.090382,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0012662,0.08686,0.10335,1,1
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
2,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
2,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
2,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.038561,0.038589,0.066038,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,6.0504e-05,1.8686,1.3798,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,5.4121e-05,1.4114,1.1209,1,1
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.2962e-05,1.2851,1.0997,1,1
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00037661,1.0456,0.76649,1,1
3,GO CYTIDINE TO URIDINE EDITING,7.3528e-06,0.92319,0.82151,1,1
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0013457,0.88987,0.68725,1,1
3,GO TOLERANCE INDUCTION,5.0683e-06,0.85031,0.78415,1,1
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.00012964,0.84853,0.59727,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00020448,0.8432,0.60034,1,1
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.0184e-05,0.81403,0.63864,1,1
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,9.8628e-07,0.79225,0.8409,1,1
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,2.4346e-05,0.78029,0.89063,1,1
3,GO REGULATION OF PLASMINOGEN ACTIVATION,0.00069957,0.77947,0.5265,1,1
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00026003,0.77062,0.4711,1,1
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.2454e-05,0.76213,0.67032,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,8.628e-07,0.76209,0.71371,1,1
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00010845,0.75763,0.55319,1,1
3,GO RESPONSE TO TYPE I INTERFERON,2.2658e-06,0.7406,0.68925,1,1
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,6.2367e-06,0.73465,0.64924,1,1
3,GO HISTAMINE SECRETION,2.0829e-07,0.72977,0.77482,1,1
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,7.8282e-05,0.69776,0.56333,1,1
3,GO GERMINAL CENTER FORMATION,1.104e-05,0.6869,0.60506,1,1
3,GO REGULATION OF TOLERANCE INDUCTION,3.0689e-05,0.68331,0.63422,1,1
3,GO LIPID DROPLET FORMATION,1.4044e-06,0.68312,0.72508,1,1
3,GO MUCUS SECRETION,0.00034072,0.67366,0.60677,1,1
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.906e-06,0.66532,0.62767,1,1
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,3.7791e-06,0.66472,0.61696,1,1
3,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00013433,0.66314,0.61703,1,1
3,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.8251e-06,0.65948,0.71164,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.0226e-05,0.65947,0.52454,1,1
3,GO HISTAMINE TRANSPORT,2.2879e-07,0.65932,0.73168,1,1
3,GO DOPAMINE BIOSYNTHETIC PROCESS,7.547e-05,0.65554,0.64528,1,1
3,GO RENAL ABSORPTION,5.0683e-06,0.65533,0.7054,1,1
3,GO T CELL MEDIATED CYTOTOXICITY,7.547e-05,0.65499,0.54066,1,1
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,2.5308e-05,0.6532,0.54831,1,1
3,GO ACTIN FILAMENT NETWORK FORMATION,0.00010092,0.64983,0.54247,1,1
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,3.0576e-06,0.64432,0.57427,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00021909,0.6403,0.53806,1,1
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00098941,0.63482,0.56601,1,1
3,GO POSITIVE REGULATION OF CELL MATURATION,2.6902e-06,0.63467,0.59936,1,1
3,GO MATURE B CELL DIFFERENTIATION,1.6455e-05,0.63305,0.46588,1,1
3,GO RESPONSE TO IMMOBILIZATION STRESS,1.4044e-06,0.63177,0.51429,1,1
3,GO PROGESTERONE METABOLIC PROCESS,0.00042998,0.62954,0.73486,1,1
3,GO DENDRITIC CELL DIFFERENTIATION,1.4609e-05,0.62672,0.52261,1,1
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,1.0604e-05,0.62318,0.51056,1,1
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.4728e-06,0.62186,0.65109,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00019079,0.62185,0.66257,1,1
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00067758,0.61735,0.50929,1,1
3,GO EOSINOPHIL MIGRATION,7.547e-05,0.61631,0.4941,1,1
3,GO RESPONSE TO NITROSATIVE STRESS,7.3528e-06,0.61391,0.56222,1,1
3,GO EOSINOPHIL CHEMOTAXIS,7.8282e-05,0.61246,0.49708,1,1
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,2.8077e-06,0.60825,0.58468,1,1
3,GO INTESTINAL ABSORPTION,1.4268e-07,0.60799,0.67455,1,1
3,GO RESPONSE TO INTERFERON BETA,0.00084609,0.60465,0.45609,1,1
3,GO DETECTION OF OTHER ORGANISM,4.2876e-06,0.60366,0.6244,1,1
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,1.6455e-05,0.59806,0.57766,1,1
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,1.104e-05,0.58873,0.46986,1,1
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.5774e-06,0.58747,0.57759,1,1
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.3418e-05,0.58705,0.64077,1,1
3,GO O GLYCAN PROCESSING,7.2756e-08,0.58593,0.58654,1,1
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,3.0689e-05,0.58386,0.47297,1,1
3,GO INTESTINAL LIPID ABSORPTION,7.3528e-06,0.58019,0.67119,1,1
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.6623e-06,0.58018,0.55528,1,1
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.4712e-06,0.57903,0.55582,1,1
3,GO GLYCOLIPID CATABOLIC PROCESS,1.349e-05,0.57833,0.57936,1,1
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.013e-05,0.57502,0.42532,1,1
3,GO SEROTONIN METABOLIC PROCESS,3.0689e-05,0.57342,0.56144,1,1
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00031859,0.57229,0.44688,1,1
3,GO RESPONSE TO INTERLEUKIN 18,0.00012964,0.57202,0.58348,1,1
3,GO GLYCOSIDE METABOLIC PROCESS,0.0034322,0.56936,0.69358,1,1
3,GO ADHESION OF SYMBIONT TO HOST,1.7118e-05,0.56592,0.51976,1,1
3,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.0025083,0.56527,0.55152,1,1
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.0784e-06,0.56359,0.56959,1,1
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,5.508e-06,0.55362,0.56044,1,1
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,8.3127e-06,0.55253,0.52474,1,1
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,8.628e-07,0.55026,0.55943,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00010845,0.54979,0.43297,1,1
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,4.6623e-06,0.54905,0.49028,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040247,0.54886,0.48798,1,1
3,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00090094,0.54754,0.45803,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,1.0184e-05,0.54749,0.58948,1,1
3,GO RESPONSE TO COLD,9.7275e-08,0.54652,0.49797,1,1
3,GO LABYRINTHINE LAYER MORPHOGENESIS,8.7323e-05,0.54562,0.54202,1,1
3,GO SPHINGOMYELIN METABOLIC PROCESS,4.1802e-07,0.54197,0.53928,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0007696,0.54111,0.39955,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.3418e-05,0.53818,0.4496,1,1
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00049035,0.53498,0.51637,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00027832,0.53288,0.55561,1,1
3,GO REGULATION OF WATER LOSS VIA SKIN,1.2962e-05,0.53073,0.50959,1,1
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0073363,0.52689,0.35263,1,1
3,GO REGULATION OF PLATELET AGGREGATION,4.0073e-05,0.52634,0.47698,1,1
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0006154,0.52603,0.41375,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,6.4994e-06,0.52584,0.45497,1,1
3,GO KETONE CATABOLIC PROCESS,0.00092958,0.52361,0.46842,1,1
3,GO CERAMIDE CATABOLIC PROCESS,0.00021909,0.522,0.46185,1,1
3,GO TOXIN METABOLIC PROCESS,6.8936e-07,0.51812,0.54734,1,1
3,GO LIPID DIGESTION,4.3218e-05,0.51795,0.58843,1,1
3,GO REGULATION OF PLATELET ACTIVATION,1.7474e-06,0.5161,0.4628,1,1
3,GO NEGATIVE REGULATION OF ANOIKIS,2.9532e-05,0.51559,0.63075,1,1
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00045924,0.51347,0.46987,1,1
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00038934,0.51166,0.46705,1,1
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00012964,0.51147,0.50834,1,1
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,9.7346e-05,0.5114,0.43952,1,1
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.0784e-06,0.511,0.43294,1,1
3,GO RESPONSE TO EPINEPHRINE,0.0023671,0.51035,0.36265,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00021167,0.50938,0.47195,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00010845,0.50847,0.44271,1,1
3,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,3.4421e-05,0.50799,0.56102,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,7.9801e-06,0.50785,0.509,1,1
3,GO ALPHA BETA T CELL PROLIFERATION,5.0683e-06,0.5073,0.42884,1,1
3,GO MICROVILLUS ORGANIZATION,6.5149e-05,0.50571,0.42802,1,1
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,4.0073e-05,0.50529,0.5496,1,1
3,GO LEYDIG CELL DIFFERENTIATION,0.00017796,0.50503,0.52752,1,1
3,GO NEGATIVE REGULATION OF BONE REMODELING,5.0683e-06,0.50383,0.54091,1,1
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,3.7145e-05,0.50187,0.44323,1,1
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,3.1904e-06,0.50107,0.60137,1,1
3,GO PHAGOLYSOSOME ASSEMBLY,1.5331e-06,0.49854,0.51077,1,1
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.5896e-07,0.49426,0.45239,1,1
3,GO SUPEROXIDE ANION GENERATION,9.7801e-06,0.49258,0.46357,1,1
3,GO ACTIN FILAMENT SEVERING,0.00072223,0.49226,0.41905,1,1
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,1.5201e-05,0.49102,0.41043,1,1
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,2.9532e-05,0.4905,0.55658,1,1
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.8282e-05,0.49024,0.37533,1,1
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0083534,0.48947,0.50379,1,1
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,7.8282e-05,0.48935,0.40951,1,1
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,4.6623e-06,0.48811,0.49115,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,6.2786e-05,0.48408,0.4135,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0001165,0.48394,0.44288,1,1
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0010528,0.48295,0.31272,1,1
3,GO REGULATION OF INTEGRIN ACTIVATION,1.1267e-06,0.48196,0.50931,1,1
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,7.547e-05,0.48186,0.4162,1,1
3,GO RESPONSE TO DIETARY EXCESS,1.1493e-05,0.48098,0.47393,1,1
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019079,0.47975,0.40714,1,1
3,GO BARBED END ACTIN FILAMENT CAPPING,0.00014935,0.47903,0.44768,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,2.7343e-05,0.47706,0.48913,1,1
3,GO REGULATION OF TISSUE REMODELING,7.2111e-07,0.47639,0.42627,1,1
3,GO REGULATION OF MYOBLAST FUSION,2.5308e-05,0.47453,0.40957,1,1
3,GO REGULATION OF BONE REMODELING,5.753e-07,0.4727,0.48385,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,3.5759e-05,0.47119,0.45868,1,1
3,GO GALACTOSE METABOLIC PROCESS,1.7806e-05,0.47058,0.57245,1,1
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.017969,0.47049,0.24748,1,1
3,GO PLASMINOGEN ACTIVATION,0.00028792,0.47035,0.46981,1,1
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00027832,0.47028,0.39968,1,1
3,GO CELLULAR DEFENSE RESPONSE,5.4977e-07,0.46944,0.46523,1,1
3,GO REGULATION OF NEURON MATURATION,2.6902e-06,0.46918,0.44646,1,1
3,GO EPITHELIAL CELL MORPHOGENESIS,0.00018427,0.46676,0.40776,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00014935,0.46528,0.4766,1,1
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,9.8628e-07,0.46449,0.47648,1,1
3,GO HEPATOCYTE APOPTOTIC PROCESS,0.0015653,0.46331,0.46288,1,1
3,GO ZYMOGEN ACTIVATION,4.8379e-05,0.46214,0.44305,1,1
3,GO IMMUNOGLOBULIN SECRETION,0.00013917,0.46006,0.37894,1,1
3,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,6.5149e-05,0.46,0.5031,1,1
3,GO CELL ADHESION MEDIATED BY INTEGRIN,1.2962e-05,0.4586,0.43176,1,1
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.4712e-06,0.45785,0.50089,1,1
3,GO SIGNAL PEPTIDE PROCESSING,7.9801e-06,0.45727,0.44568,1,1
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0047853,0.45709,0.32171,1,1
3,GO FOAM CELL DIFFERENTIATION,1.0184e-05,0.45689,0.39678,1,1
3,GO FRUCTOSE METABOLIC PROCESS,0.0019282,0.4567,0.4931,1,1
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.3528e-06,0.45632,0.49088,1,1
3,GO BONE RESORPTION,3.17e-07,0.45599,0.4754,1,1
3,GO MITOCHONDRIAL DEPOLARIZATION,2.6902e-06,0.45468,0.42244,1,1
3,GO RESPONSE TO REDOX STATE,0.00059588,0.45409,0.32958,1,1
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,6.2786e-05,0.45333,0.40313,1,1
3,GO MEMBRANE LIPID CATABOLIC PROCESS,1.2454e-05,0.45268,0.47274,1,1
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.5149e-05,0.45244,0.41024,1,1
3,GO RESPONSE TO STEROL DEPLETION,1.6729e-06,0.44979,0.50642,1,1
3,GO REGULATION OF FIBRINOLYSIS,0.00036427,0.44959,0.40134,1,1
3,GO PROTEIN DEGLYCOSYLATION,9.7801e-06,0.44919,0.42669,1,1
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.1964e-05,0.44823,0.41247,1,1
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00019753,0.44737,0.45263,1,1
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,2.7343e-05,0.44732,0.50567,1,1
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00032948,0.44658,0.34564,1,1
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00087311,0.44649,0.34484,1,1
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.00032948,0.44564,0.42341,1,1
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,2.1663e-05,0.4452,0.44876,1,1
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,6.4994e-06,0.44454,0.48983,1,1
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00067758,0.44375,0.30524,1,1
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.0551e-05,0.4425,0.38421,1,1
3,GO REGULATION OF CHOLESTEROL ESTERIFICATION,5.2139e-05,0.44208,0.58756,1,1
3,GO QUINONE METABOLIC PROCESS,0.00014418,0.44202,0.57893,1,1
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.7118e-05,0.44142,0.36999,1,1
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,5.7413e-06,0.44076,0.48663,1,1
3,GO T CELL MEDIATED IMMUNITY,0.00013433,0.44007,0.3395,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00036427,0.43919,0.43403,1,1
3,GO REGULATORY T CELL DIFFERENTIATION,5.0226e-05,0.43866,0.39951,1,1
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.3418e-05,0.43865,0.39356,1,1
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,5.4121e-05,0.43846,0.36596,1,1
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,5.7413e-06,0.43836,0.3857,1,1
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00069957,0.43706,0.37884,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.9904e-06,0.43605,0.48305,1,1
3,GO STEROID ESTERIFICATION,1.7806e-05,0.43604,0.57379,1,1
3,GO ENDOTHELIAL CELL CHEMOTAXIS,5.0226e-05,0.43481,0.38825,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00024286,0.4346,0.46187,1,1
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.0571e-06,0.43454,0.41352,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.4039e-05,0.43359,0.45431,1,1
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00090094,0.43308,0.34103,1,1
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,5.0683e-06,0.43215,0.40331,1,1
3,GO RESPONSE TO INTERLEUKIN 15,0.001191,0.43116,0.30786,1,1
3,GO ENTRY INTO HOST,0.00010845,0.43018,0.30049,1,1
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00353,0.43008,0.40568,1,1
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.0085714,0.42937,0.29304,1,1
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.00092958,0.42905,0.39628,1,1
3,GO LIVER MORPHOGENESIS,9.7346e-05,0.42898,0.40792,1,1
3,GO RESPONSE TO INTERFERON GAMMA,2.6307e-05,0.42877,0.38362,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00029782,0.42872,0.39608,1,1
3,GO NEUROTRANSMITTER METABOLIC PROCESS,1.1493e-05,0.42794,0.40012,1,1
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.041093,0.42757,0.22351,1,1
3,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.029068,0.42724,0.25083,1,1
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,3.1888e-05,0.42694,0.38713,1,1
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,4.4878e-05,0.42591,0.32745,1,1
3,GO RESPONSE TO THYROID HORMONE,6.0504e-05,0.42573,0.38198,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00016023,0.42494,0.35251,1,1
3,GO REGULATION OF VIRAL GENOME REPLICATION,0.00010092,0.42415,0.3294,1,1
3,GO PROTEIN O LINKED GLYCOSYLATION,1.6452e-07,0.42401,0.39682,1,1
3,GO L PHENYLALANINE METABOLIC PROCESS,3.4421e-05,0.42376,0.63389,1,1
3,GO INTRACELLULAR STEROL TRANSPORT,3.1888e-05,0.42364,0.37517,1,1
3,GO ICOSANOID METABOLIC PROCESS,2.4692e-06,0.42324,0.39274,1,1
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.018836,0.42318,0.35364,1,1
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00090094,0.42307,0.37313,1,1
3,GO IMMUNOLOGICAL MEMORY PROCESS,4.0073e-05,0.42166,0.39437,1,1
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00029782,0.42101,0.47855,1,1
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.3418e-05,0.42065,0.3965,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0006154,0.42061,0.3421,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0001165,0.41995,0.30048,1,1
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,2.3654e-06,0.41966,0.36543,1,1
3,GO POSITIVE REGULATION OF WOUND HEALING,1.4044e-06,0.41941,0.4366,1,1
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,9.0179e-06,0.41919,0.38059,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.0194e-07,0.41896,0.49438,1,1
3,GO B CELL APOPTOTIC PROCESS,2.8077e-06,0.41876,0.45778,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,9.7346e-05,0.41855,0.60743,1,1
3,GO LIPOXYGENASE PATHWAY,0.0085714,0.41835,0.33795,1,1
3,GO AMINE BIOSYNTHETIC PROCESS,2.8891e-07,0.41833,0.4528,1,1
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,8.4205e-05,0.41645,0.35744,1,1
3,GO CORTICOSTEROID HORMONE SECRETION,0.00022676,0.41318,0.41936,1,1
3,GO LABYRINTHINE LAYER DEVELOPMENT,6.0504e-05,0.41242,0.3379,1,1
3,GO NEGATIVE REGULATION OF COAGULATION,0.00098941,0.41182,0.34694,1,1
3,GO FUCOSE METABOLIC PROCESS,0.0013054,0.41147,0.35741,1,1
3,GO PROTEIN DEMANNOSYLATION,9.3916e-06,0.41112,0.43729,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0013872,0.41092,0.35342,1,1
3,GO REGULATION OF PROTEIN GLYCOSYLATION,5.2139e-05,0.4108,0.49349,1,1
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,6.8936e-07,0.41057,0.3593,1,1
3,GO REGULATION OF VIRAL LIFE CYCLE,7.547e-05,0.40999,0.32035,1,1
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00087311,0.40997,0.34065,1,1
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00065623,0.4099,0.37519,1,1
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.0829e-07,0.40972,0.39856,1,1
3,GO VITAMIN D METABOLIC PROCESS,3.3132e-05,0.40885,0.38917,1,1
3,GO EPITHELIAL CELL CELL ADHESION,0.00022676,0.40761,0.48334,1,1
3,GO MYOBLAST FUSION,0.00012074,0.40729,0.30549,1,1
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,6.2786e-05,0.40699,0.41973,1,1
3,GO AMMONIUM ION METABOLIC PROCESS,2.2524e-05,0.4052,0.48952,1,1
3,GO LEUKOTRIENE METABOLIC PROCESS,5.4121e-05,0.40483,0.36861,1,1
3,GO REGULATION OF COAGULATION,0.00010092,0.40474,0.34072,1,1
3,GO SMOOTH MUSCLE CELL MIGRATION,0.00017796,0.40433,0.32474,1,1
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.6584e-06,0.40424,0.38974,1,1
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.349e-05,0.40421,0.36239,1,1
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00023468,0.4042,0.36766,1,1
3,GO VASODILATION,5.8301e-05,0.40384,0.42929,1,1
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0010206,0.40303,0.36804,1,1
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,2.8418e-05,0.40268,0.31898,1,1
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.0025817,0.40246,0.3912,1,1
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,3.0689e-05,0.40243,0.3373,1,1
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,9.7801e-06,0.40206,0.36477,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00020448,0.40182,0.39419,1,1
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00072223,0.40165,0.31638,1,1
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.9418e-06,0.4014,0.38448,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00095906,0.40108,0.27774,1,1
3,GO LUNG CELL DIFFERENTIATION,0.00013917,0.40107,0.48645,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.0221e-07,0.40096,0.44792,1,1
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,3.8583e-05,0.40061,0.32549,1,1
3,GO BONE REMODELING,1.4674e-06,0.40058,0.40107,1,1
3,GO LIPID TRANSLOCATION,6.5896e-07,0.40012,0.36171,1,1
3,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0032441,0.39989,0.36436,1,1
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,8.6584e-06,0.39923,0.38687,1,1
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00038934,0.39883,0.35921,1,1
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00067758,0.3987,0.46127,1,1
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0020453,0.39844,0.42912,1,1
3,GO REGULATION OF CELL PROJECTION SIZE,0.0011549,0.39826,0.32801,1,1
3,GO MAGNESIUM ION TRANSPORT,1.0604e-05,0.39815,0.34716,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00037661,0.398,0.36637,1,1
3,GO POSITIVE REGULATION OF CELL KILLING,1.2962e-05,0.39772,0.36826,1,1
3,GO ACUTE INFLAMMATORY RESPONSE,1.5816e-05,0.39768,0.37473,1,1
3,GO DEFENSE RESPONSE TO VIRUS,2.3418e-05,0.39734,0.32273,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,5.8301e-05,0.39723,0.39533,1,1
3,GO DIGESTION,9.3916e-06,0.39593,0.34095,1,1
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0001547,0.39588,0.28877,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.5774e-06,0.39454,0.40401,1,1
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0013054,0.3941,0.36093,1,1
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00027832,0.39403,0.41298,1,1
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00038934,0.39349,0.33215,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.9841e-06,0.39289,0.36901,1,1
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00042998,0.39216,0.34579,1,1
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0025083,0.39213,0.32232,1,1
3,GO DIGESTIVE SYSTEM PROCESS,3.9418e-06,0.39141,0.32342,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,7.2754e-05,0.39093,0.37352,1,1
3,GO N GLYCAN PROCESSING,7.2754e-05,0.38964,0.38284,1,1
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00013917,0.38903,0.37042,1,1
3,GO VASCULAR WOUND HEALING,0.00081984,0.38903,0.39035,1,1
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00081984,0.38892,0.3485,1,1
3,GO MUSCLE ATROPHY,0.0059384,0.38846,0.27105,1,1
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.001191,0.38792,0.38854,1,1
3,GO POSITIVE REGULATION OF FERTILIZATION,0.001872,0.38774,0.31308,1,1
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,2.0833e-05,0.38748,0.40334,1,1
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0001165,0.38746,0.44124,1,1
3,GO PARENTAL BEHAVIOR,0.017137,0.38745,0.25434,1,1
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.4044e-06,0.38692,0.40209,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0064317,0.3867,0.42602,1,1
3,GO REGULATION OF STEROID METABOLIC PROCESS,5.9841e-06,0.3861,0.33383,1,1
3,GO ARACHIDONIC ACID METABOLIC PROCESS,4.8612e-06,0.38584,0.3748,1,1
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00032948,0.38535,0.30826,1,1
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0010528,0.38531,0.31978,1,1
3,GO SECONDARY METABOLIC PROCESS,0.00030804,0.38505,0.38274,1,1
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,2.3418e-05,0.3847,0.46457,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00092958,0.38385,0.28621,1,1
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.4421e-05,0.38382,0.27534,1,1
3,GO KERATAN SULFATE METABOLIC PROCESS,1.5201e-05,0.38333,0.32645,1,1
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.9263e-05,0.3829,0.38908,1,1
3,GO RESPONSE TO INTERLEUKIN 2,7.9801e-06,0.38261,0.33278,1,1
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00024286,0.3825,0.32865,1,1
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0001547,0.38238,0.32298,1,1
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028141,0.38213,0.4577,1,1
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.1267e-06,0.38176,0.39592,1,1
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.046579,0.38037,0.27172,1,1
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.037747,0.38022,0.2508,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.4205e-05,0.38019,0.32383,1,1
3,GO BASEMENT MEMBRANE ORGANIZATION,0.0023671,0.38,0.29213,1,1
3,GO RETINAL METABOLIC PROCESS,0.0024367,0.37994,0.49678,1,1
3,GO RELAXATION OF CARDIAC MUSCLE,0.0011549,0.37867,0.31277,1,1
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.7728e-06,0.37814,0.35478,1,1
3,GO TISSUE REMODELING,3.4728e-06,0.37798,0.34121,1,1
3,GO UBIQUINONE METABOLIC PROCESS,3.6228e-06,0.37784,0.3534,1,1
3,GO ANOIKIS,8.6584e-06,0.37697,0.39455,1,1
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,4.6623e-06,0.37634,0.36878,1,1
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.0012662,0.37608,0.36359,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.3132e-05,0.37543,0.42632,1,1
3,GO ACUTE PHASE RESPONSE,8.7323e-05,0.37529,0.33849,1,1
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,3.0576e-06,0.37473,0.35023,1,1
3,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,1.9263e-05,0.37439,0.37699,1,1
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,1.5201e-05,0.37373,0.43415,1,1
3,GO REGULATION OF VASCULOGENESIS,0.0014738,0.37368,0.36539,1,1
3,GO LIPID DROPLET ORGANIZATION,6.7728e-06,0.37349,0.35242,1,1
3,GO EPOXYGENASE P450 PATHWAY,0.0046564,0.37348,0.30977,1,1
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0007696,0.3729,0.32032,1,1
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,8.4205e-05,0.37159,0.39228,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018427,0.37096,0.29684,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.1964e-05,0.37091,0.31683,1,1
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,1.4609e-05,0.37073,0.31841,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00038934,0.37059,0.28008,1,1
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.0075304,0.37059,0.30797,1,1
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00034072,0.37057,0.32582,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.016734,0.37056,0.19178,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.8379e-05,0.37053,0.26669,1,1
3,GO AMINO SUGAR CATABOLIC PROCESS,5.8301e-05,0.37022,0.35781,1,1
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00092958,0.36963,0.27856,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.8301e-05,0.36959,0.31717,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.547e-05,0.36935,0.32374,1,1
3,GO REGULATION OF ACROSOME REACTION,0.0023671,0.36898,0.37765,1,1
3,GO RESPONSE TO LITHIUM ION,6.7728e-06,0.36896,0.48743,1,1
3,GO DORSAL AORTA DEVELOPMENT,0.0016129,0.36836,0.29542,1,1
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,3.5759e-05,0.36808,0.27286,1,1
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,4.2876e-06,0.36788,0.32366,1,1
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0034322,0.36747,0.34232,1,1
3,GO MOVEMENT IN HOST ENVIRONMENT,9.7346e-05,0.36725,0.27213,1,1
3,GO B CELL MEDIATED IMMUNITY,2.3418e-05,0.36712,0.32084,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0031536,0.36667,0.30131,1,1
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.5813e-07,0.36643,0.33571,1,1
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.035393,0.36631,0.25202,1,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0034322,0.36613,0.36995,1,1
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.00034072,0.36542,0.2596,1,1
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.365,0.24014,1,1
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00095906,0.36447,0.33971,1,1
3,GO PHAGOSOME ACIDIFICATION,1.906e-06,0.36432,0.37574,1,1
3,GO REGULATION OF LIGASE ACTIVITY,0.0021689,0.36364,0.23832,1,1
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.0012662,0.36364,0.34249,1,1
3,GO REGULATION OF ICOSANOID SECRETION,1.0311e-06,0.36362,0.41494,1,1
3,GO ETHER METABOLIC PROCESS,0.00010462,0.36357,0.30359,1,1
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.001662,0.3635,0.29859,1,1
3,GO PHOSPHOLIPID EFFLUX,0.00016023,0.36345,0.39608,1,1
3,GO ANTIBACTERIAL HUMORAL RESPONSE,1.5201e-05,0.36343,0.37041,1,1
3,GO LYMPHOCYTE MEDIATED IMMUNITY,1.5201e-05,0.3634,0.3046,1,1
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,6.5149e-05,0.36324,0.3014,1,1
3,GO RESPONSE TO COPPER ION,0.00084609,0.36221,0.42817,1,1
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,4.6623e-06,0.36183,0.28485,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0028957,0.36125,0.32549,1,1
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00027832,0.36119,0.25268,1,1
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.055956,0.36026,0.29091,1,1
3,GO BILE ACID AND BILE SALT TRANSPORT,0.00028792,0.35997,0.56635,1,1
3,GO STEROL HOMEOSTASIS,1.104e-05,0.35929,0.36391,1,1
3,GO REGULATION OF B CELL PROLIFERATION,1.0779e-06,0.35923,0.37653,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.7596e-05,0.35903,0.33,1,1
3,GO VIRAL GENOME REPLICATION,0.00010462,0.35831,0.27992,1,1
3,GO REGULATION OF EXOSOMAL SECRETION,2.6307e-05,0.35826,0.31762,1,1
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,2.7578e-07,0.35805,0.34784,1,1
3,GO LIPOPROTEIN CATABOLIC PROCESS,9.7346e-05,0.35792,0.30826,1,1
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,5.0683e-06,0.35767,0.38834,1,1
3,GO SNARE COMPLEX ASSEMBLY,0.0010528,0.35758,0.2525,1,1
3,GO INTEGRIN ACTIVATION,1.104e-05,0.35733,0.34102,1,1
3,GO RESPONSE TO XENOBIOTIC STIMULUS,6.5149e-05,0.35729,0.33272,1,1
3,GO REGULATION OF B CELL ACTIVATION,2.8077e-06,0.35688,0.29066,1,1
3,GO RESPONSE TO WATER,0.0034322,0.35662,0.30837,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,6.2786e-05,0.35645,0.26705,1,1
3,GO RESPONSE TO CAFFEINE,0.0015653,0.35556,0.25764,1,1
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.35547,0.30749,1,1
3,GO STEROL METABOLIC PROCESS,6.8936e-07,0.35516,0.3281,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00026003,0.35467,0.31759,1,1
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00057693,0.35436,0.27136,1,1
3,GO METHIONINE METABOLIC PROCESS,4.4878e-05,0.35395,0.33269,1,1
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00030804,0.35378,0.36954,1,1
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.7596e-05,0.35352,0.26078,1,1
3,GO BILE ACID METABOLIC PROCESS,4.4712e-06,0.35349,0.38793,1,1
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,1.4674e-06,0.35319,0.3569,1,1
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,2.0033e-05,0.35265,0.31129,1,1
3,GO RESPONSE TO ACIDIC PH,0.0017123,0.35217,0.2895,1,1
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00017186,0.35208,0.3657,1,1
3,GO REGULATION OF CELL KILLING,2.3418e-05,0.35203,0.32506,1,1
3,GO OSTEOBLAST PROLIFERATION,0.00013917,0.35186,0.32919,1,1
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0011549,0.35146,0.32268,1,1
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.508e-06,0.35143,0.30196,1,1
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.00026003,0.35127,0.26701,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0027346,0.35118,0.35853,1,1
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.3418e-05,0.35073,0.317,1,1
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,7.547e-05,0.35064,0.29353,1,1
3,GO SPHINGOLIPID METABOLIC PROCESS,2.8891e-07,0.35023,0.3153,1,1
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0075304,0.35003,0.30806,1,1
3,GO GLYCOSYLATION,1.8084e-07,0.34993,0.33656,1,1
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,6.7596e-05,0.34964,0.28546,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.026586,0.34962,0.32893,1,1
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,5.6174e-05,0.34912,0.31284,1,1
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.5759e-05,0.34904,0.2831,1,1
3,GO STEROID HORMONE SECRETION,0.00013917,0.34878,0.343,1,1
3,GO LYTIC VACUOLE ORGANIZATION,3.31e-08,0.34874,0.38603,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.7118e-05,0.34824,0.30217,1,1
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.1888e-05,0.3479,0.33054,1,1
3,GO NATURAL KILLER CELL PROLIFERATION,0.0020453,0.34763,0.32407,1,1
3,GO APICAL JUNCTION ASSEMBLY,9.4334e-07,0.34712,0.4129,1,1
3,GO INNATE IMMUNE RESPONSE,4.4712e-06,0.34678,0.28134,1,1
3,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0037331,0.34628,0.35378,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.00010845,0.34614,0.43614,1,1
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00050664,0.34613,0.4104,1,1
3,GO GASTRULATION WITH MOUTH FORMING SECOND,8.4205e-05,0.34567,0.32903,1,1
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,1.2962e-05,0.34546,0.40105,1,1
3,GO CORNIFICATION,7.0571e-06,0.34542,0.35019,1,1
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0085714,0.34497,0.19667,1,1
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,7.2754e-05,0.34468,0.4017,1,1
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,1.0604e-05,0.34444,0.30228,1,1
3,GO REGULATION OF WOUND HEALING,1.349e-05,0.34438,0.32955,1,1
3,GO DIOL METABOLIC PROCESS,3.3132e-05,0.34404,0.35962,1,1
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,8.6584e-06,0.34392,0.30334,1,1
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.3528e-06,0.34382,0.29859,1,1
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,4.4878e-05,0.34296,0.33147,1,1
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00079435,0.34292,0.2597,1,1
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4692e-06,0.34281,0.37615,1,1
3,GO PLATELET DEGRANULATION,0.00031859,0.34277,0.27102,1,1
3,GO MEMBRANE LIPID METABOLIC PROCESS,5.0194e-07,0.34267,0.31235,1,1
3,GO RESPONSE TO MINERALOCORTICOID,0.00013433,0.34266,0.29587,1,1
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.34262,0.24282,1,1
3,GO CATECHOLAMINE UPTAKE,0.0053338,0.34259,0.28612,1,1
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0026572,0.34252,0.30929,1,1
3,GO RESPONSE TO TUMOR CELL,0.00069957,0.34233,0.34064,1,1
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00059588,0.34231,0.37596,1,1
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00031859,0.34216,0.27348,1,1
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0010206,0.34162,0.22898,1,1
3,GO PARAXIAL MESODERM MORPHOGENESIS,0.013798,0.3415,0.30052,1,1
3,GO LINOLEIC ACID METABOLIC PROCESS,0.0022332,0.34138,0.35248,1,1
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,2.8418e-05,0.34135,0.39306,1,1
3,GO PROTEIN N LINKED GLYCOSYLATION,1.4039e-05,0.34125,0.28895,1,1
3,GO REGULATION OF ORGANIC ACID TRANSPORT,4.8379e-05,0.34114,0.3081,1,1
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0011549,0.34105,0.22938,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0022332,0.34022,0.25433,1,1
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0017123,0.34,0.39595,1,1
3,GO MAST CELL ACTIVATION,1.1493e-05,0.33985,0.30655,1,1
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,5.0683e-06,0.33966,0.35316,1,1
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,9.389e-05,0.33913,0.36791,1,1
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.00052342,0.33869,0.26912,1,1
3,GO B CELL PROLIFERATION,2.0784e-06,0.33854,0.2981,1,1
3,GO IMMUNE EFFECTOR PROCESS,7.6603e-06,0.3385,0.27707,1,1
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.3418e-05,0.33837,0.30857,1,1
3,GO OPTIC NERVE DEVELOPMENT,0.00023468,0.33825,0.40016,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00035231,0.33809,0.23915,1,1
3,GO RESPONSE TO VIRUS,1.8521e-05,0.33806,0.27555,1,1
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,9.389e-05,0.33778,0.33114,1,1
3,GO INSEMINATION,0.0010859,0.33772,0.32376,1,1
3,GO TYPE I INTERFERON PRODUCTION,1.5816e-05,0.33707,0.28588,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.0226e-05,0.33685,0.27037,1,1
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,6.2786e-05,0.33674,0.36548,1,1
3,GO DNA DEAMINATION,0.0030654,0.3367,0.33984,1,1
3,GO MAST CELL MEDIATED IMMUNITY,2.6307e-05,0.3364,0.30225,1,1
3,GO STEROID METABOLIC PROCESS,7.889e-07,0.3363,0.33898,1,1
3,GO CELLULAR RESPONSE TO FATTY ACID,7.2754e-05,0.33626,0.32978,1,1
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00012074,0.33612,0.37488,1,1
3,GO KERATINOCYTE DEVELOPMENT,0.0056288,0.33608,0.33256,1,1
3,GO STEROID BIOSYNTHETIC PROCESS,3.7791e-06,0.33602,0.30431,1,1
3,GO KERATINIZATION,4.4712e-06,0.33601,0.31005,1,1
3,GO POSITIVE REGULATION OF TISSUE REMODELING,8.4205e-05,0.33591,0.35595,1,1
3,GO LEUKOCYTE MEDIATED IMMUNITY,7.9801e-06,0.33584,0.28971,1,1
3,GO T CELL CYTOKINE PRODUCTION,0.0010206,0.33576,0.25369,1,1
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00050664,0.33574,0.33194,1,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.0079323,0.33558,0.22245,1,1
3,GO REGULATION OF NEUTROPHIL MIGRATION,1.1267e-06,0.33545,0.37608,1,1
3,GO CELL CELL JUNCTION ORGANIZATION,1.4039e-05,0.3352,0.26847,1,1
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0013054,0.33415,0.26703,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,6.5149e-05,0.33381,0.27345,1,1
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,3.4421e-05,0.33335,0.27029,1,1
3,GO ETHER BIOSYNTHETIC PROCESS,0.011612,0.33328,0.17397,1,1
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.010245,0.333,0.3082,1,1
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.014841,0.33289,0.28767,1,1
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,6.5149e-05,0.33279,0.25779,1,1
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0604e-05,0.33257,0.28202,1,1
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,9.0179e-06,0.33241,0.29973,1,1
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,4.8612e-06,0.33211,0.28857,1,1
3,GO POSITIVE REGULATION OF BONE RESORPTION,6.5149e-05,0.33197,0.42539,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00011241,0.33195,0.24343,1,1
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,3.5759e-05,0.33175,0.27592,1,1
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00017796,0.33142,0.2999,1,1
3,GO RESPONSE TO PEPTIDOGLYCAN,0.00032948,0.33138,0.26628,1,1
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,6.5149e-05,0.33136,0.28335,1,1
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,9.0179e-06,0.33093,0.26835,1,1
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0054795,0.33078,0.23943,1,1
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00042998,0.33054,0.32309,1,1
3,GO KETONE BIOSYNTHETIC PROCESS,0.0001547,0.33049,0.31016,1,1
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0029794,0.33037,0.18874,1,1
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00010845,0.33036,0.36701,1,1
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.00040247,0.33031,0.29579,1,1
3,GO OLIGOPEPTIDE TRANSPORT,0.00055855,0.33028,0.37735,1,1
3,GO CELL KILLING,2.9301e-06,0.33,0.28597,1,1
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00021909,0.3297,0.32451,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.4421e-05,0.32931,0.24815,1,1
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,4.1617e-05,0.32923,0.31969,1,1
3,GO CERAMIDE BIOSYNTHETIC PROCESS,7.889e-07,0.3288,0.28532,1,1
3,GO LIPID STORAGE,1.5201e-05,0.3285,0.29977,1,1
3,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00041602,0.32836,0.30987,1,1
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,5.0194e-07,0.32832,0.34363,1,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.00034072,0.32826,0.47496,1,1
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0051916,0.32813,0.31268,1,1
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,4.2876e-06,0.32811,0.27063,1,1
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010462,0.32753,0.37958,1,1
3,GO NADP METABOLIC PROCESS,0.0011199,0.32703,0.2924,1,1
3,GO INTERLEUKIN 1 PRODUCTION,0.00028792,0.32689,0.24798,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00067758,0.32681,0.21575,1,1
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00079435,0.32666,0.34359,1,1
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0018173,0.32599,0.29172,1,1
3,GO BLOOD VESSEL REMODELING,0.00012964,0.32594,0.28741,1,1
3,GO RESPONSE TO CORTICOSTERONE,0.00028792,0.32533,0.32841,1,1
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00022676,0.32525,0.28281,1,1
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.023741,0.32488,0.24287,1,1
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.4878e-05,0.32464,0.29502,1,1
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,3.1888e-05,0.32427,0.3314,1,1
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00026903,0.32418,0.21961,1,1
3,GO RESPONSE TO MAGNESIUM ION,0.00016023,0.32408,0.42707,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.6597e-05,0.32404,0.3206,1,1
3,GO INTERLEUKIN 10 PRODUCTION,2.5308e-05,0.32401,0.28363,1,1
3,GO ADAPTIVE IMMUNE RESPONSE,1.7806e-05,0.32387,0.30169,1,1
3,GO REGULATION OF PROSTAGLANDIN SECRETION,4.6597e-05,0.32356,0.35877,1,1
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00042998,0.32336,0.24823,1,1
3,GO LIPOPROTEIN METABOLIC PROCESS,4.1112e-06,0.32327,0.26151,1,1
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,3.1888e-05,0.32307,0.30101,1,1
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,4.1617e-05,0.32257,0.2553,1,1
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.5759e-05,0.32249,0.27894,1,1
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,3.3287e-06,0.32235,0.33087,1,1
3,GO CAMP BIOSYNTHETIC PROCESS,0.0066042,0.32216,0.26619,1,1
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.0054795,0.32207,0.34755,1,1
3,GO B CELL HOMEOSTASIS,0.00011241,0.32174,0.28424,1,1
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.7791e-06,0.32159,0.2941,1,1
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.02843,0.32158,0.28133,1,1
3,GO PHOSPHOLIPID CATABOLIC PROCESS,1.0184e-05,0.32114,0.36253,1,1
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.0018173,0.32059,0.23639,1,1
3,GO TRANSPOSITION,0.0017641,0.32051,0.30702,1,1
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00050664,0.32016,0.36735,1,1
3,GO BILE ACID BIOSYNTHETIC PROCESS,2.7343e-05,0.31979,0.32408,1,1
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.7474e-06,0.3197,0.31653,1,1
3,GO CHEMOKINE PRODUCTION,8.1192e-05,0.31911,0.2607,1,1
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.0015189,0.31905,0.21368,1,1
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.3418e-05,0.3187,0.3346,1,1
3,GO RESPONSE TO GROWTH HORMONE,7.0571e-06,0.31851,0.36818,1,1
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00030804,0.31845,0.26379,1,1
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,8.7323e-05,0.31834,0.3877,1,1
3,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.9801e-06,0.31807,0.29622,1,1
3,GO LIPOSACCHARIDE METABOLIC PROCESS,5.9841e-06,0.31756,0.30614,1,1
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,9.0221e-07,0.31752,0.28318,1,1
3,GO INTERLEUKIN 6 PRODUCTION,9.3916e-06,0.31744,0.25963,1,1
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00011241,0.31701,0.24969,1,1
3,GO INTERLEUKIN 8 PRODUCTION,4.4878e-05,0.31695,0.29674,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,4.1617e-05,0.31686,0.34068,1,1
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.004408,0.31679,0.29436,1,1
3,GO PURINE NUCLEOTIDE TRANSPORT,4.4712e-06,0.31669,0.27674,1,1
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00034072,0.31651,0.32959,1,1
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00067758,0.31646,0.31052,1,1
3,GO BASIC AMINO ACID TRANSPORT,0.0073363,0.31643,0.32189,1,1
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0054795,0.31641,0.39235,1,1
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.349e-05,0.3163,0.3163,1,1
3,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00010845,0.31624,0.36248,1,1
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.0784e-06,0.3159,0.28673,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,2.3418e-05,0.31577,0.26517,1,1
3,GO RESPONSE TO ISCHEMIA,4.8379e-05,0.31559,0.26539,1,1
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,5.508e-06,0.31543,0.32208,1,1
3,GO ADRENAL GLAND DEVELOPMENT,0.0001165,0.31537,0.39887,1,1
3,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00013433,0.31529,0.27726,1,1
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,2.2658e-06,0.3142,0.25916,1,1
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,9.3916e-06,0.31382,0.27726,1,1
3,GO ALANINE TRANSPORT,0.0030654,0.31381,0.28908,1,1
3,GO PIRNA METABOLIC PROCESS,0.01282,0.31363,0.26008,1,1
3,GO MEMBRANE FISSION,0.0023671,0.31331,0.25396,1,1
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.7145e-05,0.31292,0.30628,1,1
3,GO LUNG ALVEOLUS DEVELOPMENT,5.2837e-06,0.31261,0.35074,1,1
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0001547,0.3123,0.2789,1,1
3,GO REGULATION OF ENDOCRINE PROCESS,1.104e-05,0.31213,0.29231,1,1
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0037331,0.31207,0.23476,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.5308e-05,0.312,0.28947,1,1
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00047456,0.31164,0.22219,1,1
3,GO ICOSANOID BIOSYNTHETIC PROCESS,4.3218e-05,0.31126,0.31372,1,1
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.00087311,0.31115,0.40191,1,1
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.014486,0.31101,0.23888,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0021062,0.31089,0.31197,1,1
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2308e-06,0.31085,0.33175,1,1
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.2367e-06,0.31082,0.28156,1,1
3,GO OLIGODENDROCYTE DEVELOPMENT,2.0033e-05,0.31072,0.29567,1,1
3,GO RESPONSE TO PROTOZOAN,0.00014418,0.31066,0.2512,1,1
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.0059384,0.31065,0.24937,1,1
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.4039e-05,0.31032,0.26907,1,1
3,GO RETINOL METABOLIC PROCESS,0.00035231,0.31004,0.398,1,1
3,GO REGULATION OF SYMBIOTIC PROCESS,0.00019753,0.30992,0.22411,1,1
3,GO HYPOTHALAMUS DEVELOPMENT,0.001191,0.30974,0.27921,1,1
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00013433,0.30934,0.31717,1,1
3,GO LUNG EPITHELIUM DEVELOPMENT,0.00092958,0.30923,0.30469,1,1
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,6.0504e-05,0.3092,0.26189,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00020448,0.30899,0.32299,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.00041602,0.30881,0.30211,1,1
3,GO CYCLOOXYGENASE PATHWAY,0.0083534,0.30874,0.39175,1,1
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00012964,0.30865,0.27059,1,1
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.033166,0.30841,0.26592,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.011047,0.30809,0.23365,1,1
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00016023,0.30798,0.31246,1,1
3,GO REGULATION OF TRANSPOSITION,0.0036303,0.30778,0.31014,1,1
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,3.0576e-06,0.30749,0.27473,1,1
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00016023,0.30741,0.30259,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0046564,0.30723,0.22232,1,1
3,GO CERAMIDE METABOLIC PROCESS,8.2505e-07,0.30702,0.30023,1,1
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00028792,0.3069,0.31547,1,1
3,GO NUCLEOTIDE SALVAGE,0.0083534,0.30637,0.25957,1,1
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.00038934,0.3061,0.29893,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.8418e-05,0.30589,0.28086,1,1
3,GO MYELOID LEUKOCYTE ACTIVATION,7.9801e-06,0.30572,0.27955,1,1
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0015653,0.30552,0.19269,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,5.0683e-06,0.30545,0.32975,1,1
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00069957,0.30535,0.22505,1,1
3,GO WATER HOMEOSTASIS,6.2367e-06,0.30534,0.31725,1,1
3,GO LEUKOCYTE PROLIFERATION,2.1663e-05,0.30524,0.24713,1,1
3,GO LIPID LOCALIZATION,2.7578e-07,0.30521,0.30596,1,1
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.052669,0.30518,0.30622,1,1
3,GO PHAGOSOME MATURATION,1.0184e-05,0.30491,0.31694,1,1
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,2.9301e-06,0.30469,0.29973,1,1
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.0015189,0.30465,0.33442,1,1
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0036303,0.30443,0.30689,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.1702e-06,0.3044,0.35833,1,1
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.0036303,0.30403,0.29923,1,1
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.30386,0.25922,1,1
3,GO AMELOGENESIS,0.00040247,0.30376,0.29111,1,1
3,GO VACUOLAR ACIDIFICATION,3.7791e-06,0.30365,0.36015,1,1
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.00028792,0.30333,0.36872,1,1
3,GO BEHAVIORAL RESPONSE TO PAIN,0.0028957,0.30323,0.28903,1,1
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0056288,0.30313,0.25492,1,1
3,GO SPHINGOID METABOLIC PROCESS,0.00044439,0.3031,0.30586,1,1
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00021909,0.30299,0.29161,1,1
3,GO INTERLEUKIN 12 PRODUCTION,2.2658e-06,0.30274,0.32427,1,1
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.5201e-05,0.30257,0.29396,1,1
3,GO FUCOSYLATION,0.00016595,0.30249,0.34571,1,1
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,6.0504e-05,0.30207,0.32945,1,1
3,GO CARBOHYDRATE TRANSPORT,1.4674e-06,0.30176,0.27867,1,1
3,GO TYPE 2 IMMUNE RESPONSE,0.0022992,0.30173,0.25993,1,1
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.4421e-05,0.30172,0.28774,1,1
3,GO REGULATION OF INNATE IMMUNE RESPONSE,3.1904e-06,0.30172,0.27413,1,1
3,GO POSITIVE REGULATION OF CELL SIZE,4.1617e-05,0.30155,0.35051,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.0784e-06,0.3014,0.36963,1,1
3,GO LYMPHOCYTE MIGRATION,2.0833e-05,0.30132,0.24112,1,1
3,GO HAIR CELL DIFFERENTIATION,3.8583e-05,0.30067,0.2758,1,1
3,GO ALPHA BETA T CELL ACTIVATION,2.9532e-05,0.30057,0.25571,1,1
3,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0060989,0.30053,0.25063,1,1
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.6228e-06,0.3004,0.29238,1,1
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00090094,0.30002,0.29571,1,1
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00018427,0.29997,0.26529,1,1
3,GO SYNCYTIUM FORMATION,0.00022676,0.29948,0.2276,1,1
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,5.0226e-05,0.29909,0.24468,1,1
3,GO DIET INDUCED THERMOGENESIS,0.00092958,0.29902,0.25655,1,1
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00026903,0.29896,0.27282,1,1
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0013872,0.29881,0.23868,1,1
3,GO PROTEIN HYDROXYLATION,0.0037331,0.29878,0.23813,1,1
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00098941,0.29871,0.27399,1,1
3,GO INTERLEUKIN 13 PRODUCTION,0.0037331,0.29871,0.2707,1,1
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0006154,0.29862,0.31515,1,1
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00010845,0.29847,0.28807,1,1
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.00038934,0.29821,0.25853,1,1
3,GO MANNOSYLATION,1.6455e-05,0.29791,0.276,1,1
3,GO REGULATION OF RESPONSE TO WOUNDING,8.4205e-05,0.2977,0.25917,1,1
3,GO AMYLOID FIBRIL FORMATION,0.00069957,0.29752,0.2779,1,1
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.2962e-05,0.2975,0.25962,1,1
3,GO PROGRAMMED NECROTIC CELL DEATH,7.2754e-05,0.29729,0.30644,1,1
3,GO ARACHIDONIC ACID SECRETION,3.1888e-05,0.29699,0.28033,1,1
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.2658e-06,0.29637,0.27777,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00018427,0.29569,0.22613,1,1
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.00023468,0.29564,0.23175,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,4.6623e-06,0.29563,0.25892,1,1
3,GO GOLGI TO ENDOSOME TRANSPORT,0.00016595,0.29541,0.30137,1,1
3,GO FATTY ACID CATABOLIC PROCESS,1.349e-05,0.29541,0.28332,1,1
3,GO POSITIVE REGULATION OF ANION TRANSPORT,1.5816e-05,0.29534,0.33817,1,1
3,GO PROTEIN TARGETING TO LYSOSOME,0.001986,0.29493,0.29528,1,1
3,GO PHOSPHOLIPID TRANSPORT,9.0221e-07,0.29488,0.27245,1,1
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,5.7413e-06,0.29439,0.26169,1,1
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.004408,0.29429,0.22668,1,1
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,5.6174e-05,0.29423,0.24935,1,1
3,GO INTERFERON BETA PRODUCTION,0.00031859,0.29423,0.22375,1,1
3,GO DISACCHARIDE METABOLIC PROCESS,0.00022676,0.29419,0.40408,1,1
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0010859,0.29385,0.28595,1,1
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.00055855,0.29381,0.25284,1,1
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.00067758,0.29352,0.30227,1,1
3,GO CELL CELL JUNCTION ASSEMBLY,3.4728e-06,0.29347,0.28994,1,1
3,GO POSITIVE REGULATION OF CELL ADHESION,0.00014418,0.29324,0.21579,1,1
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00026903,0.29318,0.28352,1,1
3,GO T CELL PROLIFERATION,8.7323e-05,0.29261,0.23196,1,1
3,GO DEFENSE RESPONSE,3.4728e-06,0.29261,0.25801,1,1
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0006154,0.29251,0.27372,1,1
3,GO GLYCEROLIPID CATABOLIC PROCESS,3.8583e-05,0.29242,0.27449,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00019079,0.29199,0.22395,1,1
3,GO EPITHELIAL CELL FATE COMMITMENT,0.011326,0.29195,0.26528,1,1
3,GO INTERFERON ALPHA PRODUCTION,3.3132e-05,0.29175,0.28949,1,1
3,GO CARNITINE METABOLIC PROCESS,0.0049174,0.29162,0.2462,1,1
3,GO DEFENSE RESPONSE TO BACTERIUM,5.4977e-07,0.29159,0.28734,1,1
3,GO PROSTANOID METABOLIC PROCESS,0.00079435,0.29143,0.38009,1,1
3,GO POLYOL TRANSPORT,0.0021689,0.29143,0.30674,1,1
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.0207e-07,0.29102,0.2888,1,1
3,GO REGULATION OF RESPIRATORY BURST,0.00019753,0.29029,0.34711,1,1
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0012662,0.29,0.30112,1,1
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,2.4692e-06,0.28993,0.33388,1,1
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,1.104e-05,0.28973,0.32306,1,1
3,GO REGULATION OF NECROTIC CELL DEATH,0.00026903,0.28965,0.29109,1,1
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0069616,0.28961,0.24887,1,1
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.01282,0.28938,0.20468,1,1
3,GO DOPAMINE METABOLIC PROCESS,0.00092958,0.28923,0.29326,1,1
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.00031859,0.2892,0.24725,1,1
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.5816e-05,0.2892,0.26892,1,1
3,GO REGULATION OF ACTIN NUCLEATION,0.00036427,0.28914,0.3006,1,1
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,9.8628e-07,0.28913,0.2704,1,1
3,GO T CELL MIGRATION,0.00072223,0.28883,0.22003,1,1
3,GO FATTY ACID DERIVATIVE TRANSPORT,1.0184e-05,0.28864,0.30176,1,1
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0026572,0.28853,0.1982,1,1
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0057817,0.28847,0.27732,1,1
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0029794,0.28844,0.21292,1,1
3,GO POLYSACCHARIDE METABOLIC PROCESS,1.3441e-06,0.28844,0.26833,1,1
3,GO PROTEIN PROCESSING,7.0571e-06,0.28781,0.27388,1,1
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0039469,0.28746,0.24733,1,1
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.014138,0.28729,0.19349,1,1
3,GO RESPONSE TO DEXAMETHASONE,0.00092958,0.287,0.2393,1,1
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0025817,0.28689,0.234,1,1
3,GO REGULATION OF FERTILIZATION,0.00014935,0.28643,0.33253,1,1
3,GO PROTEIN AUTO ADP RIBOSYLATION,0.011612,0.28628,0.27108,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0016129,0.28615,0.28166,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0022992,0.28594,0.26115,1,1
3,GO TISSUE HOMEOSTASIS,1.6729e-06,0.28589,0.25097,1,1
3,GO EXTRACELLULAR VESICLE BIOGENESIS,2.0033e-05,0.28579,0.26966,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.009256,0.28578,0.13974,1,1
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,2.3418e-05,0.28572,0.24667,1,1
3,GO HORMONE CATABOLIC PROCESS,0.009256,0.28539,0.35403,1,1
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,6.7728e-06,0.28536,0.27987,1,1
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.0041716,0.28528,0.3388,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00040247,0.28508,0.23155,1,1
3,GO INTERLEUKIN 5 PRODUCTION,0.024288,0.28505,0.21003,1,1
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00052342,0.2849,0.21055,1,1
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0064317,0.28462,0.23204,1,1
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0022992,0.28406,0.24409,1,1
3,GO B CELL ACTIVATION,7.9801e-06,0.28406,0.23062,1,1
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.001986,0.28404,0.27099,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00012512,0.2836,0.28055,1,1
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,0.28357,0.2236,1,1
3,GO PROSTAGLANDIN TRANSPORT,0.00027832,0.28315,0.34485,1,1
3,GO GANGLIOSIDE METABOLIC PROCESS,0.010245,0.28309,0.19297,1,1
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.014138,0.28304,0.29293,1,1
3,GO PHOSPHOLIPID HOMEOSTASIS,0.0036303,0.28253,0.26064,1,1
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0062634,0.28251,0.19755,1,1
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.0033e-05,0.28234,0.26237,1,1
3,GO HETEROTYPIC CELL CELL ADHESION,0.0028141,0.28226,0.21376,1,1
3,GO DIOL BIOSYNTHETIC PROCESS,0.00011241,0.28207,0.36689,1,1
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0039469,0.28195,0.27379,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.1904e-06,0.28159,0.24497,1,1
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00017186,0.28137,0.29083,1,1
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0011199,0.28123,0.18058,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0016129,0.28112,0.24256,1,1
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,8.7323e-05,0.28111,0.22749,1,1
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.8418e-05,0.28108,0.22238,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00013433,0.28084,0.21015,1,1
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00020448,0.28082,0.33045,1,1
3,GO LEUKOCYTE MIGRATION,1.2962e-05,0.28079,0.25177,1,1
3,GO STEROID CATABOLIC PROCESS,0.00353,0.28055,0.28135,1,1
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.4044e-06,0.28044,0.27278,1,1
3,GO PH REDUCTION,1.1493e-05,0.28021,0.26013,1,1
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0007696,0.28002,0.22549,1,1
3,GO STEROL BIOSYNTHETIC PROCESS,3.1888e-05,0.27962,0.27916,1,1
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.8301e-05,0.27908,0.20362,1,1
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,1.2454e-05,0.27888,0.27501,1,1
3,GO REGULATION OF RUFFLE ASSEMBLY,0.00095906,0.27883,0.22552,1,1
3,GO ER NUCLEUS SIGNALING PATHWAY,0.00025131,0.27868,0.28494,1,1
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,3.6228e-06,0.27852,0.26487,1,1
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00017186,0.27827,0.29771,1,1
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0067808,0.27804,0.19202,1,1
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,2.0784e-06,0.27786,0.2719,1,1
3,GO HOMOTYPIC CELL CELL ADHESION,2.8418e-05,0.27785,0.30646,1,1
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0028957,0.27785,0.35417,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0085714,0.27782,0.19123,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.013798,0.27776,0.24165,1,1
3,GO ANTIMICROBIAL HUMORAL RESPONSE,7.9801e-06,0.27772,0.27237,1,1
3,GO RESPONSE TO BIOTIC STIMULUS,8.6584e-06,0.27766,0.23251,1,1
3,GO CELLULAR RESPONSE TO STARVATION,3.7791e-06,0.2776,0.25964,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.012203,0.2775,0.138,1,1
3,GO LEUKOCYTE CELL CELL ADHESION,9.389e-05,0.27727,0.21696,1,1
3,GO ENDOCRINE PROCESS,2.8418e-05,0.27722,0.29202,1,1
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0007696,0.27685,0.26042,1,1
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00020448,0.27678,0.31525,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00030804,0.27676,0.20152,1,1
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,2.8077e-06,0.27672,0.26193,1,1
3,GO RESPONSE TO CYTOKINE,1.7118e-05,0.2767,0.2278,1,1
3,GO STEROL TRANSPORT,1.4039e-05,0.27647,0.29349,1,1
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.00072223,0.27647,0.26228,1,1
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0036303,0.27642,0.19243,1,1
3,GO AMYLOID BETA METABOLIC PROCESS,0.0001165,0.2764,0.26276,1,1
3,GO CYTOPLASM ORGANIZATION,0.00017186,0.27614,0.32069,1,1
3,GO RESPONSE TO FATTY ACID,0.00017186,0.27603,0.23993,1,1
3,GO INTERLEUKIN 4 PRODUCTION,0.0042883,0.27598,0.20857,1,1
3,GO NUCLEOTIDE TRANSPORT,3.6228e-06,0.27578,0.26896,1,1
3,GO TRANSCYTOSIS,0.00014418,0.2755,0.28752,1,1
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,6.0504e-05,0.2752,0.21769,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,5.0226e-05,0.27519,0.28243,1,1
3,GO AMINE METABOLIC PROCESS,1.0311e-06,0.27516,0.29883,1,1
3,GO DRUG METABOLIC PROCESS,0.00036427,0.2751,0.32673,1,1
3,GO RESPONSE TO INTERLEUKIN 6,0.00026903,0.27506,0.28251,1,1
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,1.4039e-05,0.27488,0.27901,1,1
3,GO MYELOID LEUKOCYTE MIGRATION,9.7801e-06,0.2746,0.23812,1,1
3,GO REGULATION OF PEPTIDASE ACTIVITY,1.8521e-05,0.2746,0.25378,1,1
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.8251e-06,0.27458,0.22536,1,1
3,GO RESPONSE TO PROGESTERONE,0.00025131,0.27402,0.25588,1,1
3,GO CYTOKINE PRODUCTION,1.5816e-05,0.27399,0.24421,1,1
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.014486,0.27382,0.25491,1,1
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00036427,0.27371,0.21081,1,1
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00090094,0.27366,0.27464,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00059588,0.27341,0.21104,1,1
3,GO RESPONSE TO NUTRIENT,0.00050664,0.27331,0.19079,1,1
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0032441,0.2729,0.18808,1,1
3,GO GAMMA DELTA T CELL DIFFERENTIATION,0.012203,0.27287,0.33877,1,1
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00026003,0.27286,0.24896,1,1
3,GO DETERMINATION OF ADULT LIFESPAN,0.00027832,0.27282,0.28837,1,1
3,GO POSITIVE REGULATION OF COAGULATION,0.00038934,0.27263,0.26831,1,1
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.7323e-05,0.27227,0.22247,1,1
3,GO EXOCYTOSIS,6.7728e-06,0.27215,0.22476,1,1
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,9.389e-05,0.27198,0.21512,1,1
3,GO PEPTIDE SECRETION,9.0221e-07,0.27186,0.23407,1,1
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00095906,0.27126,0.26955,1,1
3,GO RESPONSE TO FORSKOLIN,0.031748,0.27115,0.23486,1,1
3,GO REGULATION OF B CELL DIFFERENTIATION,0.00045924,0.2711,0.25722,1,1
3,GO CYTOKINE METABOLIC PROCESS,0.00010092,0.271,0.23112,1,1
3,GO REGULATION OF IMMUNE RESPONSE,5.0226e-05,0.27098,0.19863,1,1
3,GO REGULATION OF CELL CELL ADHESION,4.6597e-05,0.27096,0.22934,1,1
3,GO GLYCOPROTEIN METABOLIC PROCESS,7.6603e-06,0.27071,0.24353,1,1
3,GO ACTIVATION OF IMMUNE RESPONSE,6.5149e-05,0.27056,0.20011,1,1
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,4.1617e-05,0.27047,0.21928,1,1
3,GO CYTOKINE SECRETION,1.104e-05,0.27029,0.26124,1,1
3,GO BONE CELL DEVELOPMENT,0.0083534,0.26952,0.18245,1,1
3,GO MUSCLE CELL MIGRATION,0.0017123,0.26911,0.21291,1,1
3,GO CELL ACTIVATION,1.9263e-05,0.26875,0.21553,1,1
3,GO PARTURITION,0.021165,0.26859,0.25203,1,1
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0013457,0.26858,0.19913,1,1
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.033166,0.26856,0.20831,1,1
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.7118e-05,0.26853,0.24878,1,1
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0011199,0.2685,0.27894,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.8583e-05,0.26844,0.23972,1,1
3,GO SODIUM ION HOMEOSTASIS,6.2786e-05,0.26807,0.24102,1,1
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.4121e-05,0.26794,0.21822,1,1
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0039469,0.26793,0.29191,1,1
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.010245,0.26776,0.23324,1,1
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00098941,0.26765,0.28101,1,1
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00092958,0.26738,0.21388,1,1
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,5.9841e-06,0.26733,0.29841,1,1
3,GO PANCREATIC JUICE SECRETION,0.022165,0.26725,0.17574,1,1
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00034072,0.26689,0.2,1,1
3,GO INTRACELLULAR LIPID TRANSPORT,4.1617e-05,0.26678,0.26883,1,1
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0011199,0.26671,0.25066,1,1
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0020453,0.26663,0.28299,1,1
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0017123,0.26609,0.23108,1,1
3,GO AUTOPHAGY OF NUCLEUS,0.00353,0.26607,0.23631,1,1
3,GO DOPAMINE TRANSPORT,0.0017641,0.26585,0.32252,1,1
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00059588,0.26573,0.2347,1,1
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.6455e-05,0.26572,0.22115,1,1
3,GO REGULATION OF MUSCLE ADAPTATION,0.00052342,0.26558,0.19083,1,1
3,GO RESPONSE TO PH,0.0015653,0.26528,0.19796,1,1
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,3.6414e-07,0.26523,0.23941,1,1
3,GO EPIDERMAL CELL DIFFERENTIATION,7.9801e-06,0.26522,0.27486,1,1
3,GO VITAMIN TRANSPORT,0.0073363,0.26484,0.21699,1,1
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,3.4421e-05,0.26415,0.27801,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00013433,0.26404,0.23643,1,1
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0001547,0.26357,0.21062,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE,1.7118e-05,0.26347,0.2243,1,1
3,GO INFLAMMATORY RESPONSE,8.3127e-06,0.2634,0.24213,1,1
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,8.6584e-06,0.26335,0.24513,1,1
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,1.7118e-05,0.26334,0.23606,1,1
3,GO KERATINOCYTE DIFFERENTIATION,1.349e-05,0.26325,0.27629,1,1
3,GO HORMONE METABOLIC PROCESS,4.4878e-05,0.26322,0.28692,1,1
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,5.8301e-05,0.26315,0.21761,1,1
3,GO SEQUESTERING OF TRIGLYCERIDE,0.0067808,0.26302,0.23856,1,1
3,GO TRANSFERRIN TRANSPORT,1.8251e-06,0.26283,0.33931,1,1
3,GO REGULATION OF BODY FLUID LEVELS,4.6597e-05,0.26258,0.20443,1,1
3,GO CELLULAR RESPONSE TO STEROL,0.00063551,0.26248,0.28561,1,1
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00052342,0.26229,0.23272,1,1
3,GO RENAL SYSTEM PROCESS,3.4421e-05,0.26221,0.23194,1,1
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,6.5149e-05,0.26213,0.21304,1,1
3,GO NECROTIC CELL DEATH,8.7323e-05,0.26201,0.2899,1,1
3,GO REGULATION OF FATTY ACID TRANSPORT,5.7413e-06,0.262,0.39294,1,1
3,GO RESPONSE TO BACTERIUM,1.6455e-05,0.26191,0.23038,1,1
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,1.7474e-06,0.26187,0.27482,1,1
3,GO ETHANOL METABOLIC PROCESS,0.04854,0.26127,0.19393,1,1
3,GO SECRETION BY TISSUE,0.00035231,0.26114,0.24522,1,1
3,GO PLASMA MEMBRANE FUSION,0.0041716,0.26113,0.23432,1,1
3,GO ANDROGEN METABOLIC PROCESS,5.0226e-05,0.26105,0.39653,1,1
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,9.0179e-06,0.26079,0.23904,1,1
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.0047853,0.26075,0.22297,1,1
3,GO GRANULOCYTE MIGRATION,2.9532e-05,0.26065,0.22851,1,1
3,GO RESPONSE TO GONADOTROPIN,0.00014418,0.26059,0.26161,1,1
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00052342,0.26033,0.26876,1,1
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00092958,0.26005,0.2655,1,1
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0027346,0.25995,0.21814,1,1
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,5.508e-06,0.25995,0.28823,1,1
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.023205,0.2597,0.18921,1,1
3,GO REGULATION OF RECEPTOR BINDING,0.0041716,0.25957,0.28154,1,1
3,GO DENDRITIC CELL MIGRATION,0.0050528,0.25954,0.18558,1,1
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,5.0194e-07,0.25946,0.26982,1,1
3,GO ORGANELLE MEMBRANE FUSION,0.00014418,0.25928,0.21431,1,1
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.031059,0.25891,0.17968,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0010528,0.25882,0.17671,1,1
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.00069957,0.25878,0.21734,1,1
3,GO CELLULAR KETONE METABOLIC PROCESS,0.00012964,0.25878,0.24141,1,1
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.3418e-05,0.25855,0.26057,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.0037331,0.2585,0.21433,1,1
3,GO ER OVERLOAD RESPONSE,0.00042998,0.25824,0.28159,1,1
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00041602,0.25815,0.28122,1,1
3,GO MYELIN MAINTENANCE,0.0075304,0.25807,0.28513,1,1
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,6.7596e-05,0.25799,0.2633,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0041716,0.25795,0.28369,1,1
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,4.7955e-07,0.25784,0.25215,1,1
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00057693,0.25775,0.32896,1,1
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.25766,0.17988,1,1
3,GO AMMONIUM TRANSPORT,0.00052342,0.25748,0.27184,1,1
3,GO DETECTION OF CALCIUM ION,0.0059384,0.25734,0.3143,1,1
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00052342,0.25695,0.21488,1,1
3,GO GPI ANCHOR METABOLIC PROCESS,6.0504e-05,0.25689,0.26564,1,1
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0079323,0.25687,0.17674,1,1
3,GO REGULATION OF LIPID STORAGE,0.00016023,0.25619,0.22796,1,1
3,GO CELLULAR RESPONSE TO LITHIUM ION,0.00098941,0.25617,0.28244,1,1
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.011904,0.25605,0.26168,1,1
3,GO REGULATION OF DEFENSE RESPONSE,8.3127e-06,0.25594,0.22935,1,1
3,GO ALPHA BETA T CELL DIFFERENTIATION,0.0001547,0.25572,0.22104,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,5.0683e-06,0.25558,0.26623,1,1
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00024286,0.25523,0.21275,1,1
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0017123,0.25501,0.22613,1,1
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,7.2754e-05,0.25487,0.33449,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00017186,0.25483,0.19082,1,1
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.027803,0.25476,0.14861,1,1
3,GO COAGULATION,0.00020448,0.25418,0.19545,1,1
3,GO OXALATE TRANSPORT,0.004408,0.25365,0.19589,1,1
3,GO XENOBIOTIC TRANSPORT,0.00013917,0.25356,0.3249,1,1
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,5.4121e-05,0.25353,0.27034,1,1
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0073363,0.2532,0.25128,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0024367,0.25317,0.23436,1,1
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00011241,0.25267,0.23378,1,1
3,GO REGULATION OF PEPTIDE SECRETION,3.8131e-07,0.2524,0.23559,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.3418e-05,0.25239,0.24779,1,1
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.8583e-05,0.25224,0.20546,1,1
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0099891,0.25218,0.20359,1,1
3,GO SKIN DEVELOPMENT,6.2786e-05,0.25193,0.21586,1,1
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.014138,0.2518,0.16833,1,1
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.053746,0.25124,0.17756,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00026003,0.25124,0.18006,1,1
3,GO MUSCLE HYPERTROPHY,0.0001165,0.25109,0.21702,1,1
3,GO REGULATION OF T CELL ACTIVATION,0.00013917,0.25071,0.19542,1,1
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,9.7346e-05,0.2507,0.22596,1,1
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00029782,0.2503,0.21742,1,1
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.6455e-05,0.25027,0.19218,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00029782,0.2502,0.32889,1,1
3,GO VESICLE BUDDING FROM MEMBRANE,0.00047456,0.25014,0.2051,1,1
3,GO CELLULAR GLUCAN METABOLIC PROCESS,3.5759e-05,0.25004,0.22284,1,1
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0025083,0.24994,0.23272,1,1
3,GO RESPONSE TO INSECTICIDE,0.0054795,0.24989,0.29192,1,1
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00027832,0.24976,0.21171,1,1
3,GO REGULATION OF T CELL MIGRATION,0.0013054,0.24961,0.21828,1,1
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00027832,0.24941,0.25232,1,1
3,GO MEMBRANE FUSION,3.0689e-05,0.24936,0.21774,1,1
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,1.4039e-05,0.24898,0.23913,1,1
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.0226e-05,0.24889,0.29822,1,1
3,GO ISOPRENOID METABOLIC PROCESS,0.00018427,0.24883,0.24664,1,1
3,GO RESPONSE TO CADMIUM ION,0.0097392,0.24882,0.20501,1,1
3,GO T CELL ACTIVATION,4.8379e-05,0.24824,0.20955,1,1
3,GO LEUKOCYTE CHEMOTAXIS,1.5201e-05,0.24804,0.22826,1,1
3,GO ADIPOSE TISSUE DEVELOPMENT,0.00057693,0.24803,0.21003,1,1
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,4.6597e-05,0.24799,0.19592,1,1
3,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0024367,0.24792,0.27582,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.0071468,0.24786,0.19848,1,1
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0071468,0.24781,0.18307,1,1
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0010859,0.24766,0.24935,1,1
3,GO EPIDERMIS DEVELOPMENT,3.4421e-05,0.24753,0.22298,1,1
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.6228e-06,0.24728,0.22168,1,1
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00016595,0.24725,0.24165,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0013872,0.24708,0.23918,1,1
3,GO CHLORIDE ION HOMEOSTASIS,0.00059588,0.24704,0.23787,1,1
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0040578,0.24682,0.23974,1,1
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.5759e-05,0.2468,0.2384,1,1
3,GO REGULATION OF CELL ADHESION,0.00022676,0.24672,0.19137,1,1
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00084609,0.24659,0.2785,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0016129,0.24656,0.20939,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00014418,0.24626,0.2099,1,1
3,GO ALCOHOL METABOLIC PROCESS,3.4728e-06,0.24611,0.26483,1,1
3,GO REGULATION OF ACTION POTENTIAL,0.0010206,0.24569,0.2269,1,1
3,GO PLATELET ACTIVATION,0.00010845,0.24558,0.21191,1,1
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.1493e-05,0.24557,0.25825,1,1
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.034637,0.24535,0.1515,1,1
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0054795,0.24508,0.22432,1,1
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0014738,0.24475,0.21444,1,1
3,GO B CELL RECEPTOR SIGNALING PATHWAY,9.0551e-05,0.24473,0.30898,1,1
3,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0094949,0.24465,0.19363,1,1
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00010462,0.24448,0.24237,1,1
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0037331,0.244,0.32707,1,1
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00037661,0.24362,0.18619,1,1
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00090094,0.24351,0.22974,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.045624,0.24347,0.25092,1,1
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.018836,0.24331,0.22273,1,1
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0060989,0.24327,0.21672,1,1
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.023205,0.24321,0.15108,1,1
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00034072,0.24288,0.23521,1,1
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.043763,0.24256,0.13254,1,1
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00055855,0.24216,0.20687,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0018173,0.24171,0.19542,1,1
3,GO INSULIN SECRETION,5.2837e-06,0.2417,0.23213,1,1
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0014299,0.24167,0.20573,1,1
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00055855,0.24154,0.23351,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.013465,0.24149,0.28337,1,1
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.0010528,0.2414,0.20021,1,1
3,GO CELL CHEMOTAXIS,1.104e-05,0.24114,0.24088,1,1
3,GO REGULATION OF CHLORIDE TRANSPORT,0.007729,0.24099,0.30993,1,1
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00052342,0.24089,0.22338,1,1
3,GO POSITIVE CHEMOTAXIS,0.0010206,0.24075,0.18441,1,1
3,GO GLIAL CELL PROLIFERATION,0.0023671,0.24051,0.2238,1,1
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0060989,0.24047,0.21665,1,1
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00017796,0.24011,0.2586,1,1
3,GO AMINOGLYCAN METABOLIC PROCESS,0.00019079,0.23992,0.2231,1,1
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,5.0226e-05,0.2398,0.27413,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.016734,0.23977,0.24263,1,1
3,GO CARBOHYDRATE HOMEOSTASIS,8.6584e-06,0.23976,0.21825,1,1
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,4.8379e-05,0.23952,0.19828,1,1
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0062634,0.23935,0.18769,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.014841,0.23932,0.23785,1,1
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00012074,0.23891,0.24987,1,1
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00021909,0.23879,0.22526,1,1
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,4.8612e-06,0.23864,0.22582,1,1
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.038561,0.23863,0.16368,1,1
3,GO MUSCLE ADAPTATION,0.00036427,0.2386,0.18736,1,1
3,GO LOCOMOTOR RHYTHM,0.0075304,0.23835,0.18849,1,1
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.043763,0.23822,0.2764,1,1
3,GO CELLULAR RESPONSE TO KETONE,0.0015653,0.23782,0.19902,1,1
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0085714,0.23775,0.1795,1,1
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,5.8301e-05,0.23773,0.20459,1,1
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,9.0551e-05,0.23753,0.2592,1,1
3,GO VESICLE TARGETING,0.00063551,0.23752,0.21004,1,1
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.036948,0.23745,0.18114,1,1
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.018398,0.23744,0.17241,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0028141,0.23733,0.28321,1,1
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.0020453,0.23723,0.35055,1,1
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.00098941,0.23708,0.22324,1,1
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.00074557,0.237,0.20441,1,1
3,GO ALCOHOL BIOSYNTHETIC PROCESS,3.7145e-05,0.23674,0.23389,1,1
3,GO I KAPPAB PHOSPHORYLATION,0.013798,0.23671,0.16757,1,1
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.00034072,0.23671,0.23887,1,1
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00087311,0.23657,0.28248,1,1
3,GO MONOCYTE CHEMOTAXIS,0.0012662,0.23629,0.21282,1,1
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.00026903,0.23622,0.17805,1,1
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0059384,0.23616,0.15196,1,1
3,GO PIGMENTATION,0.00014935,0.23614,0.17595,1,1
3,GO RESPONSE TO STARVATION,1.2962e-05,0.23612,0.23688,1,1
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.019739,0.23609,0.12842,1,1
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,5.8301e-05,0.23583,0.22721,1,1
3,GO RESPONSE TO CALCIUM ION,0.00034072,0.23565,0.198,1,1
3,GO LIPID BIOSYNTHETIC PROCESS,2.6902e-06,0.23557,0.22925,1,1
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,2.8418e-05,0.23536,0.19535,1,1
3,GO GRANULOCYTE CHEMOTAXIS,0.00010462,0.23526,0.18768,1,1
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00036427,0.23525,0.24977,1,1
3,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.020205,0.23525,0.22512,1,1
3,GO REGULATION OF INSULIN SECRETION,2.0033e-05,0.23525,0.20683,1,1
3,GO SECRETION,4.4712e-06,0.23506,0.20048,1,1
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.9532e-05,0.23494,0.19229,1,1
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0064317,0.23477,0.19568,1,1
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00012512,0.23444,0.25336,1,1
3,GO RESPONSE TO STEROL,0.0014738,0.23429,0.21918,1,1
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.00040247,0.23421,0.19188,1,1
3,GO PROTEIN MATURATION,1.5201e-05,0.2342,0.22042,1,1
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0057817,0.23417,0.25458,1,1
3,GO CELLULAR LIPID CATABOLIC PROCESS,4.2876e-06,0.23406,0.28294,1,1
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00010462,0.23389,0.19156,1,1
3,GO LIPID HOMEOSTASIS,3.0689e-05,0.2337,0.25657,1,1
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00030804,0.23365,0.23344,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.052669,0.23317,0.13958,1,1
3,GO INOSITOL METABOLIC PROCESS,0.00025131,0.23308,0.26677,1,1
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.00067758,0.23291,0.30722,1,1
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.2454e-05,0.23285,0.23295,1,1
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,4.4878e-05,0.23282,0.19776,1,1
3,GO GLUCOSE METABOLIC PROCESS,9.4334e-07,0.23255,0.24922,1,1
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,5.8301e-05,0.23254,0.2605,1,1
3,GO CHOLESTEROL STORAGE,0.00023468,0.23245,0.29255,1,1
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0042883,0.23224,0.2238,1,1
3,GO RESPONSE TO CORTICOSTEROID,0.00059588,0.23213,0.19489,1,1
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,6.2786e-05,0.23206,0.23262,1,1
3,GO PROTEIN AUTOPROCESSING,0.00019079,0.232,0.34266,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00010845,0.23196,0.20153,1,1
3,GO REGULATION OF LIPID TRANSPORT,3.7145e-05,0.23182,0.25531,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0066042,0.23174,0.21943,1,1
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.0033e-05,0.23162,0.20048,1,1
3,GO PROTEIN KINASE C SIGNALING,0.027803,0.23145,0.21089,1,1
3,GO GDP METABOLIC PROCESS,0.041093,0.23138,0.19319,1,1
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00065623,0.23113,0.23583,1,1
3,GO VITAMIN METABOLIC PROCESS,0.0041716,0.2309,0.20524,1,1
3,GO PANCREAS DEVELOPMENT,0.011904,0.2308,0.16446,1,1
3,GO B CELL DIFFERENTIATION,6.4994e-06,0.23078,0.2296,1,1
3,GO MACROMOLECULE DEPALMITOYLATION,0.00055855,0.23068,0.23755,1,1
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.0033e-05,0.23066,0.21044,1,1
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00022676,0.23046,0.18007,1,1
3,GO NEUTROPHIL MIGRATION,1.0604e-05,0.23035,0.22176,1,1
3,GO REGULATION OF PH,1.6015e-06,0.22996,0.23875,1,1
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00084609,0.22994,0.18461,1,1
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.015574,0.22994,0.14522,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00055855,0.22965,0.17594,1,1
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.0001547,0.22963,0.26304,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0053338,0.22947,0.24757,1,1
3,GO GOLGI VESICLE BUDDING,8.4205e-05,0.22943,0.21741,1,1
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00012964,0.22927,0.1941,1,1
3,GO REGULATION OF CELL ACTIVATION,0.00014935,0.22927,0.18166,1,1
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00065623,0.22923,0.22058,1,1
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.029068,0.22891,0.2031,1,1
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,7.013e-05,0.22875,0.1792,1,1
3,GO SPLEEN DEVELOPMENT,0.0011199,0.22848,0.20862,1,1
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0056288,0.22847,0.16629,1,1
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0022992,0.22838,0.22091,1,1
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.011326,0.2282,0.14017,1,1
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.031748,0.22807,0.18858,1,1
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.010773,0.22805,0.23208,1,1
3,GO RESPONSE TO METAL ION,7.3528e-06,0.22801,0.22765,1,1
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0028141,0.22793,0.17938,1,1
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,7.9801e-06,0.22785,0.23266,1,1
3,GO LIPID OXIDATION,8.7323e-05,0.22778,0.23328,1,1
3,GO REGULATION OF HEART RATE,0.00047456,0.22759,0.21851,1,1
3,GO LYMPHOCYTE HOMEOSTASIS,5.4121e-05,0.2275,0.22044,1,1
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.00069957,0.2274,0.19742,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.00092958,0.22723,0.19859,1,1
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0031536,0.22712,0.321,1,1
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.018398,0.22705,0.26321,1,1
3,GO PHAGOCYTOSIS,0.00052342,0.227,0.1694,1,1
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.2454e-05,0.22693,0.22233,1,1
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0027346,0.22674,0.19541,1,1
3,GO CELLULAR RESPONSE TO ALKALOID,1.349e-05,0.22674,0.26003,1,1
3,GO FLUID TRANSPORT,0.00013433,0.22652,0.21945,1,1
3,GO REGULATION OF BLOOD PRESSURE,2.7343e-05,0.22652,0.19815,1,1
3,GO WOUND HEALING,0.00045924,0.22651,0.18737,1,1
3,GO LYMPHOCYTE COSTIMULATION,0.00067758,0.22641,0.19658,1,1
3,GO RESPONSE TO KETONE,0.00032948,0.22634,0.18013,1,1
3,GO REGULATION OF CELLULAR PH,1.906e-06,0.22619,0.23942,1,1
3,GO RESPONSE TO ALCOHOL,0.00013433,0.22566,0.17209,1,1
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0036303,0.22561,0.19439,1,1
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0067808,0.22543,0.17529,1,1
3,GO POSITIVE REGULATION OF SECRETION,5.508e-06,0.22526,0.21575,1,1
3,GO LIPID EXPORT FROM CELL,0.00028792,0.22499,0.28709,1,1
3,GO MECHANORECEPTOR DIFFERENTIATION,0.0001547,0.22487,0.20349,1,1
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.013798,0.22483,0.24855,1,1
3,GO SEQUESTERING OF CALCIUM ION,0.00036427,0.22475,0.17852,1,1
3,GO EPITHELIAL CELL DIFFERENTIATION,4.4878e-05,0.22469,0.20538,1,1
3,GO ACROSOME REACTION,0.02166,0.2246,0.17534,1,1
3,GO REGULATION OF ANION TRANSPORT,6.7596e-05,0.22459,0.24872,1,1
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00030804,0.22459,0.3128,1,1
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.012508,0.22453,0.2713,1,1
3,GO REGULATION OF T CELL DIFFERENTIATION,0.00029782,0.22452,0.16142,1,1
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00044439,0.22452,0.2261,1,1
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00069957,0.22442,0.16461,1,1
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,4.4878e-05,0.22395,0.33943,1,1
3,GO GLOMERULUS DEVELOPMENT,0.0040578,0.22393,0.1947,1,1
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00019079,0.22379,0.20183,1,1
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0010859,0.22346,0.24892,1,1
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.001986,0.22331,0.18745,1,1
3,GO FATTY ACID BIOSYNTHETIC PROCESS,2.3418e-05,0.22329,0.2583,1,1
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00035231,0.22325,0.18293,1,1
3,GO AMYLOID BETA FORMATION,0.001872,0.22318,0.23329,1,1
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,7.6603e-06,0.22315,0.24073,1,1
3,GO PROTEIN DESTABILIZATION,3.7145e-05,0.22308,0.20274,1,1
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00052342,0.22307,0.23797,1,1
3,GO RESPONSE TO INSULIN,1.4609e-05,0.22279,0.19157,1,1
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00067758,0.22274,0.17912,1,1
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,3.0689e-05,0.22265,0.22926,1,1
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00054072,0.22232,0.26721,1,1
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,7.8282e-05,0.22226,0.2311,1,1
3,GO NEUTRAL AMINO ACID TRANSPORT,0.01282,0.22224,0.24287,1,1
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00038934,0.22212,0.16104,1,1
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00016023,0.22206,0.32755,1,1
3,GO REGULATION OF LIPID LOCALIZATION,5.4121e-05,0.22164,0.23412,1,1
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00013433,0.22157,0.21227,1,1
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.00059588,0.22141,0.19729,1,1
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.0010206,0.22109,0.25307,1,1
3,GO REGULATION OF GLUCONEOGENESIS,2.4692e-06,0.221,0.28863,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.001228,0.22083,0.19672,1,1
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0007696,0.2208,0.24993,1,1
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00010092,0.22077,0.18561,1,1
3,GO REGULATION OF NUCLEASE ACTIVITY,0.0037331,0.22077,0.17742,1,1
3,GO T CELL DIFFERENTIATION,3.4421e-05,0.22074,0.1844,1,1
3,GO REGULATION OF FATTY ACID OXIDATION,0.0037331,0.22053,0.20753,1,1
3,GO APOPTOTIC SIGNALING PATHWAY,3.3132e-05,0.22052,0.19038,1,1
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00353,0.22041,0.20405,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00010462,0.22017,0.19692,1,1
3,GO REGULATION OF AMYLOID BETA FORMATION,0.0026572,0.22008,0.25152,1,1
3,GO T HELPER CELL LINEAGE COMMITMENT,0.0057817,0.22008,0.17561,1,1
3,GO REGULATION OF CELL MATRIX ADHESION,0.0013872,0.21975,0.20653,1,1
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00050664,0.21965,0.21634,1,1
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,4.8379e-05,0.2196,0.19146,1,1
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00032948,0.21944,0.25145,1,1
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0025817,0.21933,0.17742,1,1
3,GO SUPEROXIDE METABOLIC PROCESS,0.0001165,0.2192,0.24403,1,1
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,5.6174e-05,0.2191,0.17709,1,1
3,GO REGULATION OF MAST CELL ACTIVATION,0.0014299,0.21908,0.21524,1,1
3,GO ENGULFMENT OF APOPTOTIC CELL,0.0016129,0.21906,0.20982,1,1
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.052669,0.21897,0.1884,1,1
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.00092958,0.21844,0.1579,1,1
3,GO FIBROBLAST PROLIFERATION,0.0031536,0.21808,0.18484,1,1
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0021689,0.21805,0.15451,1,1
3,GO LEUKOCYTE DIFFERENTIATION,2.6307e-05,0.218,0.18465,1,1
3,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.050569,0.21797,0.17892,1,1
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,9.0551e-05,0.21796,0.25019,1,1
3,GO TERPENOID METABOLIC PROCESS,0.00049035,0.21795,0.22904,1,1
3,GO PROTEIN KINASE B SIGNALING,0.00087311,0.21771,0.15659,1,1
3,GO REGULATION OF HORMONE LEVELS,1.8251e-06,0.21767,0.24697,1,1
3,GO AUTOPHAGIC CELL DEATH,0.0037331,0.21734,0.19619,1,1
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00019079,0.21732,0.23053,1,1
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,1.349e-05,0.21715,0.1972,1,1
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.02166,0.21713,0.2003,1,1
3,GO NATURAL KILLER CELL ACTIVATION,6.0504e-05,0.21707,0.21579,1,1
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0018173,0.21705,0.18624,1,1
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0050528,0.21704,0.20557,1,1
3,GO LIPID METABOLIC PROCESS,3.1904e-06,0.21694,0.22268,1,1
3,GO REGULATION OF PROTEOLYSIS,7.8282e-05,0.21692,0.18068,1,1
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0017641,0.21663,0.17544,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.011326,0.21661,0.14523,1,1
3,GO PEROXISOMAL TRANSPORT,0.0006154,0.21644,0.21202,1,1
3,GO CELLULAR LIPID METABOLIC PROCESS,3.4728e-06,0.21625,0.22606,1,1
3,GO CELL CELL ADHESION,0.00019753,0.21607,0.17692,1,1
3,GO RESPONSE TO IRON ION,0.0011199,0.21596,0.22411,1,1
3,GO RESPONSE TO OSMOTIC STRESS,0.00054072,0.21561,0.21783,1,1
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,9.3916e-06,0.21548,0.20056,1,1
3,GO PLACENTA DEVELOPMENT,0.014486,0.21533,0.13437,1,1
3,GO PROTEIN ADP RIBOSYLATION,0.0097392,0.21523,0.16914,1,1
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0025817,0.21521,0.30492,1,1
3,GO ORGANELLE FUSION,0.00026003,0.21503,0.1741,1,1
3,GO RESPONSE TO INORGANIC SUBSTANCE,6.4994e-06,0.21503,0.18731,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.2876e-06,0.21501,0.2084,1,1
3,GO RESPONSE TO DSRNA,0.00044439,0.21471,0.1758,1,1
3,GO ERK1 AND ERK2 CASCADE,0.0011549,0.21467,0.17326,1,1
3,GO POSITIVE REGULATION OF HORMONE SECRETION,4.1617e-05,0.21453,0.23499,1,1
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.00063551,0.21432,0.14927,1,1
3,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00010092,0.21402,0.19074,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0033369,0.2139,0.16286,1,1
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.0013457,0.21374,0.17946,1,1
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.00040247,0.21342,0.19172,1,1
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,9.389e-05,0.21328,0.17781,1,1
3,GO REGULATION OF HORMONE SECRETION,9.7801e-06,0.21326,0.21644,1,1
3,GO CATECHOLAMINE METABOLIC PROCESS,0.001872,0.2132,0.25671,1,1
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.21319,0.19121,1,1
3,GO LONG CHAIN FATTY ACID TRANSPORT,3.7791e-06,0.21281,0.24415,1,1
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,2.3418e-05,0.21267,0.19264,1,1
3,GO GAMMA DELTA T CELL ACTIVATION,0.010506,0.21265,0.25463,1,1
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.00034072,0.21258,0.18971,1,1
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,5.0226e-05,0.21245,0.17402,1,1
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.0604e-05,0.21204,0.26219,1,1
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.00027832,0.21182,0.18005,1,1
3,GO SULFUR COMPOUND TRANSPORT,9.7346e-05,0.21176,0.21851,1,1
3,GO FATTY ACID TRANSPORT,1.1493e-05,0.21164,0.24296,1,1
3,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0007696,0.21145,0.17157,1,1
3,GO LYMPHOCYTE ACTIVATION,7.013e-05,0.21124,0.17938,1,1
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.011612,0.21121,0.19135,1,1
3,GO PHOSPHOLIPID METABOLIC PROCESS,2.9301e-06,0.21067,0.19355,1,1
3,GO RESPONSE TO MECHANICAL STIMULUS,2.7343e-05,0.21065,0.21746,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.2837e-06,0.21008,0.2144,1,1
3,GO CHEMICAL HOMEOSTASIS,4.1112e-06,0.20983,0.18823,1,1
3,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0075304,0.20977,0.33233,1,1
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.00092958,0.20966,0.18941,1,1
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00036427,0.20958,0.20866,1,1
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.0059384,0.20957,0.16725,1,1
3,GO MANGANESE ION TRANSPORT,0.00090094,0.20935,0.2214,1,1
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.00031859,0.20933,0.17985,1,1
3,GO WHITE FAT CELL DIFFERENTIATION,0.0051916,0.20931,0.18895,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.0026572,0.20929,0.14642,1,1
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.011612,0.20918,0.17861,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00042998,0.20905,0.1779,1,1
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00017186,0.20902,0.23365,1,1
3,GO GLUTAMATE METABOLIC PROCESS,0.0007696,0.20895,0.20073,1,1
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.1663e-05,0.2088,0.23356,1,1
3,GO ADAPTIVE THERMOGENESIS,2.2658e-06,0.20858,0.22659,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.004408,0.20837,0.23222,1,1
3,GO NOTCH SIGNALING PATHWAY,0.00017796,0.20821,0.20025,1,1
3,GO PROSTAGLANDIN SECRETION,0.0021062,0.2082,0.25095,1,1
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.013465,0.20813,0.19607,1,1
3,GO REGULATION OF TUBE SIZE,0.00019079,0.20798,0.19555,1,1
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.033894,0.20796,0.18765,1,1
3,GO VACUOLE ORGANIZATION,9.4334e-07,0.20791,0.24743,1,1
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0036303,0.20784,0.17928,1,1
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.00090094,0.2076,0.1866,1,1
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.001191,0.20748,0.27589,1,1
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,3.9418e-06,0.20669,0.22032,1,1
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.00014418,0.20664,0.18331,1,1
3,GO INORGANIC ANION TRANSPORT,1.1964e-05,0.20651,0.18273,1,1
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.018398,0.20628,0.19753,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0040578,0.20622,0.17382,1,1
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,3.1888e-05,0.20608,0.21185,1,1
3,GO SENSORY PERCEPTION OF TASTE,0.00049035,0.20608,0.17253,1,1
3,GO FC RECEPTOR SIGNALING PATHWAY,0.00050664,0.20603,0.15166,1,1
3,GO ACTIN FILAMENT BASED TRANSPORT,0.011047,0.20593,0.21709,1,1
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0001165,0.20591,0.20908,1,1
3,GO LYMPHOCYTE CHEMOTAXIS,0.0023671,0.20582,0.15056,1,1
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0075304,0.20579,0.16674,1,1
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.4044e-06,0.20578,0.2308,1,1
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0081404,0.20554,0.15178,1,1
3,GO HORMONE TRANSPORT,4.8612e-06,0.20545,0.23347,1,1
3,GO ACTIN NUCLEATION,0.00047456,0.20544,0.19608,1,1
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041093,0.20531,0.17216,1,1
3,GO IRON ION TRANSPORT,3.3132e-05,0.20503,0.25203,1,1
3,GO ENDOCYTIC RECYCLING,0.00050664,0.20491,0.17031,1,1
3,GO REGULATION OF BONE DEVELOPMENT,0.017969,0.20475,0.13937,1,1
3,GO CHYLOMICRON ASSEMBLY,0.014841,0.20472,0.24087,1,1
3,GO EPITHELIAL CELL DEVELOPMENT,0.0010859,0.20414,0.16619,1,1
3,GO PEPTIDE HORMONE SECRETION,7.3528e-06,0.20402,0.22407,1,1
3,GO SYNAPTIC VESICLE BUDDING,0.025994,0.20362,0.20151,1,1
3,GO ENDOTHELIAL CELL MIGRATION,0.0013054,0.20338,0.17717,1,1
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,1.4039e-05,0.20293,0.21236,1,1
3,GO REGULATION OF HEMOPOIESIS,0.00010462,0.20276,0.16111,1,1
3,GO DETOXIFICATION,0.05161,0.20253,0.166,1,1
3,GO MONOSACCHARIDE METABOLIC PROCESS,3.0576e-06,0.20248,0.25926,1,1
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.016339,0.20246,0.12815,1,1
3,GO GLUCOSE IMPORT,0.00087311,0.20225,0.18555,1,1
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0066042,0.20222,0.17753,1,1
3,GO FATTY ACID METABOLIC PROCESS,1.1493e-05,0.20153,0.25707,1,1
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.0013054,0.20148,0.1667,1,1
3,GO EPITHELIUM DEVELOPMENT,0.0001165,0.20116,0.1558,1,1
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.01282,0.20107,0.28733,1,1
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.0087944,0.20091,0.23831,1,1
3,GO CHLORIDE TRANSPORT,2.4346e-05,0.20085,0.1849,1,1
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0019282,0.20083,0.17365,1,1
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0020453,0.2007,0.19327,1,1
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.019283,0.20063,0.18222,1,1
3,GO HEXOSE CATABOLIC PROCESS,0.029719,0.20063,0.18481,1,1
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.055956,0.20061,0.12719,1,1
3,GO COPII COATED VESICLE BUDDING,0.00026903,0.20059,0.19962,1,1
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.027188,0.20017,0.18865,1,1
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.00057693,0.20015,0.16197,1,1
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.014486,0.20011,0.1377,1,1
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.001662,0.2001,0.20438,1,1
3,GO REGULATION OF APPETITE,0.0069616,0.19986,0.13148,1,1
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.037747,0.19983,0.098114,1,1
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00052342,0.19981,0.16106,1,1
3,GO PROTEOLYSIS,2.8418e-05,0.19977,0.15797,1,1
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.022165,0.19973,0.17426,1,1
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,1.7806e-05,0.19959,0.23688,1,1
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00012074,0.19945,0.21094,1,1
3,GO REGULATION OF LIPID METABOLIC PROCESS,3.5759e-05,0.19923,0.19551,1,1
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00014935,0.19911,0.22104,1,1
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0094949,0.19894,0.14323,1,1
3,GO ORGANIC ANION TRANSPORT,2.3654e-06,0.19881,0.22081,1,1
3,GO ANION TRANSPORT,2.5774e-06,0.19818,0.20301,1,1
3,GO RESPONSE TO WOUNDING,0.00069957,0.19816,0.16908,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00022676,0.19806,0.19638,1,1
3,GO REGULATION OF SECRETION,1.1493e-05,0.19762,0.17953,1,1
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0015653,0.19752,0.20194,1,1
3,GO BROWN FAT CELL DIFFERENTIATION,0.0010859,0.1973,0.22874,1,1
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0010528,0.19676,0.19737,1,1
3,GO REGULATION OF MAP KINASE ACTIVITY,0.00024286,0.19597,0.17222,1,1
3,GO PLASMA MEMBRANE ORGANIZATION,0.00032948,0.19582,0.18828,1,1
3,GO VESICLE ORGANIZATION,8.4205e-05,0.1957,0.18013,1,1
3,GO CIRCULATORY SYSTEM PROCESS,6.0504e-05,0.19567,0.15659,1,1
3,GO CAMP METABOLIC PROCESS,0.036164,0.19558,0.15622,1,1
3,GO SPERM CAPACITATION,0.0047853,0.19546,0.20572,1,1
3,GO BICARBONATE TRANSPORT,0.011047,0.195,0.17465,1,1
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0099891,0.19483,0.17096,1,1
3,GO INTERFERON GAMMA PRODUCTION,0.0017641,0.1948,0.15645,1,1
3,GO PEROXISOME ORGANIZATION,0.00072223,0.19471,0.20022,1,1
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.001872,0.19433,0.17584,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.03245,0.1943,0.16219,1,1
3,GO HUMORAL IMMUNE RESPONSE,7.3528e-06,0.19426,0.2446,1,1
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.00041602,0.19414,0.15039,1,1
3,GO ANION TRANSMEMBRANE TRANSPORT,2.9532e-05,0.19403,0.18627,1,1
3,GO RESPONSE TO STEROID HORMONE,0.00028792,0.19384,0.17076,1,1
3,GO RESPONSE TO CHEMOKINE,0.0001165,0.19381,0.18449,1,1
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0025083,0.19374,0.23014,1,1
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0038387,0.19372,0.15186,1,1
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0029794,0.19346,0.20298,1,1
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0023671,0.19332,0.15646,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0010206,0.19327,0.14832,1,1
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00095906,0.19296,0.13677,1,1
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00021909,0.19295,0.18974,1,1
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0011549,0.19294,0.17609,1,1
3,GO ENERGY RESERVE METABOLIC PROCESS,0.00054072,0.19291,0.18042,1,1
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,9.389e-05,0.19283,0.19156,1,1
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.6603e-06,0.19274,0.18481,1,1
3,GO LYMPHOCYTE DIFFERENTIATION,6.0504e-05,0.19269,0.16277,1,1
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00010462,0.19246,0.14877,1,1
3,GO TISSUE MIGRATION,0.0010528,0.19242,0.17169,1,1
3,GO RESPONSE TO FUNGUS,0.00013917,0.19235,0.1826,1,1
3,GO MONOCARBOXYLIC ACID TRANSPORT,2.4346e-05,0.19227,0.23577,1,1
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00019753,0.19225,0.18945,1,1
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.030383,0.19201,0.181,1,1
3,GO RENAL TUBULE DEVELOPMENT,0.0050528,0.19198,0.14491,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028141,0.19196,0.21005,1,1
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.00010462,0.19164,0.24419,1,1
3,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0010528,0.19146,0.17612,1,1
3,GO CARBOHYDRATE METABOLIC PROCESS,5.2837e-06,0.19129,0.21817,1,1
3,GO POSITIVE REGULATION OF CELL AGING,0.012203,0.19121,0.19476,1,1
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0010206,0.19089,0.24146,1,1
3,GO RESPONSE TO DRUG,0.00012964,0.19079,0.17705,1,1
3,GO LYSOSOME LOCALIZATION,0.00028792,0.19079,0.17435,1,1
3,GO OXIDATION REDUCTION PROCESS,3.4421e-05,0.19069,0.20816,1,1
3,GO REGULATION OF VASCULAR PERMEABILITY,0.00028792,0.19066,0.24347,1,1
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00032948,0.19043,0.16859,1,1
3,GO ION TRANSPORT,2.0833e-05,0.19039,0.16879,1,1
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0038387,0.1902,0.17711,1,1
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.02843,0.18986,0.15361,1,1
3,GO REGULATION OF DENDRITE EXTENSION,0.014138,0.18959,0.30451,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0040578,0.18957,0.15717,1,1
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0031536,0.18952,0.13838,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0010859,0.18926,0.16756,1,1
3,GO RESPONSE TO TOXIC SUBSTANCE,0.00065623,0.18924,0.19692,1,1
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00011241,0.18912,0.16217,1,1
3,GO GOLGI ORGANIZATION,3.8583e-05,0.18899,0.1808,1,1
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.7145e-05,0.18854,0.1765,1,1
3,GO GLYCEROLIPID METABOLIC PROCESS,9.0179e-06,0.18833,0.18288,1,1
3,GO MYOTUBE DIFFERENTIATION,0.0001547,0.1883,0.19426,1,1
3,GO LIPID CATABOLIC PROCESS,4.1112e-06,0.1881,0.24463,1,1
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0016129,0.18774,0.1759,1,1
3,GO NERVE DEVELOPMENT,0.038561,0.18758,0.1518,1,1
3,GO ANION HOMEOSTASIS,0.0075304,0.18742,0.17637,1,1
3,GO DEVELOPMENTAL PIGMENTATION,0.0027346,0.18706,0.1452,1,1
3,GO NEUTROPHIL CHEMOTAXIS,4.4878e-05,0.18691,0.16837,1,1
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0045306,0.18681,0.15561,1,1
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00040247,0.18679,0.16847,1,1
3,GO LEUKOCYTE HOMEOSTASIS,0.0020453,0.18671,0.15727,1,1
3,GO MYELOID CELL DIFFERENTIATION,9.389e-05,0.1867,0.1615,1,1
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.038561,0.18636,0.1905,1,1
3,GO POLYOL BIOSYNTHETIC PROCESS,7.2754e-05,0.18625,0.23862,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0014299,0.18596,0.2188,1,1
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.016339,0.18584,0.14863,1,1
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0029794,0.18575,0.12665,1,1
3,GO ESTROGEN METABOLIC PROCESS,0.013465,0.1857,0.18595,1,1
3,GO ION HOMEOSTASIS,2.4346e-05,0.18564,0.16581,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.009256,0.18559,0.17925,1,1
3,GO ENDOCRINE HORMONE SECRETION,0.00047456,0.18533,0.20043,1,1
3,GO AGING,4.3218e-05,0.18482,0.15792,1,1
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.012508,0.18471,0.14071,1,1
3,GO FATTY ACID BETA OXIDATION,0.00084609,0.18471,0.20724,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.011326,0.1845,0.14131,1,1
3,GO PLATELET MORPHOGENESIS,0.010773,0.18441,0.17076,1,1
3,GO MYELIN ASSEMBLY,0.02068,0.1842,0.17544,1,1
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00026903,0.18418,0.21332,1,1
3,GO CELLULAR RESPONSE TO LIPID,0.0013054,0.18414,0.1413,1,1
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00063551,0.18392,0.17405,1,1
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1.5201e-05,0.1837,0.23744,1,1
3,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.013465,0.18361,0.28149,1,1
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.0059384,0.1836,0.11945,1,1
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.0226e-05,0.18353,0.16412,1,1
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.019739,0.18349,0.13836,1,1
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0017641,0.18346,0.20553,1,1
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.020205,0.18345,0.16864,1,1
3,GO HOMEOSTATIC PROCESS,5.7413e-06,0.18272,0.15553,1,1
3,GO BIOLOGICAL ADHESION,0.0011199,0.18266,0.14391,1,1
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00084609,0.18257,0.18142,1,1
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,1.7118e-05,0.1823,0.18813,1,1
3,GO PROTON TRANSMEMBRANE TRANSPORT,1.4039e-05,0.18201,0.21477,1,1
3,GO ZINC ION TRANSPORT,0.022165,0.18178,0.16068,1,1
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0039469,0.18171,0.15233,1,1
3,GO LUNG MORPHOGENESIS,0.020205,0.18157,0.13727,1,1
3,GO TEMPERATURE HOMEOSTASIS,2.6307e-05,0.18151,0.18984,1,1
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0071468,0.18147,0.18587,1,1
3,GO ACTIVATED T CELL PROLIFERATION,0.001872,0.18145,0.18695,1,1
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.1663e-05,0.18116,0.1678,1,1
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0034322,0.18111,0.12741,1,1
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0006154,0.181,0.18465,1,1
3,GO RESPONSE TO LIPID,0.00031859,0.18096,0.15577,1,1
3,GO REGULATION OF BLOOD CIRCULATION,0.0010859,0.18061,0.15187,1,1
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00017186,0.18046,0.14184,1,1
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0001165,0.18046,0.18098,1,1
3,GO BIOMINERALIZATION,0.0014299,0.18031,0.16447,1,1
3,GO SENSORY PERCEPTION OF SMELL,4.8379e-05,0.18001,0.19401,1,1
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.027803,0.17994,0.11559,1,1
3,GO REGULATION OF RESPONSE TO STRESS,0.00010845,0.17981,0.14488,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010092,0.17943,0.17118,1,1
3,GO DENDRITIC CELL CHEMOTAXIS,0.046579,0.17938,0.13054,1,1
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0025817,0.17932,0.16751,1,1
3,GO GLAND DEVELOPMENT,0.00035231,0.17929,0.1459,1,1
3,GO KERATINOCYTE MIGRATION,0.0099891,0.1792,0.15487,1,1
3,GO RENAL WATER HOMEOSTASIS,0.036948,0.1787,0.097893,1,1
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0028141,0.17868,0.1855,1,1
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.018398,0.17859,0.13973,1,1
3,GO METAL ION HOMEOSTASIS,3.1888e-05,0.17809,0.15868,1,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.013465,0.17803,0.18603,1,1
3,GO RESPONSE TO ETHER,0.00353,0.17797,0.1799,1,1
3,GO TRANSITION METAL ION HOMEOSTASIS,0.0067808,0.17789,0.14958,1,1
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.0049174,0.17784,0.1657,1,1
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0030654,0.17777,0.16052,1,1
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.00353,0.17755,0.12585,1,1
3,GO ENDOSOME ORGANIZATION,0.00040247,0.17737,0.17672,1,1
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.019283,0.17734,0.15461,1,1
3,GO REGULATION OF SODIUM ION TRANSPORT,0.011047,0.17722,0.1553,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0019282,0.17702,0.1797,1,1
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,4.3218e-05,0.1768,0.16498,1,1
3,GO CELLULAR PIGMENTATION,0.00028792,0.17671,0.18971,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.6597e-05,0.17661,0.16518,1,1
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00021909,0.17636,0.22639,1,1
3,GO IMMUNE SYSTEM DEVELOPMENT,5.6174e-05,0.17636,0.14701,1,1
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.018398,0.176,0.11782,1,1
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00037661,0.17581,0.15255,1,1
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0014738,0.17563,0.17594,1,1
3,GO METAL ION TRANSPORT,0.00030804,0.17549,0.13733,1,1
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.016734,0.17534,0.16246,1,1
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.02068,0.17501,0.16858,1,1
3,GO LIPID MODIFICATION,5.4121e-05,0.17469,0.18377,1,1
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.0099891,0.17456,0.27831,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0010206,0.1745,0.15282,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00021167,0.1744,0.18281,1,1
3,GO REGULATION OF HYDROLASE ACTIVITY,0.00037661,0.17435,0.12754,1,1
3,GO MONONUCLEAR CELL MIGRATION,0.0036303,0.17378,0.15132,1,1
3,GO MACROPHAGE ACTIVATION,0.00020448,0.17371,0.19441,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0039469,0.17339,0.20947,1,1
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.00028792,0.17297,0.13916,1,1
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00090094,0.1729,0.15743,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,5.8301e-05,0.17265,0.15371,1,1
3,GO RETINA HOMEOSTASIS,0.00045924,0.17223,0.12693,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00044439,0.17219,0.17382,1,1
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0001165,0.17203,0.18966,1,1
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.017549,0.17175,0.13784,1,1
3,GO REGULATION OF ATP METABOLIC PROCESS,0.0053338,0.17161,0.1204,1,1
3,GO OOCYTE DIFFERENTIATION,0.00063551,0.1715,0.16102,1,1
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,8.1192e-05,0.17148,0.20713,1,1
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.018398,0.17147,0.15661,1,1
3,GO NEUROINFLAMMATORY RESPONSE,0.01282,0.17107,0.13365,1,1
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.001191,0.17095,0.13588,1,1
3,GO DETECTION OF STIMULUS,2.1663e-05,0.17072,0.14615,1,1
3,GO CATION TRANSPORT,0.00021167,0.17072,0.14279,1,1
3,GO RESPONSE TO OXIDATIVE STRESS,9.389e-05,0.17055,0.16306,1,1
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00045924,0.17026,0.13928,1,1
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.031748,0.17025,0.14802,1,1
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.007729,0.17024,0.16881,1,1
3,GO T CELL HOMEOSTASIS,0.014841,0.16996,0.13463,1,1
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,7.2754e-05,0.16996,0.15282,1,1
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0013872,0.16984,0.21514,1,1
3,GO GLIAL CELL DEVELOPMENT,0.0071468,0.1697,0.14547,1,1
3,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.011047,0.1695,0.24792,1,1
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0049174,0.16943,0.1869,1,1
3,GO ACID SECRETION,0.001662,0.1694,0.16324,1,1
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.0042883,0.16937,0.15883,1,1
3,GO MICROVILLUS ASSEMBLY,0.052669,0.16937,0.20803,1,1
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00084609,0.16914,0.15459,1,1
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0007696,0.16913,0.18636,1,1
3,GO MYELOID CELL HOMEOSTASIS,0.0037331,0.16885,0.12517,1,1
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00012964,0.16874,0.14713,1,1
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.050569,0.16864,0.1272,1,1
3,GO ACETYL COA METABOLIC PROCESS,0.019739,0.16857,0.14695,1,1
3,GO REGULATION OF GLUCOSE IMPORT,0.00072223,0.16834,0.18386,1,1
3,GO REGULATION OF PEPTIDE TRANSPORT,1.9904e-06,0.16833,0.16827,1,1
3,GO REGULATION OF CELLULAR RESPIRATION,0.03245,0.1683,0.19601,1,1
3,GO REGULATION OF TRANSPORT,0.00016023,0.16822,0.11906,1,1
3,GO ORGANIC ACID CATABOLIC PROCESS,0.00050664,0.16802,0.20004,1,1
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,9.7346e-05,0.16777,0.20913,1,1
3,GO REGULATION OF CHEMOTAXIS,0.00090094,0.16764,0.1408,1,1
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.00069957,0.16743,0.23478,1,1
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00021909,0.16711,0.14384,1,1
3,GO NEPHRON DEVELOPMENT,0.0090226,0.16695,0.1166,1,1
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.04854,0.16692,0.15145,1,1
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011904,0.16688,0.18741,1,1
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,3.1888e-05,0.16681,0.15086,1,1
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0006154,0.1664,0.14916,1,1
3,GO CHOLESTEROL EFFLUX,0.0021689,0.16632,0.1952,1,1
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0016129,0.16616,0.1847,1,1
3,GO THYMIC T CELL SELECTION,0.017969,0.16612,0.096415,1,1
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00047456,0.16596,0.17814,1,1
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0026572,0.16588,0.13814,1,1
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.02068,0.16558,0.13488,1,1
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,2.2524e-05,0.1655,0.18615,1,1
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,5.4121e-05,0.16545,0.175,1,1
3,GO PEPTIDYL TYROSINE MODIFICATION,0.0010859,0.16514,0.14848,1,1
3,GO DEFENSE RESPONSE TO FUNGUS,0.0025817,0.16494,0.15522,1,1
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00067758,0.16454,0.15968,1,1
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.037747,0.16432,0.14608,1,1
3,GO ION TRANSMEMBRANE TRANSPORT,9.0551e-05,0.16424,0.14865,1,1
3,GO MULTIVESICULAR BODY SORTING PATHWAY,0.001228,0.16416,0.15814,1,1
3,GO RESPONSE TO NITROGEN COMPOUND,5.4121e-05,0.16407,0.13294,1,1
3,GO ERBB SIGNALING PATHWAY,0.0062634,0.16384,0.14521,1,1
3,GO TRANSMEMBRANE TRANSPORT,2.2524e-05,0.16382,0.16443,1,1
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0099891,0.16351,0.13314,1,1
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00012074,0.16342,0.14513,1,1
3,GO ORGANELLE DISASSEMBLY,0.00049035,0.1634,0.16004,1,1
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.013798,0.16324,0.10991,1,1
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00013433,0.16282,0.13028,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0031536,0.16265,0.13248,1,1
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.013465,0.16251,0.15664,1,1
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,5.508e-06,0.16247,0.19693,1,1
3,GO PROTEIN K48 LINKED UBIQUITINATION,0.0013872,0.16228,0.12783,1,1
3,GO TUMOR NECROSIS FACTOR SECRETION,0.016339,0.16214,0.10583,1,1
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00019079,0.16187,0.15225,1,1
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0025817,0.16186,0.16348,1,1
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,9.389e-05,0.1618,0.1775,1,1
3,GO RUFFLE ORGANIZATION,0.00050664,0.1617,0.19804,1,1
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0006154,0.16168,0.22662,1,1
3,GO EXECUTION PHASE OF APOPTOSIS,3.1904e-06,0.16131,0.19998,1,1
3,GO REGULATION OF ION TRANSPORT,0.0017123,0.16105,0.12816,1,1
3,GO TRANSLESION SYNTHESIS,0.0028141,0.161,0.12925,1,1
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00044439,0.16069,0.1702,1,1
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.010245,0.16061,0.15865,1,1
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00016595,0.16038,0.13709,1,1
3,GO ATP TRANSPORT,0.024288,0.16036,0.1111,1,1
3,GO CELLULAR EXTRAVASATION,0.013139,0.16019,0.11958,1,1
3,GO CELLULAR ION HOMEOSTASIS,9.7346e-05,0.15987,0.14383,1,1
3,GO REGULATION OF CELL MATURATION,0.0028957,0.15932,0.16774,1,1
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0036303,0.15903,0.16437,1,1
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00047456,0.15875,0.25812,1,1
3,GO NEGATIVE T CELL SELECTION,0.015953,0.15874,0.1139,1,1
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.0039469,0.15803,0.1704,1,1
3,GO RENAL SODIUM EXCRETION,0.0034322,0.15795,0.19629,1,1
3,GO ACTIVATION OF MAPK ACTIVITY,7.2754e-05,0.15778,0.17178,1,1
3,GO RDNA HETEROCHROMATIN ASSEMBLY,0.0034322,0.15757,0.17234,1,1
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.02068,0.15736,0.13307,1,1
3,GO ORGANIC ACID METABOLIC PROCESS,0.00019079,0.15718,0.18488,1,1
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.055956,0.1568,0.097864,1,1
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.024846,0.1567,0.17051,1,1
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00014418,0.15633,0.1309,1,1
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0071468,0.15632,0.11098,1,1
3,GO RESPONSE TO CARBOHYDRATE,0.00031859,0.1563,0.15139,1,1
3,GO MULTIVESICULAR BODY ORGANIZATION,0.004408,0.15615,0.13167,1,1
3,GO ENDOCYTOSIS,0.0069616,0.15612,0.10475,1,1
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.012508,0.15599,0.10483,1,1
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.037747,0.15567,0.25185,1,1
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0073363,0.15558,0.12328,1,1
3,GO RESPONSE TO ACID CHEMICAL,0.0023671,0.15556,0.12605,1,1
3,GO REGULATION OF MAPK CASCADE,0.00042998,0.15537,0.14883,1,1
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.009256,0.1553,0.13237,1,1
3,GO POSITIVE REGULATION OF TRANSPORT,0.00019079,0.15525,0.12696,1,1
3,GO CALCIUM ION IMPORT,0.0057817,0.15516,0.12082,1,1
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.0025817,0.15503,0.11308,1,1
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0045306,0.15494,0.16594,1,1
3,GO RESPONSE TO HORMONE,9.7346e-05,0.15492,0.15735,1,1
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00023468,0.15447,0.14129,1,1
3,GO PROTEIN PALMITOYLATION,0.0097392,0.15434,0.15485,1,1
3,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0067808,0.1543,0.37216,1,1
3,GO CELL MOTILITY,0.001872,0.15416,0.12104,1,1
3,GO POSITIVE REGULATION OF SIGNALING,5.8301e-05,0.15407,0.13813,1,1
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.00022676,0.15406,0.15672,1,1
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.15401,0.11666,1,1
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00028792,0.154,0.14481,1,1
3,GO REGULATION OF HISTONE DEACETYLATION,0.0023671,0.15395,0.1934,1,1
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00020448,0.15375,0.15083,1,1
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00052342,0.15347,0.12587,1,1
3,GO RESPONSE TO ALKALOID,0.0026572,0.15332,0.15028,1,1
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00013917,0.1533,0.13442,1,1
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00054072,0.15287,0.14784,1,1
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.019283,0.15278,0.11422,1,1
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.050569,0.15265,0.16645,1,1
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.017969,0.15256,0.19675,1,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.036948,0.15227,0.13246,1,1
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00025131,0.15198,0.14121,1,1
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.8282e-05,0.15195,0.19759,1,1
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.001191,0.15191,0.1851,1,1
3,GO T CELL SELECTION,0.00069957,0.15176,0.14205,1,1
3,GO ESTROGEN BIOSYNTHETIC PROCESS,0.020205,0.15155,0.22875,1,1
3,GO RESPONSE TO ANTIBIOTIC,0.0010528,0.15138,0.17327,1,1
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.029068,0.15134,0.10715,1,1
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001191,0.1511,0.13713,1,1
3,GO POSITIVE REGULATION OF CELL DEATH,0.0011199,0.15098,0.11963,1,1
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0024367,0.15079,0.14721,1,1
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.011326,0.15076,0.13634,1,1
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.029068,0.15073,0.20623,1,1
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.001191,0.15068,0.15272,1,1
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0019282,0.15067,0.12269,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.00081984,0.15044,0.12961,1,1
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0039469,0.15033,0.16328,1,1
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0013054,0.15029,0.13099,1,1
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.00010462,0.15017,0.19864,1,1
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.03245,0.15015,0.16211,1,1
3,GO ORGANIC ACID TRANSPORT,1.2454e-05,0.15007,0.21103,1,1
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0015189,0.14996,0.12046,1,1
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.040234,0.14987,0.09488,1,1
3,GO CELLULAR RESPONSE TO PEPTIDE,0.00010092,0.14985,0.14129,1,1
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00014418,0.14905,0.21783,1,1
3,GO REGULATION OF CHROMATIN ASSEMBLY,0.0023671,0.14827,0.14352,1,1
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00055855,0.14772,0.17452,1,1
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0028141,0.14753,0.22896,1,1
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00042998,0.14752,0.12064,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.001872,0.14746,0.13587,1,1
3,GO RESPONSE TO MONOSACCHARIDE,0.00036427,0.14737,0.15241,1,1
3,GO SINGLE FERTILIZATION,0.0027346,0.14678,0.10627,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00030804,0.14675,0.13732,1,1
3,GO FAT CELL DIFFERENTIATION,0.00092958,0.14672,0.16446,1,1
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00050664,0.14663,0.13613,1,1
3,GO ERYTHROCYTE HOMEOSTASIS,0.0010206,0.14634,0.13907,1,1
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.0604e-05,0.14623,0.17943,1,1
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0037331,0.14616,0.16773,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.7323e-05,0.14582,0.14376,1,1
3,GO RESPONSE TO ACTIVITY,0.0028957,0.14581,0.16088,1,1
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.027803,0.1458,0.15544,1,1
3,GO EXCRETION,0.00050664,0.14572,0.17482,1,1
3,GO CELL MATURATION,8.1192e-05,0.14547,0.15816,1,1
3,GO AUTOPHAGY OF MITOCHONDRION,0.00095906,0.14545,0.16722,1,1
3,GO MEMBRANE ORGANIZATION,0.00074557,0.14523,0.11594,1,1
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00040247,0.14519,0.12695,1,1
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0025083,0.14498,0.12117,1,1
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00014418,0.14453,0.17815,1,1
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0015653,0.14443,0.10966,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.00054072,0.14437,0.15268,1,1
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0069616,0.14436,0.15741,1,1
3,GO ALCOHOL CATABOLIC PROCESS,0.001228,0.14355,0.17336,1,1
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.04854,0.14339,0.12468,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0007696,0.1433,0.14759,1,1
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0037331,0.14329,0.11522,1,1
3,GO TRANSITION METAL ION TRANSPORT,2.9532e-05,0.14326,0.22689,1,1
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00074557,0.14323,0.11038,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.1431,0.093453,1,1
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.015574,0.14307,0.13265,1,1
3,GO PIGMENT GRANULE LOCALIZATION,0.0081404,0.14301,0.14299,1,1
3,GO PROTEIN AUTOUBIQUITINATION,4.3218e-05,0.14297,0.14358,1,1
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0017123,0.14297,0.12286,1,1
3,GO RUFFLE ASSEMBLY,0.027188,0.14294,0.12112,1,1
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0031536,0.14284,0.15907,1,1
3,GO FATTY ACYL COA METABOLIC PROCESS,0.0029794,0.14277,0.21509,1,1
3,GO SODIUM ION TRANSPORT,0.0011549,0.14268,0.16491,1,1
3,GO RESPONSE TO ETHANOL,0.0028957,0.1426,0.13463,1,1
3,GO POTASSIUM ION HOMEOSTASIS,0.017549,0.14254,0.14344,1,1
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.0013054,0.14244,0.1325,1,1
3,GO RESPONSE TO PEPTIDE HORMONE,4.6597e-05,0.14208,0.15029,1,1
3,GO CELL JUNCTION ASSEMBLY,0.013139,0.1413,0.10827,1,1
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00010462,0.1413,0.20081,1,1
3,GO POSITIVE T CELL SELECTION,0.0050528,0.14109,0.12115,1,1
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.001986,0.14098,0.1829,1,1
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00095906,0.14095,0.13929,1,1
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,4.1617e-05,0.1407,0.14437,1,1
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.01282,0.14066,0.14427,1,1
3,GO RESPONSE TO ESTRADIOL,0.0081404,0.14039,0.10006,1,1
3,GO CELLULAR HOMEOSTASIS,0.00014418,0.14024,0.13347,1,1
3,GO DRUG CATABOLIC PROCESS,0.0049174,0.14022,0.24113,1,1
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0037331,0.14016,0.1111,1,1
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00034072,0.13994,0.12169,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.0067808,0.13966,0.2079,1,1
3,GO REGULATION OF PROTEIN BINDING,0.0013054,0.13966,0.1398,1,1
3,GO MEGAKARYOCYTE DIFFERENTIATION,0.0029794,0.13956,0.11504,1,1
3,GO THIOESTER METABOLIC PROCESS,0.00055855,0.13944,0.19297,1,1
3,GO CALCIUM MEDIATED SIGNALING,9.389e-05,0.13937,0.12187,1,1
3,GO SIGNAL RELEASE,0.00021909,0.13895,0.15515,1,1
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,1.5201e-05,0.1389,0.17196,1,1
3,GO GOLGI RIBBON FORMATION,0.021165,0.13862,0.16506,1,1
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0001547,0.13839,0.14074,1,1
3,GO RESPONSE TO PEPTIDE,0.00012512,0.13838,0.13591,1,1
3,GO GOLGI TO VACUOLE TRANSPORT,0.022165,0.13824,0.14224,1,1
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0071468,0.13808,0.1313,1,1
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010506,0.13791,0.10022,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,2.1663e-05,0.1376,0.1445,1,1
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00055855,0.13754,0.11763,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0064317,0.1375,0.099987,1,1
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.020205,0.13733,0.15826,1,1
3,GO ORGANELLE INHERITANCE,0.023741,0.13722,0.11737,1,1
3,GO SULFATE TRANSPORT,0.050569,0.13709,0.10378,1,1
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00069957,0.13703,0.13053,1,1
3,GO RESPONSE TO OXYGEN LEVELS,0.0014738,0.13702,0.1328,1,1
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.02166,0.13693,0.15517,1,1
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.036948,0.13678,0.085035,1,1
3,GO ACTIVATION OF GTPASE ACTIVITY,0.00090094,0.13641,0.12,1,1
3,GO WATER TRANSPORT,0.026586,0.1364,0.094761,1,1
3,GO REGULATION OF TOR SIGNALING,0.00036427,0.13629,0.12312,1,1
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.024846,0.13597,0.16334,1,1
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.00047456,0.13582,0.2303,1,1
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00026903,0.13581,0.11865,1,1
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.004408,0.13579,0.10726,1,1
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.00098941,0.13501,0.12831,1,1
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.0021062,0.135,0.13512,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0022992,0.13489,0.17093,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION,5.6174e-05,0.13487,0.12616,1,1
3,GO DNA CATABOLIC PROCESS,0.00057693,0.13416,0.12943,1,1
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.0016129,0.13406,0.11041,1,1
3,GO REGULATION OF CELL DEATH,0.00029782,0.134,0.12204,1,1
3,GO CARNITINE SHUTTLE,0.0028957,0.13391,0.22747,1,1
3,GO REGULATION OF PROTEIN DEACETYLATION,0.029719,0.13361,0.12753,1,1
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0017641,0.13353,0.1243,1,1
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00030804,0.13347,0.16692,1,1
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.00013917,0.13326,0.14468,1,1
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.011326,0.13283,0.094365,1,1
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.017549,0.13279,0.077676,1,1
3,GO GLUTATHIONE METABOLIC PROCESS,0.012203,0.13244,0.24449,1,1
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.011047,0.13238,0.11705,1,1
3,GO FEEDING BEHAVIOR,0.0079323,0.13201,0.13285,1,1
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00024286,0.13193,0.1267,1,1
3,GO RESPONSE TO ABIOTIC STIMULUS,0.00050664,0.13177,0.11086,1,1
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00047456,0.13141,0.15431,1,1
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0015189,0.13123,0.11802,1,1
3,GO NEGATIVE REGULATION OF SECRETION,0.0011549,0.13109,0.11943,1,1
3,GO REGULATION OF PROTEIN STABILITY,0.00036427,0.12998,0.12468,1,1
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.011326,0.12997,0.14206,1,1
3,GO IN UTERO EMBRYONIC DEVELOPMENT,0.013798,0.1297,0.075315,1,1
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.00018427,0.12961,0.13645,1,1
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00098941,0.12911,0.11845,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0028141,0.12892,0.14213,1,1
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.0073363,0.12868,0.094897,1,1
3,GO POLYOL METABOLIC PROCESS,0.0010206,0.12844,0.14343,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0025817,0.12836,0.16079,1,1
3,GO APOPTOTIC PROCESS,0.00019753,0.12818,0.12567,1,1
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.030383,0.12802,0.16605,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0066042,0.12758,0.15272,1,1
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00057693,0.12743,0.17123,1,1
3,GO REGULATION OF MUSCLE CONTRACTION,0.017137,0.12679,0.094778,1,1
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.0027346,0.12654,0.12164,1,1
3,GO MAINTENANCE OF LOCATION IN CELL,0.00059588,0.12617,0.12532,1,1
3,GO PIGMENT CELL DIFFERENTIATION,0.049546,0.1261,0.084858,1,1
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023741,0.12603,0.093448,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0049174,0.1259,0.11326,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0042883,0.12519,0.15714,1,1
3,GO RESPONSE TO GROWTH FACTOR,0.024846,0.12497,0.078586,1,1
3,GO MYELOID CELL DEVELOPMENT,0.012508,0.12477,0.11354,1,1
3,GO MESONEPHROS DEVELOPMENT,0.0083534,0.12443,0.13644,1,1
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.016339,0.12439,0.091701,1,1
3,GO REGULATION OF AUTOPHAGY,0.00014935,0.12429,0.13329,1,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.011326,0.12406,0.15294,1,1
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.03939,0.12385,0.136,1,1
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.023205,0.12372,0.11322,1,1
3,GO REGULATION OF VACUOLE ORGANIZATION,0.0067808,0.12371,0.13621,1,1
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.0019282,0.12339,0.11468,1,1
3,GO IMPORT INTO CELL,0.024288,0.12322,0.11372,1,1
3,GO SOMITOGENESIS,0.0037331,0.12298,0.13168,1,1
3,GO MITOPHAGY,0.036948,0.12296,0.12414,1,1
3,GO ORGANIC CATION TRANSPORT,0.0049174,0.12273,0.20437,1,1
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.04854,0.12267,0.13398,1,1
3,GO RESPONSE TO INTERLEUKIN 4,0.0060989,0.12263,0.13894,1,1
3,GO POSITIVE REGULATION OF MYELINATION,0.02166,0.12259,0.11637,1,1
3,GO REGULATION OF PHOSPHORYLATION,0.0006154,0.12219,0.114,1,1
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.036164,0.12207,0.10394,1,1
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.054842,0.12176,0.090207,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0030654,0.12172,0.11667,1,1
3,GO CERAMIDE TRANSPORT,0.053746,0.12154,0.21531,1,1
3,GO RESPONSE TO OXYGEN RADICAL,0.0053338,0.12127,0.17081,1,1
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.00054072,0.12109,0.17824,1,1
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.0051916,0.121,0.10426,1,1
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.03939,0.12098,0.12658,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.0073363,0.12093,0.11049,1,1
3,GO ADHERENS JUNCTION ORGANIZATION,0.029068,0.12089,0.12716,1,1
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.0010206,0.12075,0.16753,1,1
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.00098941,0.12047,0.12075,1,1
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0075304,0.11992,0.11329,1,1
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0013872,0.11985,0.16654,1,1
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0059384,0.11959,0.1456,1,1
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00026903,0.11943,0.16237,1,1
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0011549,0.11936,0.11635,1,1
3,GO TOR SIGNALING,7.547e-05,0.11887,0.10888,1,1
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0083534,0.11867,0.10382,1,1
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00353,0.11847,0.12674,1,1
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.023205,0.11835,0.13381,1,1
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.041967,0.11828,0.16323,1,1
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0029794,0.11771,0.11603,1,1
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.007729,0.11766,0.10212,1,1
3,GO PROTEIN AUTOPHOSPHORYLATION,0.0028141,0.11763,0.10048,1,1
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0016129,0.11681,0.1026,1,1
3,GO POSITIVE REGULATION OF CELL GROWTH,0.0097392,0.11633,0.086744,1,1
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00040247,0.1163,0.10852,1,1
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0022992,0.11591,0.11806,1,1
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0081404,0.11561,0.13309,1,1
3,GO LYMPH NODE DEVELOPMENT,0.019739,0.11534,0.15762,1,1
3,GO RESPONSE TO SALT,0.023741,0.1153,0.11223,1,1
3,GO ANATOMICAL STRUCTURE MATURATION,0.001228,0.11518,0.11527,1,1
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.02166,0.11503,0.092311,1,1
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.001228,0.11491,0.1113,1,1
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00092958,0.11476,0.10293,1,1
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0057817,0.11467,0.13684,1,1
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.00052342,0.11464,0.10958,1,1
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.03939,0.11443,0.10894,1,1
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.012203,0.11428,0.11285,1,1
3,GO REGULATION OF METAL ION TRANSPORT,0.026586,0.11417,0.079715,1,1
3,GO SENSORY PERCEPTION,0.0017641,0.11367,0.092897,1,1
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0024367,0.11358,0.10608,1,1
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.014841,0.11344,0.16623,1,1
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00049035,0.11343,0.11131,1,1
3,GO BLASTOCYST DEVELOPMENT,0.0010206,0.11307,0.11333,1,1
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.0081404,0.11165,0.17253,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.035393,0.11159,0.15423,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.02166,0.1111,0.071085,1,1
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.029719,0.11102,0.1039,1,1
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.037747,0.11075,0.1397,1,1
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.047551,0.11068,0.10652,1,1
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0081404,0.11012,0.18066,1,1
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0071468,0.10996,0.14214,1,1
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.00050664,0.10995,0.13154,1,1
3,GO MUSCLE CELL DIFFERENTIATION,0.024846,0.10845,0.085869,1,1
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0025817,0.10822,0.15187,1,1
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0085714,0.10753,0.12753,1,1
3,GO POLYOL CATABOLIC PROCESS,0.011326,0.10744,0.13538,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0038387,0.10721,0.090593,1,1
3,GO ELECTRON TRANSPORT CHAIN,0.0046564,0.10666,0.18691,1,1
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0099891,0.1066,0.071774,1,1
3,GO BODY FLUID SECRETION,0.012508,0.10641,0.099181,1,1
3,GO ENDOSOMAL TRANSPORT,0.00072223,0.10628,0.096939,1,1
3,GO FERTILIZATION,0.0051916,0.10607,0.088828,1,1
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.025414,0.10547,0.088727,1,1
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.024288,0.10529,0.11032,1,1
3,GO REPRODUCTION,0.0025083,0.10525,0.089921,1,1
3,GO MULTI ORGANISM PROCESS,0.0060989,0.10516,0.076833,1,1
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.02166,0.10376,0.088254,1,1
3,GO OOGENESIS,0.031059,0.1032,0.080946,1,1
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0025083,0.10292,0.088741,1,1
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0081404,0.10234,0.11803,1,1
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0054795,0.1008,0.10076,1,1
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0019282,0.10037,0.1049,1,1
3,GO DEPHOSPHORYLATION,0.0031536,0.098729,0.079848,1,1
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.02068,0.098559,0.15302,1,1
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0017641,0.098318,0.10308,1,1
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.030383,0.098234,0.076076,1,1
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0057817,0.09707,0.13163,1,1
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.046579,0.096891,0.064257,1,1
3,GO NEGATIVE REGULATION OF SIGNALING,0.0085714,0.09689,0.084201,1,1
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0087944,0.096829,0.11139,1,1
3,GO NEURON DEATH,0.023741,0.096396,0.062775,1,1
3,GO PROTEIN STABILIZATION,0.018836,0.096232,0.083834,1,1
3,GO PEPTIDYL SERINE MODIFICATION,0.023205,0.096006,0.063863,1,1
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.040234,0.09592,0.091336,1,1
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.019283,0.095849,0.069404,1,1
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.0025817,0.094984,0.09485,1,1
3,GO REGULATION OF GROWTH,0.042857,0.093759,0.063435,1,1
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.024288,0.093507,0.080662,1,1
3,GO CYTOSOLIC TRANSPORT,0.0032441,0.093116,0.09783,1,1
3,GO VESICLE LOCALIZATION,0.0099891,0.092571,0.10122,1,1
3,GO JNK CASCADE,0.0030654,0.092536,0.11521,1,1
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00353,0.092302,0.088702,1,1
3,GO POSITIVE REGULATION OF GROWTH,0.050569,0.09122,0.060543,1,1
3,GO REGULATION OF CELLULAR LOCALIZATION,0.010773,0.091084,0.064696,1,1
3,GO REGULATION OF JUN KINASE ACTIVITY,0.02843,0.090975,0.09425,1,1
3,GO POTASSIUM ION TRANSPORT,0.031059,0.090727,0.1234,1,1
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0045306,0.090648,0.093154,1,1
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.015953,0.090492,0.14968,1,1
3,GO ACTIN FILAMENT BASED PROCESS,0.047551,0.09046,0.060824,1,1
3,GO ACTIN FILAMENT ORGANIZATION,0.022165,0.089571,0.076619,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.03939,0.089488,0.084978,1,1
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0069616,0.089457,0.084674,1,1
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0073363,0.088701,0.11793,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.02166,0.087581,0.063673,1,1
3,GO NEGATIVE REGULATION OF TRANSPORT,0.0087944,0.087406,0.088532,1,1
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.03939,0.087039,0.054701,1,1
3,GO PIGMENT GRANULE ORGANIZATION,0.026586,0.086564,0.098272,1,1
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.045624,0.086024,0.19985,1,1
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.054842,0.085639,0.045393,1,1
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.011612,0.085515,0.10204,1,1
3,GO RESPONSE TO CAMP,0.031059,0.085101,0.10399,1,1
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.041967,0.085082,0.074056,1,1
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.015953,0.08426,0.11682,1,1
3,GO MITOCHONDRIAL TRANSPORT,0.012508,0.084216,0.079493,1,1
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.055956,0.082437,0.065975,1,1
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.011326,0.081128,0.077332,1,1
3,GO REGULATION OF EXOCYTOSIS,0.015203,0.081075,0.11755,1,1
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0041716,0.079987,0.074886,1,1
3,GO ENSHEATHMENT OF NEURONS,0.052669,0.077014,0.093996,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.020205,0.076296,0.063424,1,1
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.042857,0.075989,0.063899,1,1
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.024846,0.071007,0.04986,1,1
3,GO INTRACELLULAR TRANSPORT,0.0036303,0.069899,0.07034,1,1
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.050569,0.069697,0.060611,1,1
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.014138,0.069433,0.06277,1,1
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.029719,0.069368,0.054717,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.024846,0.068846,0.09338,1,1
3,GO MALE GAMETE GENERATION,0.038561,0.06868,0.056067,1,1
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.009256,0.067731,0.058529,1,1
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.050569,0.067584,0.07392,1,1
3,GO POSITIVE REGULATION OF CELL CYCLE,0.042857,0.065903,0.054056,1,1
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.022165,0.065756,0.086851,1,1
3,GO SEXUAL REPRODUCTION,0.017549,0.064668,0.060896,1,1
3,GO REGULATION OF GTPASE ACTIVITY,0.016734,0.064284,0.07873,1,1
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.018398,0.06318,0.07845,1,1
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0057817,0.06215,0.064575,1,1
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.030383,0.061281,0.083602,1,1
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.037747,0.06094,0.064436,1,1
3,GO GAMETE GENERATION,0.03939,0.058099,0.053382,1,1
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0036303,0.057519,0.087337,1,1
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.049546,0.056497,0.051487,1,1
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.037747,0.050038,0.049854,1,1
4,GO FOREBRAIN NEURON FATE COMMITMENT,2.0033e-05,0.73192,0.87575,1,1
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0023671,0.56017,0.44578,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.9801e-06,0.55173,0.50333,1,1
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.001986,0.51584,0.40296,1,1
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,9.7801e-06,0.42961,0.42688,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00035231,0.37051,0.36539,1,1
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0062634,0.34268,0.38577,1,1
4,GO THALAMUS DEVELOPMENT,0.010773,0.32591,0.2592,1,1
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.0057817,0.31895,0.27221,1,1
4,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,5.6174e-05,0.30278,0.46527,1,1
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.014138,0.27628,0.26023,1,1
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.009256,0.26035,0.22544,1,1
4,GO KINETOCHORE ORGANIZATION,0.0010859,0.25256,0.21653,1,1
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0015653,0.247,0.21634,1,1
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.23977,0.22439,1,1
4,GO MRNA SPLICE SITE SELECTION,6.2786e-05,0.23498,0.26471,1,1
4,GO V D J RECOMBINATION,0.0025083,0.22829,0.2371,1,1
4,GO VIRAL LATENCY,0.0057817,0.2272,0.18246,1,1
4,GO KINETOCHORE ASSEMBLY,0.0036303,0.21244,0.1824,1,1
4,GO HISTONE H4 K16 ACETYLATION,7.013e-05,0.20893,0.21446,1,1
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.015574,0.20253,0.21156,1,1
4,GO CHROMATIN REMODELING AT CENTROMERE,0.00081984,0.20199,0.19604,1,1
4,GO HISTONE H2A MONOUBIQUITINATION,3.5759e-05,0.19936,0.22881,1,1
4,GO DENDRITIC TRANSPORT,0.015953,0.19529,0.1869,1,1
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0056288,0.19042,0.15185,1,1
4,GO MITOTIC DNA REPLICATION CHECKPOINT,0.011047,0.18921,0.13824,1,1
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0094949,0.18427,0.13809,1,1
4,GO CENTROMERE COMPLEX ASSEMBLY,0.0010859,0.1826,0.18466,1,1
4,GO SINGLE STRAND BREAK REPAIR,0.011612,0.18037,0.14414,1,1
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.035393,0.17925,0.14575,1,1
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00012512,0.17735,0.19558,1,1
4,GO HISTONE H4 K5 ACETYLATION,0.00019753,0.17219,0.22065,1,1
4,GO REGULATION OF SISTER CHROMATID COHESION,0.0027346,0.17143,0.16066,1,1
4,GO GENETIC IMPRINTING,0.0028141,0.17101,0.1877,1,1
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.02268,0.16964,0.14731,1,1
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00065623,0.16926,0.16169,1,1
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0021689,0.16217,0.1571,1,1
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00090094,0.16197,0.16195,1,1
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.0042883,0.16081,0.18134,1,1
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.02068,0.15991,0.14099,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00081984,0.15959,0.151,1,1
4,GO RESPONSE TO HYDROXYUREA,0.010245,0.15834,0.184,1,1
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.0049174,0.15646,0.17189,1,1
4,GO ACROSOME ASSEMBLY,0.052669,0.1562,0.11135,1,1
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.02843,0.1525,0.13344,1,1
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0094949,0.15239,0.1655,1,1
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.011904,0.15061,0.12489,1,1
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.010773,0.1449,0.13328,1,1
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.02166,0.14457,0.092113,1,1
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0028141,0.1445,0.18799,1,1
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0083534,0.14327,0.11782,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.019739,0.14304,0.13259,1,1
4,GO DNA REPLICATION CHECKPOINT,0.02068,0.14289,0.11185,1,1
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0007696,0.14262,0.15124,1,1
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0040578,0.14194,0.116,1,1
4,GO HISTONE H2A UBIQUITINATION,0.0017123,0.14189,0.14466,1,1
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.0079323,0.14171,0.13958,1,1
4,GO CENTROSOME DUPLICATION,0.001986,0.14114,0.13301,1,1
4,GO MITOTIC CHROMOSOME CONDENSATION,0.001872,0.1411,0.17772,1,1
4,GO CENTRIOLE ASSEMBLY,0.00353,0.13945,0.11742,1,1
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0019282,0.13856,0.11389,1,1
4,GO DOSAGE COMPENSATION,0.0031536,0.13802,0.12128,1,1
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00020448,0.13743,0.1466,1,1
4,GO HISTONE H2A ACETYLATION,0.0022992,0.13688,0.15963,1,1
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.023741,0.13621,0.15554,1,1
4,GO REGULATION OF CILIUM ASSEMBLY,0.0057817,0.13062,0.11455,1,1
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0019282,0.12899,0.11682,1,1
4,GO POST ANAL TAIL MORPHOGENESIS,0.03245,0.12724,0.11595,1,1
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.009256,0.12664,0.1551,1,1
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0079323,0.12632,0.23323,1,1
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.0037331,0.12422,0.12922,1,1
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.017969,0.12062,0.145,1,1
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.00098941,0.11954,0.133,1,1
4,GO HISTONE H4 ACETYLATION,0.00044439,0.11655,0.12092,1,1
4,GO DNA STRAND ELONGATION,0.0081404,0.11409,0.12012,1,1
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0060989,0.11323,0.10197,1,1
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.013798,0.11285,0.12274,1,1
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0024367,0.11267,0.13829,1,1
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.04854,0.11256,0.073081,1,1
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.019739,0.11248,0.14007,1,1
4,GO HISTONE MONOUBIQUITINATION,0.00047456,0.11174,0.12935,1,1
4,GO NUCLEOSOME ASSEMBLY,0.0049174,0.11165,0.13647,1,1
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.0073363,0.11063,0.13981,1,1
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.0047853,0.10959,0.11747,1,1
4,GO G0 TO G1 TRANSITION,0.0033369,0.1072,0.13291,1,1
4,GO PEPTIDYL LYSINE ACETYLATION,0.0012662,0.10704,0.08635,1,1
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.041967,0.10456,0.13158,1,1
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0057817,0.10436,0.086338,1,1
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.017137,0.10403,0.088365,1,1
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.055956,0.099741,0.10261,1,1
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0014299,0.098336,0.114,1,1
4,GO CELL CYCLE DNA REPLICATION,0.03245,0.094995,0.078337,1,1
4,GO HISTONE H3 K4 METHYLATION,0.0069616,0.092819,0.13187,1,1
4,GO PROTEIN ACETYLATION,0.004408,0.091896,0.06502,1,1
4,GO NUCLEOSOME ORGANIZATION,0.0090226,0.09049,0.096242,1,1
4,GO PEPTIDYL LYSINE METHYLATION,0.0085714,0.085453,0.088612,1,1
4,GO RECOMBINATIONAL REPAIR,0.017549,0.081364,0.065194,1,1
4,GO INTERSTRAND CROSS LINK REPAIR,0.0059384,0.080915,0.089999,1,1
4,GO REGULATION OF MRNA PROCESSING,0.042857,0.080296,0.068197,1,1
4,GO HISTONE EXCHANGE,0.012203,0.079558,0.10728,1,1
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.017969,0.076051,0.11087,1,1
4,GO CHROMOSOME SEGREGATION,0.025994,0.073111,0.055105,1,1
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.01282,0.07068,0.08865,1,1
4,GO CELL CYCLE CHECKPOINT,0.011326,0.066261,0.058079,1,1
4,GO PEPTIDYL LYSINE MODIFICATION,0.033166,0.066025,0.043682,1,1
4,GO HETEROCHROMATIN ORGANIZATION,0.0067808,0.065941,0.093481,1,1
4,GO REGULATION OF DNA REPAIR,0.036164,0.065502,0.056553,1,1
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.035393,0.059419,0.049952,1,1
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.033894,0.058823,0.070184,1,1
4,GO SISTER CHROMATID SEGREGATION,0.014841,0.057264,0.071304,1,1
4,GO DNA PACKAGING,0.0042883,0.057153,0.091516,1,1
4,GO DNA INTEGRITY CHECKPOINT,0.031059,0.055933,0.048829,1,1
4,GO PROTEIN MONOUBIQUITINATION,0.041093,0.055354,0.056463,1,1
4,GO DNA CONFORMATION CHANGE,0.041093,0.053238,0.05452,1,1
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.030383,0.05044,0.050679,1,1
4,GO CHROMATIN ORGANIZATION,0.013139,0.049741,0.051725,1,1
4,GO REGULATION OF RNA SPLICING,0.042857,0.048391,0.051909,1,1
